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I INTRODUCTION 
 
 
I.1 Plant molecular farming 
 
Plant molecular farming (PMF) is the production of pharmaceutically important and 
commercially valuable proteins in plants (Franken et al., 1997). It exploits heterologous 
protein expression systems, such as plants, for the large-scale production of recombinant 
proteins that are therapeutically valuable, industrial enzymes, diagnostic and technical 
proteins.  
 
I.1.1 Plant made pharmaceuticals (PMP) 
The recombinant production of pharmaceuticals in plants is expected to challenge already 
established production technologies that currently are bacterial fermentation (Escherichia 
coli), yeast cell cultures (Saccharomyces cerevisiae, Pichia pastoris), insect cells, or 
mammalian cell cultures (NS0, BHK, CHO), for several reasons. First of all, molecular 
farming in plants provides an inexpensive and convenient way to produce 
biopharmaceutical molecules on a large scale. Using open-field cultivation, transgenic 
plants have superior advantages over all established expression systems in terms of capacity, 
flexibility, scalability, and production costs (Boehm, 2007). In fact, production of PMPs in 
whole plants needs simple and inexpensive inputs like sunlight, water and nutrients, it 
enables unsophisticated and rapid increase of production through increasing the area put to 
seed, and low technology harvest and processing for production of pharmaceuticals (Rigano 
and Walmsley, 2005). Therefore, the use of transgenic plants could be a valid solution to the 
need for a scale-up in the production capacity of recombinant proteins. 
Another fundamental advantage of plants is the range and diversity of recombinant 
molecules that they can potentially produce. As higher eukaryotes, plants are able to 
synthesize small peptides, polypeptides and complex multimeric proteins, many of which 
cannot be made in microbial systems (Ma et al., 2003). For many molecules, such as 
antibodies, the presence of plant chaperones that are homologous to those in mammalian 
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cells is an important factor, as these chaperones control the efficiency of protein assembly 
and the extent of protein degradation. In addition, targeting recombinant proteins to the 
plant secretory pathway ensures that N-glycosylation and other post-translational 
modifications take place.  
Unlike microbial or mammalian cell culture systems, plants ensure production of safe 
biopharmaceuticals, because they lack human pathogens, oncogenic DNA sequences, 
prions, and endotoxins (Commandeur et al., 2003).  
Moreover, recombinant pharmaceutical proteins can be expressed in definite compartments 
or even targeted to storage organs such as seeds, where they remain stable for months at 
ambient temperatures, enormously reducing the costs of storage and distribution (Stoger et 
al., 2000). 
Furthermore, plants can be exploited not only as production platforms for pharmaceutical 
proteins, but also as delivery systems for certain products when the plant tissue containing 
the recombinant protein is used as food, making extensive purification unnecessary and 
dramatically cutting down production costs (Lal et al., 2007). 
Many pharmaceutical proteins of mammalian origin have been synthesized in plants. These 
range from blood products, such as human serum albumin for which there is an annual 
demand of more than 500 tonnes, to cytokines and other signaling molecules that are 
required in much smaller amounts (Giddings et al., 2000). Several full size 
immunoglobulines, secretory antibodies and further antibody derivatives have been 
expressed successfully in plants, including scFvs, diabodies, and antibody-fusion proteins 
(Ma et al., 2003 and references therein; Lienard et al., 2007). In the past 15 years, 
plant-made vaccines have also gained a lot of attention, and a long list of antigens that 
includes viral (Mason et al., 1996; Meyers et al., 2008; Santi et al., 2008), bacterial 
(Brennan et al., 1999; Walmsley et al., 2003; Frutos et al., 2008), enteric (Mason et al., 
1998; Tacket, 2005) and nonenteric pathogen antigens (Mason et al., 1992; Lou et al., 2007) 
as well as autoimmune antigens (Fitchen et al., 1995; Avesani et al., 2003; Wang et al., 
2008b) have been expressed in different plant and expression systems. 
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I.1.2 Edible vaccines 
Problems with current vaccines include the need for multiple doses and boosters, the 
dependence on a functional cold chain and the potential infection hazards associated with 
unsafe injections. These problems are recognized by international agencies as a generic 
global barrier preventing the efficient delivery of all vaccines to those in developing 
countries with poor infrastructures (Tregoning et al., 2005). In response to these problems 
there has been increased interest in vaccination regimes that can be delivered without 
needles and have reduced dependence on the cold chain. One possible solution is to develop 
practical mucosal vaccines. Of particular relevance in the developing world is the 
development of vaccines expressed in plants.  
Plant systems offer the oral delivery option of pharmaceuticals aimed at mucosal 
immunization or tolerance, overcoming the cost and inconvenience of injection of vaccines 
(Yusibov et al., 2002). In fact, plants are ideal not only as bioreactors but also as delivery 
systems for pharmaceuticals, given that the rigid cell walls protect the recombinant protein 
from the acidic environment in the stomach (Kong et al., 2001) and enable intact antigen to 
reach the gut-associated lymphoid tissue (GALT) (Rigano et al., 2003). Because protein 
purification costs can outweigh the economic advantage of any production system, the 
additional advantage of using transgenic plants for oral tolerance is that they allow to avoid 
extensive purification. Therefore, PMPs could undoubtedly assist vaccine programs in 
developing countries by simplifying immunization regimens and tremendously reducing the 
costs of vaccine production, purification, storage and administration (Nochi et al., 2007). In 
the beginning, consumption of antigen-bearing fruit and vegetables was proposed for this 
purpose. Considerations and hesitation about the regulatory requirements such as 
consistency between lots and uniformity of dosage have resulted in a refinement of the 
concept of “edible vaccines”. In fact, edible vaccines, as regulated products, would require 
controlled delivery of standardized doses, so some level of processing of the edible plant 
material would be required. This will not include complex purification, but is more likely to 
involve simple and inexpensive food processing techniques that are readily available, such 
as freeze drying, and batch processing (Ma et al., 2005). Therefore, if some regulatory 
issues like homogeneous vaccine dose per gram fresh weight can be solved satisfactorily, 
plant-derived vaccines will hold many promises for safe and cost-effective mass 
immunization of mankind much more than any other production system (Boehm, 2007). 
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Antigens already expressed as components of experimental plant-based vaccines include the 
B subunit of E. coli heat-labile enterotoxin (LTB) (Kim et al., 2007), Norwalk virus-like 
particles (Tacket et al., 2000) and hepatitis B surface antigen (Kong et al., 2001).  
 
I.1.3 Plant expression strategies 
I.1.3.1 Stable nuclear transformation  
The most common approach to produce heterologous proteins in plants, that is applicable to 
a wide range of species, is to use agrobacteria or biolistics to generate stably transformed 
plants (Davey et al., 1989; Gelvin, 2003). Agrobacterium-mediated plant transformation at 
the moment is one of the most applicable and widespread methods of foreign genetic 
material transfer into plant cells. Extensive studies in the past years resulted in 
establishment of highly-effective recombinant Agrobacterium strains, vectors and protocols 
and considerably extended the range of hosts (Gelvin, 2003). By this method, recombinant 
gene sequences are integrated in the host plant’s nuclear genome, and this approach can be 
routinely applied, even to complex multisubunit proteins, such as secretory antibodies (Ma 
et al., 1995). 
Microparticle bombardment technologies were developed to circumvent the problems of 
incompatibility between tissues of many plant species, mainly monocotyledons, and the 
Agrobacterium vector (Smith et al., 2001). Conversely to agrotransformation, integration of 
exogenous DNA into the plant’s genetic material following particle bombardment results in 
the majority of the cases in complex multicopy integrations and broken transgene 
integration (Christou, 1997; Finer et al., 1999; Smith et al., 2001). As there is evidence for 
correlation between increasing transgene copy number and transgene silencing (Taylor and 
Fauquet, 2002), enhanced Agrobacterium transformation systems are being developed for 
the major cereal crops, such as rice (Hiei and Komari, 2008; Sripriya et al., 2008), maize 
(Vega et al., 2008), wheat (Risacher et al., 2009; Wu et al., 2009), barley (Bartlett et al., 
2008; Harwood et al., 2009), sorghum (Howe et al., 2006; Gurel et al., 2009) and oat 
(Gasparis et al., 2008), to overcome the drawbacks associated with biolistics transformation.  
Transgenic plants require a rather long time for the generation and characterization of 
production lines and the generation of a sufficient amount of seed material. However, once 
this bottleneck is overcome, an almost unlimited and sustainable production capacity can be 
                                                                                                                                Introduction 
 5 
reached using the established agricultural infrastructure in open-field or in greenhouses 
(Boehm, 2007). Stable integration of the transgene into the plant nuclear genome results in 
foreign protein levels usually not higher than 1 % of total soluble protein (TSP), although 
sometimes it reaches higher means if special strategies boosting gene expression and/or 
product accumulation have been applied. The major disadvantage of stable nuclear 
transformation is that the expression level of each gene is variable and difficult to control, 
because the integrated nuclear transgenes are highly sensitive to the surrounding chromatin 
environment, and there are also some regulatory concerns over the containment of nuclear 
transformed plants of which changes are inherited to new generations (Streatfield, 2006). 
 
I.1.3.2 Transient expression  
Transient gene expression systems in plants have several advantages over the generation of 
stably transformed transgenic plants. Transient expression is rapid and results on protein 
expression can be obtained within days (Kapila et al., 1997). This makes transient 
expression also suitable for verifying that the gene product is functional before moving on 
to the time-consuming generation of stable transgenic plants. A number of DNA transfer 
techniques, such as electroporation or particle bombardment, have been used for transient 
assays in plant tissue (To et al., 1996; Seki et al., 1999), but the two major transient 
expression systems to deliver a gene to a plant cell are either infiltration of intact tissue with 
recombinant agrobacteria (agroinfiltration), or infection with modified viral vectors. 
Agroinfiltration uses recombinant Agrobacterium tumefaciens infiltrated into plant tissue. 
The transferred T-DNA does not integrate into the host chromosome but is present in the 
nucleus, where it is transcribed, and this leads to transient expression of the gene of interest 
which does not suffer from position effects (Kapila et al., 1997). Multiple genes, present in 
different populations of agrobacteria, can also be simultaneously expressed (Vaquero et al., 
1999). It is a fast and flexible system, but it lacks the increases in production volume that 
can be achieved easily with stable transgenic plants (Sheludko, 2008). 
Production of pharmaceuticals using plant viral vectors is also a very promising strategy 
(Pogue et al., 2002; Yusibov et al., 2006). To date, the most efficient means of achieving 
high level transient expression of foreign proteins in plants has involved the use of vectors 
based on RNA plant viruses (Giritch et al., 2006; Lindbo, 2007). Plant viruses are not 
infectious in humans or animals and can accumulate large quantities of heterologous 
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proteins in the plants. Two major strategies are ‘full virus’, which allows expression of large 
fusion proteins in the viral capsid, and a developing approach of ‘deconstructed virus’, 
which relies on Agrobacterium as a vector to deliver DNA of one or more viral RNA 
replicons to plant cells (Marillonnet et al., 2004; Gleba et al., 2007). Recently, a virus-based 
system that does not rely on viral replication has also been described (Sainsbury and 
Lomonossoff, 2008), that overcomes some of the major limitation of virus-mediated 
transgene expression, such as the issue of biocontainment and the restrictions on the size of 
the insert that can be accommodated without affecting replication.  
 
I.1.3.3 Plastid transformation 
A fast developing and promising technology in the PMF scenario is the synthesis of 
biopharmaceuticals and vaccines in plastids (Daniell, 2006). Owing to the polyploidy of the 
plastid genetic system with thousands of genome copies per cell, extraordinarily high levels 
of foreign protein accumulation can be achieved in chloroplasts (McBride et al., 1995; De 
Cosa et al., 2001), making transgenic plastids ideal expression factories for high-yield 
protein production (Bock, 2001). Besides the potential for high-level production of foreign 
proteins, other attractions of the technology include its effectiveness as a high-precision 
genetic engineering technique – owing to transgene integration exclusively via homologous 
recombination – , the absence from plastids of epigenetic effects and gene silencing 
mechanisms, and the increase in transgene containment provided by the maternal mode of 
chloroplast inheritance in most crop plants, which largely excludes chloroplasts from pollen 
transmission (Bock, 2007; Ruf et al., 2007). The major restrictions of using chloroplast 
transformation for production of recombinant proteins is the limited number of hosts in 
which the technique is routine, nowadays mostly tobacco and more recently tomato (Ruf et 
al., 2001; Zhou et al., 2008), carrot (Kumar et al., 2004) and lettuce (Lelivelt et al., 2005; 
Kanamoto et al., 2006), and the lack in the plastids of post-translational modifications such 
as N-glycosylation, that is strictly connected to and required for the stability, structural 
authenticity and functionality of some pharmaceuticals. 
 
I.1.4 Optimization of recombinant protein expression in plants 
The purpose of plant molecular farming is to produce large amounts of an active, safe 
pharmaceutical protein at an affordable price. Therefore, the development of an optimized 
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expression system and its scale up to economic levels of production are crucial stages. To 
achieve high yields, expression construct design must optimize all stages of gene 
expression, from transcription to protein stability. 
For high-level transcription, the two most important elements are the promoter and the 
polyadenylation site, which are often derived from the 35S transcript of the Cauliflower 
mosaic virus (CaMV) for dicotyledonous plants (Kay et al., 1987) or the maize ubiquitin-1 
gene for monocotyledonous plants (Christensen and Quail, 1996). Codon optimization, 
bringing the transgene codon usage in line with that of the host, might also result in 
increased accumulation levels of the recombinant protein (Adang et al., 1993). Other factors 
that influence transgene expression, including the position of transgene integration, the 
structure of the transgenic locus and the gene-copy number, cannot be controlled precisely 
through construct design, and several strategies have been adopted in the attempt to 
minimize variation in transgene expression. For example, surrounding the expression 
cassette by scaffold attachment regions (Breyne et al., 1992) or using viral genes to suppress 
gene silencing (Anandalakshmi et al., 1998) can notably increase transgene expression 
levels and minimize position effects (Butaye et al., 2004). 
One of the most important factors governing the yield of recombinant proteins is subcellular 
targeting, which strongly affects the interlinked processes of folding, assembly and 
post-translational modification. The intracellular targeting of the recombinant protein is of 
great influence to protein yield and its biological properties mainly for two reasons. First, 
the subcellular environment in which the recombinant protein is synthesized is crucial for its 
correct folding and, usually, the more similar the environment to the native location, the 
more likely the protein will acquire the correct conformation and be functional. Second, 
proteolysis of the recombinant protein by host proteases and interferences between the 
recombinant molecule and the host molecular function may also lead to severe drawbacks 
and prevent to reach satisfactory accumulation levels (Barbante et al., 2008). At the current 
state of the art, the targeting of all intracellular compartments is feasible using known signal 
sequences that can be fused to the target gene. The cellular locations that have been tested 
and compared for foreign protein production include the cytosol, the endoplasmic reticulum 
(ER), the apoplast, the vacuole and the chloroplast. In comparative studies performed in 
tobacco (Fischer et al., 1999; Schillberg et al., 1999; Stoger et al., 2002) or rice (Torres et 
al., 1999), ER targeting gave rise to the highest yield of biologically active protein, most 
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likely due to the presence of chaperones, protein-disulfide isomerase, glycosylation 
enzymes and a reducing environment that favors protein stability in this compartment 
(Boehm, 2007). However, this is not the rule, as there is a number of proteins with 
pharmaceutical properties that are not satisfactorily produced in the endomembrane system 
or require the passage through the whole secretory pathway and the post-translational 
modifications therein to be functional (Vitale and Pedrazzini, 2005). A promising strategy to 
further increase protein stability in the unfavorable cytosolic and apoplastic environments, is 
to anchor the recombinant protein to the cytosolic face of the ER or to the outer side of the 
plasma membrane, and has already been successfully exploited (Schillberg et al., 2000; 
Barbante et al., 2008). Employing this strategy, interference of the recombinant protein with 
the host cell metabolism is avoided, and moreover the recombinant protein is rendered less 
susceptible to proteolytic degradation, leading to an overall increase in accumulation levels. 
In general, the lack of predictability of the best compartment for a given recombinant 
protein, implies a case-by-case experimental evaluation of different targeting strategies.  
 
 
I.1.5 Tobacco as a model system for PMP 
Tobacco is a non-food and non-feed crop that has an established history as a model system 
for molecular farming and is the most widely used species for the production of 
recombinant pharmaceutical proteins at the research laboratory level (Cramer et al., 1999; 
Fischer and Emans, 2000; Sorrentino et al., 2008; Villani et al., 2009). The main advantages 
of tobacco include the mature technology for gene transfer and expression, the high biomass 
yield (more than 100,000 kg per hectare for close-cropped tobacco), the potential for rapid 
scale-up owing to prolific seed production, and the availability of existing large-scale 
infrastructures for processing (Ma et al., 2003). Both nuclear and chloroplast genomes of 
tobacco have been transformed with relative ease. Although many tobacco cultivars produce 
high levels of toxic alkaloids, there are low-alkaloid varieties that can be used for the 
production of pharmaceutical proteins (Fischer and Emans, 2000). 
Recombinant proteins can also be produced in plant cell cultures (Hellwig et al., 2004), and 
tobacco suspension cells are easily generated by the continuous agitation of friable callus 
tissue, which results in a homogeneous suspension of single cells and small clumps. This 
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approach is particularly advantageous when defined and sterile production conditions are 
required together with straightforward purification protocols (Ma et al., 2003). 
 
I.2 Type-1 diabetes mellitus 
Type-1 diabetes mellitus (T1DM) – also called insulin-dependent diabetes mellitus (IDDM) 
or juvenile diabetes – is one of the most common chronic diseases of childhood. It is an 
autoimmune disorder associated, in genetically susceptible individuals, with the generation 
and activation of autoreactive T cells recognizing pancreatic β cell autoantigens. 
Self-reactive CD4+ and CD8+ lymphocytes infiltrate the pancreas (insulitis) and selectively 
destroy the insulin producing β cells in the islets. This destruction occurs silently and 
progressively and may stay undetected for many years. By the time the first clinical 
symptoms become apparent, nearly 80 % of the patients’ β cells have been destroyed and 
there is little hope of curing the disease. It is diagnosed in nearly 0.3% of all children, but 
clinical signs can appear at any age (Kidambi and Patel, 2008). T1DM incidence is growing 
by 3% per year in children and adolescents, and at an alarming 5% per year among 
pre-school children  (International Diabetes Federation 2007).  
It is the cause of severe and debilitating disability in many individuals worldwide. The 
chronic hyperglycemia of diabetes mellitus is associated with long-term damage, 
dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and 
blood vessels (Schuster and Duvuuri, 2002). At present, there is no clinically useful 
preventive measure against developing type 1 diabetes, nor does exist a cure, and people 
that suffer from it must take insulin by injection or insulin pump throughout their life to 
survive, generating also a great deal of health care cost, which is bound to increase with 
time and inflation. Unfortunately, in many parts of the world, insulin is not even available 
because of cost or economic geography (International Diabetes Federation, 2007). 
The principal T1DM-associated autoantigens known to date are insulin itself, the 65 kDa 
isoform of glutamic acid decarboxylase (GAD65) and tyrosine phosphatase-like IA-2. 
Susceptibility to T1DM is genetically determined, as certain alleles of major 
histocompatibility complex (MHC)-loci, are associated with either a high or a low risk to 
develop type-1 diabetes. Although the development of the disease is greatly influenced by 
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environmental factors, the events that lead to the breakdown of self-tolerance to pancreatic 
β cells are still poorly understood (Hanninen, 2000).  
Ideally, autoimmune disease therapies would uniquely target the specific autoreactive 
lymphocyte populations while leaving the rest of the immune system unaltered. 
Traditionally, tolerance has been achieved through the use of anti-inflammatory and 
immunosuppressive drugs, most notably corticosteroids, which must be taken indefinitely. 
Unfortunately, such immunosuppressive regimens non-specifically suppress the entire 
immune system, thus exposing patients to increased risk of infections and cancer. Recent 
efforts aimed at achieving tolerance through elimination of only the pathogenic immune 
response, leaving the other functions of the immune system unperturbed, investigated newer 
and more tailored tolerance therapies, such as the induction of oral tolerance (Wolfraim, 
2006). 
 
I.3 Oral tolerance and the role of T regulatory cells 
Antigens elicit qualitatively distinct immune responses based on their portal of entry, and 
antigens introduced at mucosal surfaces, such as the gastrointestinal tract, often elicit active 
and systemic inhibition of the immune response to those antigens (Mayer and Shao, 2004). 
The gut-associated lymphoid tissue (GALT) is one of the largest and most complex parts of 
the immune system. Not only does it encounter a larger variety of antigens than any other 
part of the organism, it must also discriminate between pathogenic organisms and harmless 
antigens, such as food proteins and commensal bacteria. Most human pathogens enter the 
body through the intestine, and strong immune responses are required to protect this 
essential organ. By contrast, active immunity against nonpathogenic antigens would be 
wasteful, and hypersensitivity responses against dietary antigens or commensal bacteria can 
lead to inflammatory disorders, such as celiac disease and Crohn’s disease, respectively 
(Garside et al., 1999). 
Under normal conditions, immune responses to harmless gut antigens lead to the induction 
of local and systemic immunological tolerance, known as oral tolerance. Oral tolerance can 
also be exploited for therapeutic use, as the induction of antigen-specific systemic 
immunological unresponsiveness by feeding protein antigens represents a simple and 
practical mean to prevent or treat autoimmune diseases and chronic inflammatory 
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conditions, and an attractive alternative to immunosuppressive medical interventions that 
have undesirable side-effects (Wolfraim, 2006). Oral administration of antigens is thought 
to lead to immune tolerance through one of two distinct mechanisms, depending upon dose. 
High doses of orally fed antigen lead to deletion or anergy of Th cells, which may occur 
when the T cell receptor (TCR) engages the major histocompatibility comples 
(MHC)-antigen complex in the absence of proper costimulation, whereas repeated low 
doses lead to the more long lasting induction of T-regulatory (Treg) cells (Wolfraim, 2006).  
One of the several mechanisms developed by the immune system to maintain peripheral 
tolerance is indeed the active suppression of undesired immune responses mediated by Treg 
cells (Battaglia and Roncarolo, 2004). Many different Treg cell subsets have been shown to 
play a central role in intestinal immunity. In particular, the Treg cell subset that plays a role 
in oral tolerance is represented by the T-regulatory type-1 cells (Treg1). Treg1 cells have 
been described both for murine and human animal models (Larche and Wraith, 2005). They 
display a unique profile of cytokine production that is distinct from that of other T cells. The 
main cytokines produced by Treg1 cells are IL-10 and TGF-β, which downregulate immune 
responses mediated by naive and memory T cells.  
 
 
Figure 1: Potential mechanisms of oral tolerance. 
(A) The generation of an immune response requires ligation of the T-cell receptor (TCR) with peptide-MHC 
complexes. In the context of appropriate co-stimulatory molecules (CD80 and CD86) and cytokines, an active 
immune response is generated. (B) However, with high doses of oral antigen, TCR crosslinking can occur in 
the absence of co-stimulation, or concurrently in the presence of inhibitory ligands (CD95 and CD95 ligand, 
CD95L), leading to immunosuppressive responses such as anergy and deletion. (C) Low doses of oral antigen 
lead to the activation of regulatory T cells, which suppress immune responses by cognate interactions, and 
soluble (interleukin-10, IL-10, and transforming growth factor-β, TGF-β) or cell-surface-associated 
suppressive cytokines. R, receptor. (From Mayer and Shao, 2004) 
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Treg1 cells have been extensively characterized and today are considered to be a specialized 
subset of Treg cells able to prevent immune-mediated diseases and to maintain 
immunological tolerance. For example, high doses of IL-10 and repeated TCR stimulation 
are sufficient to induce a population of murine CD4+ cells containing a high number of 
Treg1 cells with the ability to suppress immune responses both in vitro and in vivo in a 
model of inflammatory bowel disease (IBD) (Groux et al., 1996). Moreover, it has been 
shown that oral administration of antigens in combination with IL-10 is one mechanism, 
among many, for the in vivo differentiation of Treg1 cells, and this can be envisaged as a 
novel strategy for oral tolerance induction (Battaglia and Roncarolo, 2004). 
An intriguing feature of Treg1 cells is that, although they can be activated in an 
antigen-specific manner, they can suppress immune responses in the immediate surrounding 
area in an antigen non-specific manner, a phenomenon known as bystander suppression 
(Mayer and Shao, 2004). The ability to control this phenomenon is a potentially powerful 
therapeutic tool for controlling autoimmune/inflammatory conditions. 
Several successful therapeutic trials of oral tolerance induction in animal models have 
supported a limited number of human clinical trials, and, in general, oral tolerance was more 
effective as a prophylactic measure than it was in reversing ongoing diseases. 
Unfortunately, in humans, heterogeneity in the design and results of these trials have made 
efficacy still difficult to discern (reviewed in Mayer and Shao, 2004).  
 
I.3.1 Use of immunoregulatory molecules in oral tolerance induction 
The potential benefits of mucosal autoantigen administration in the treatment or prevention 
of autoimmune diseases are indisputable. In spite of this, the simultaneous induction of 
possibly detrimental immune responses cannot be overlooked, and mucosal tolerance at the 
present may still be a ‘two-edged sword’ with potential hazards that we are not yet able to 
completely control. How can we then be convinced that we are inducing tolerance and only 
tolerance if we give autoantigens via mucosal routes? Ways should be found to efficiently 
control the induction of detrimental immune responses while not blocking the induction of 
tolerance (Hanninen, 2000).  
Several ways of manipulating oral tolerance exist, some of them enhancing and others 
preventing tolerance. A strategy to improve the effect of orally administered antigens is the 
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use of mucosal immunomodulators/adjuvants, that can enhance the oral tolerance of 
co-administered antigens by targeting small amounts of protein antigens to specialized 
antigen-presenting cells of the GALT (Sun et al., 1996). Thus, reduced quantities of the 
co-administered autoantigen would be sufficient to induce oral tolerance. This would 
represent a great advantage, because a major problem recognized with the oral tolerance 
strategy is that it requires feeding large if not massive doses of autoantigens. In particular, a 
combination therapy of an autoantigen along with one or more regulatory anti-inflammatory 
cytokines given orally to enhance protection may represent an important new strategy in the 
prevention of autoimmune diseases for several reasons. First of all, it should establish a 
form of forced manipulation of antigen-specific Th1:Th2 T cell populations, and possibly 
also induce regulatory immunity (Ma et al., 2004). Additionally, being endogenous 
molecules (unlike other mucosal adjuvants like the cholera toxin B subunit (CTB) that is of 
bacterial origin), cytokines should not induce neutralizing antibody responses which could 
limit their usefulness in oral tolerance, particularly if prolonged or repeated administration is 
required to initiate or maintain tolerance (Ma et al., 2004). Moreover, as already mentioned, 
because adjuvants facilitate tolerance induction, their use would lower the required 
quantities of co-administered autoantigens and therefore notably reduce the costs of this 
therapeutic or prophylactic approach. 
I.4 Interleukin-10 
The anti-inflammatory cytokine interleukin-10 (IL-10), is a multifunctional Th2-type 
cytokine with diverse effects on most hemopoietic cell types (Sprang and Bazan, 1993). The 
open reading frames (ORF) of the IL-10 cDNAs encode secreted proteins of ~178 amino 
acids, including hydrophobic leader sequences (Moore et al., 1990; Vieira et al., 1991), with 
rather well conserved sequences – murine IL-10 (mIL-10) and human IL-10 (hIL-10) are 
~73% identical – consistent with an α-helical bundle structure (Sprang and Bazan, 1993). 
Human IL-10 is an 18 kDa polypeptide, which is not glycosylated. In contrast, both 
recombinant and T cell-derived murine IL-10 are heterogeneously N-glycosylated at a site 
near the N-terminus (Moore et al., 1990; Mosmann et al., 1990). IL-10 is biologically active 
as an homodimer and the crystal structure of hIL-10 (Figure 2) demonstrates α-helices 
within each subunit of a homodimer (Walter and Nagabhushan, 1995; Zdanov et al., 1995). 
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Figure 2: Ribbon diagram of the intertwined human IL-10 homodimer.  
The two IL-10 monomers are represented in green and pink, respectively. Intermolecular disulfide bonds are 
shown in yellow (http://www.pdb.org). 
 
While it plays a complex role in the immune system, the major activities of IL-10 are to 
inhibit cytokine production by macrophages and to suppress their accessory functions 
during T-cell activation (de Waal Malefyt et al., 1991; Fiorentino et al., 1991). Since this 
causes the termination of inflammatory responses, IL-10 is widely considered as an 
immunosuppressive and anti-inflammatory cytokine, and many investigations of IL-10 
expression in vitro, in animal models and in human patients have indicated a significant role 
in inflammatory, malignant and autoimmune diseases, highlighting the potential clinical 
value of this cytokine (Asadullah et al., 2003). However, mammalian IL-10, including the 
human one, also presents several immunostimulatory properties (e.g., activation of dendritic 
cells, NK cells, and some T cells) which appear not to be negligible when IL-10 is used in 
vivo to induce tolerance (Wakkach et al., 2000). 
I.4.1 Viral IL-10 
Interestingly, IL-10 has orthologs in several virus genomes, and the IL-10 variant produced 
by Epstein-Barr virus (vIL-10) is particularly closely related to its human counterpart (71% 
and 84% identity at the nucleotide and amino acid sequence levels, respectively) and binds 
to both human and murine receptors (Moore et al., 2001). Despite the sequence similarity, 
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vIL-10 exhibits primarily the immune-inhibitory properties associated with the cellular 
cytokine (e.g., suppression of Th1-polarized responses and monocyte inhibition) but lacks 
many of the immunostimulatory properties associated with the human IL-10 and murine 
IL-10, such as costimulation of thymocyte or mast cell proliferation, and enhancement of  
class II MHC expression on B cells (Lucas and McFadden, 2004). This exacerbated 
inhibitory effect of vIL-10 makes it an even more attractive therapeutic candidate for 
tolerance induction, as the viral cytokine could have a profoundly different effect on the 
outcome of an in vivo immune response compared to hIL-10/mIL-10 (Moore et al., 2001). 
I.4.2 IL-10 as an adjuvant for oral tolerance induction 
IL-10 has been extensively investigated as an immudomodulatory agent for the prevention 
or cure for T1DM. Depending on the time and site of administration, IL-10 alone can exert 
distinct effects on diabetes development in mice. Early systemic treatment with exogenous 
murine IL-10 inhibits T1DM in NOD mice, whereas exposure of NOD mice to IL-10 during 
the effector phase of the disease did not inhibit the diabetogenic potential of the T-cells 
(Balasa et al., 2000), and local expression of IL-10 (intraislets) even accelerated the onset of 
the disease in the same animal model (Wogensen et al., 1994). 
One promising immunomodulatory application of IL-10 is to enhance the induction of oral 
tolerance to co-administered auto-antigens, leading to the prevention or treatment of 
autoimmune diseases with lower doses of tolerizing protein. For instance, induction of oral 
tolerance for the prevention of type-1 diabetes mellitus (T1DM) could be achieved by 
repeated oral administration of small doses of one of the major auto-antigens associated 
with the disease, the 65 kDa isoform of the enzyme glutamic acid decarboxylase (GAD65). 
The characterization of transgenic tobacco plants producing immunoreactive GAD65 has 
already been reported (Avesani et al., 2003), although feeding studies in a mouse model 
have not yet been possible due to the low protein expression levels, requiring the 
consumption of unrealistically large amounts of plant material in order to achieve an oral 
tolerizing effect. However, simultaneous feeding with plant material containing IL-10 may 
reduce the amount of GAD65 necessary to induce oral tolerance. In fact, as Th1 cells are 
clearly implicated in the T1DM pathology, an immunoregulatory cytokine strongly 
promoting Th2 immune responses like IL-10, could augment tolerance to co-administered 
autoantigens such as GAD65. Additionally, IL-10 inducing the formation of Treg1 cells 
(Wakkach et al., 2000), should also drive the immune response towards active rather than a 
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passive tolerance, which should in turn provide a more robust and long-lasting protection 
from the onset of the autoimmune disease. 
 
I.4.3 Production of IL-10 in plants  
Currently, recombinant murine IL-10 (BD Pharmingen) is produced in insect cells, while 
the human (Schering-Plough) and viral IL-10 (R&D Systems) are produced in E. coli and 
refolded in vitro to reconstitute the dimers. 
These expression systems suffer from several limitations, mainly related to the necessity of 
refolding the protein after purification and to deliver an endotoxin-free product, which result 
in an extremely high price of IL-10 on the market and render the costs of research or 
treatment unsustainable in some cases. For example, it has been reported that early studies 
on the treatment of psoriasis with IL-10 suggested good efficacy (Asadullah et al., 2001; 
Kimball et al., 2002), but the outcome was not considered sufficiently cost-effective to 
justify further development of the cytokine for treatment of people with this disease (Walsh 
and Shear, 2004). 
As the interest in the use of IL-10 as a potential therapeutic agent continues to increase, a 
more efficient production system providing sufficient amounts of biologically active IL-10 
at low cost is becoming highly desirable (Wang et al., 2008a). In particular, the use of this 
cytokine either orally or topically for the cure of inflammatory diseases would require large 
amounts of recombinant protein for each treatment. This need led to the interest in 
transgenic plants as a source of low cost recombinant IL-10. 
Human IL-10 has been produced in stably transformed tobacco plants, and the ability of 
plant-produced human IL-10 to induce anti-inflammatory responses has also been 
demonstrated (Menassa et al., 2007). In two different works, Menassa and colleagues 
investigated several subcellular localizations of the recombinant protein, and among the 
compartments where human IL-10 was targeted to (apoplast, ER, chloroplast, 
mitochondrion), the ER turned out to be the most favorable one, where the protein 
accumulated to the highest levels (up to 0.0055 % TSP) (Menassa et al., 2001; Menassa et 
al., 2004). However, these yields were not satisfactory, and far below the 1 % threshold that 
has been proposed for plant-made pharmaceuticals to be economically competitive with 
current recombinant production systems (Twyman et al., 2005). In an attempt to increase the 
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stability and thus the yield of the cytokine, they subsequently generated a fusion protein of 
hIL-10 with a 27mer ELP-tag, and reached accumulation levels of 0.27 % TSP (Patel et al., 
2007).    
 
I.5 Objective and strategy of the study 
I.5.1 Objective of the study 
Transgenic plants are attractive systems for production of therapeutic proteins because of 
the ability to produce the target protein at large scale and at low cost, and the low 
maintenance requirements. They are highly amenable to oral administration and could 
become effective delivery systems without extensive protein purification.  
We are interested in the induction of oral tolerance for the prevention of type-1 diabetes 
mellitus (T1DM) which could be achieved by repeated oral administration of small doses of 
plant material expressing one of the major auto-antigens associated with the disease, 
GAD65. 
The production and characterization of transgenic tobacco plants producing immunoreactive 
GAD65 has already been reported (Porceddu et al., 1999; Avesani et al., 2003). However, 
accumulation levels of the recombinant protein were too low for an oral tolerizing effect 
using plant tissue directly. 
A strategy to improve the effect of orally administered antigens is the combined use of 
immunomodulators, such as IL-10, which should enhance the induction of oral tolerance to 
co-administered auto-antigens, leading to the prevention or treatment of autoimmune 
diseases with lower doses of tolerizing protein. 
We therefore set out to investigate the ability of tobacco plants to produce high levels of 
biologically active viral and murine IL-10. We focused on the expression of the viral IL-10 
from Epstein Barr virus because, lacking some of the immunostimulatory properties of the 
mammalian counterparts, it is an even better candidate for the induction of oral tolerance to 
co-fed autoantigens, and the murine IL-10 was also investigated as a reference, because the 
final aim is to test the recombinant cytokine in a mouse model of T1DM. In fact, a 
comparative study, feeding either recombinant vIL-10 or the recombinant endogenous 
mIL-10 together with the GAD65 auto-antigen to NOD mice, would allow to evaluate and 
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assess the outcome of the different immunomodulatory properties of the viral cytokine in 
inducing oral tolerance in the animal model, and to evaluate the possibility of exploiting 
vIL-10 for the prevention of T1DM. 
 
I.5.2 Experimental design 
The task of this thesis was to determine whether biologically active viral and murine IL-10 
could be produced in tobacco by (i) identifying the best expression strategy, (ii) performing 
a biochemical characterization of the plant-derived recombinant proteins, and (iii) 
confirming their biological activity and functionality. 
To reach high accumulation levels of the recombinant proteins, different targeting strategies 
of the nuclear encoded recombinant protein were investigated as well as plastid 
transformation with the IL-10 genes.  
The aim of the study was achieved by the following approaches: 
 
 Identification of the best strategy for the production of IL-10 in tobacco 
 
- Targeting strategies: Different constructs for targeting IL-10 to specific plant 
sub-cellular compartments (ER retained, membrane-anchored facing the apoplast 
and membrane-anchored facing the cytosol) with a C-terminal His6-tag were 
generated. The best targeting strategy was evaluated through transient expression, 
and nuclear stable transformation of tobacco plants with the most promising 
construct was performed. 
- Chloroplast (plastid) transformation: Chloroplast transformation was carried out by 
biolistic particle bombardment of N. tabacum leaves using gold particles coated with 
plasmid DNA coding for a His6-tagged version of either murine or viral IL-10. 
Primary spectinomycin-resistant transformants were passed through several 
additional rounds of selection and regeneration to obtain homoplasmic 
transplastomic tissue from which shoots were regenerated. 
- BY2 transformation and inducible transgene expression: Although it was not 
planned in the beginning of the study, stable transformation of tobacco suspension 
cell cultures was also investigated as an alternative approach to identify the most 
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suitable production platform, given the difficulties encountered during the 
experimental work in obtaining high accumulation levels of the viral IL-10. In this 
expression system, viral IL-10 expression under the control of a constitutive as well 
as an inducible promoter was performed and evaluated. 
 
 Characterization of transgenic plants and plant-produced IL-10: Determination of 
recombinant IL-10 accumulation levels was done by ELISA and/or immunoblot 
analyses. Validation of the selected targeting strategy was carried out by immunogold 
labeling and electron microscopy on the highest IL-10 producing plants. Purification of 
His6-tagged IL-10 was performed for subsequent N-terminal sequence determination, 
N-glycosylation analysis, assessment of plant-produced IL-10’s biological activity by in 
vitro assays using a murine macrophage cell line, and stability studies. 
 
A schematic representation of the experimental design is presented in Figure 3. 
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Figure 3: Schematic representation of the experimental design. 
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II MATERIALS AND METHODS 
 
 
II.1 Materials 
II.1.1 Organisms 
II.1.1.1 Plant material 
• Nicotiana tabacum L. cv. Petit Havana, used for chloroplast transformation 
• Nicotiana tabacum L. cv. Petit Havana SR1, used for agro-mediated transient expression 
and stable nuclear transformation 
• Nicotiana tabacum L. cv. Bright Yellow 2 (BY-2) cell suspension culture 
II.1.1.2 Bacterial strains 
Table 1: Bacterial strains 
Strain  Reference 
Escherichia coli 
DH5α 
recA1, endA1, hsdR17 (rk- mk+), ∆(LacZYA-argF) U169, 
supE44, Φ80d LacZ∆M15, thi-1, gyrA96, relA1 λ, deoR; 
cloning 
(Ausubel et al., 
1994) 
Agrobacterium 
tumefaciens 
GV3101 
pMP90RK 
RK GmR, KmR, RifR; gene transfer in N. tabacum SR1 
and BY-2 cells with the pTRA vectors 
(Koncz and Schell, 
1986) 
Agrobacterium 
tumefaciens 
GV2260 
RifR, CarbR; gene transfer in BY-2 cells with the 
pBinHyg vector 
(Deblaere et al., 
1985) 
 
II.1.1.3 Animal cell line 
• J774 murine macrophage cell line, kindly provided by Dr. V. Kruys, Université Libre de 
Brussels, Belgium, was used to assess IL-10 biological activity in vitro. 
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II.1.2 Nucleic acids 
II.1.2.1 Vectors 
• TOPO Cloning TA vector pCR2.1TOPO (Invitrogen, Karlsruhe, D): 3931 bp, pUC 
based cloning vector, LacZα, T7 promoter, bla, nptII. 
• pTRAkt-gfp (Thomas Rademacher, Institute for Biology VII, RWTH Aachen, 
Germany): 8352 bp, [AmpR, CarbR, KanR] binary plant expression vector, derivative of 
the pPAM expression vector (GenBank: AY027531). It contains the 35S promoter with 
duplicated enhancer region (Kay et al., 1987) and the pA35S terminator from the 
Cauliflower mosaic virus (CaMV); the 5’ untranslated region (UTR) from the Tobacco 
etch virus (TEV); two Scaffold Attachment Regions (SAR) from tobacco flanking the 
expression cassette, for  optimized transgene expression in planta (Breyne et al., 1992). 
This vector was used for cloning of the IL-10 cDNA and A. tumefaciens mediated 
transformation of tobacco. 
• TRAkc-rTPrfp (Thomas Rademacher): 8406 bp, [AmpR, CarbR, KanR], contains the 5’ 
untranslated region from the chalcone synthetase gene from Petunia hortense and the 
gene encoding the DsRed reporter molecule (Jach et al., 2001). The vector was used as 
control during agroinfiltration experiments. 
• pBinHygTX: 12095 bp (GenBank: Z37515), [KanR, HygR] derivative of the binary 
vector pBIB (Becker, 1990), harbours an expression cassette with the CaMV 35S 
promoter containing three TET-Repressor binding sites. This vector was as used for 
cloning of the IL-10 cDNA and Tc-inducible expression of transgenes.  
• pTRAhDsRed_eTX-vIL-10 (Thomas Rademacher): 11627 bp, [AmpR, CarbR, HygR], 
contains the sequence encoding DsRed under the control of a constitutive CaMV 35S 
promoter, in tandem with the sequence encoding the His-tagged ER-retained version of 
vIL-10 under the control of the modified CaMV35S promoter containing three 
TET-Repressor binding sites and the duplicated enhancer region; the two expression 
cassettes are flanked and interspaced by SARs. This vector was used for Tc-inducible 
expression of transgenes with a visible screenable marker for selection of transgenic 
clones. 
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• pHK20 (Pal Maliga, Rutgers University, Piscataway, NJ, USA): [AmpR]; was used as 
intermediate plasmid in the generation of the chloroplast transformation vector, to clone 
the IL-10 sequences in the expression cassette consisting of the ribosomal RNA operon 
promoter fused to the 5’ untranslated region (5’UTR) from gene 10 of phage T7 and the 
downstream box (DB) from E. coli (Prrn-T7g10-DB), and the 3’UTR of the plastid rbcL 
gene (TrbcL) (Kuroda and Maliga, 2001). 
• pRB95: 6810 bp, [AmpR, KanR, SpecR] chloroplast transformation vector (GenBank: 
AJ312393) harbouring the aadA gene for Spec/Strep resistance in E. coli and in plant 
chloroplasts (Ruf et al., 2001).  
II.1.2.2 Oligonucleotides 
All oligonucleotides used in this study were synthesized and HPLC purified by Invitrogen 
or MWG Biotech (Ebersberg, D). Stock solutions of 200 pmol in autoclaved ddH2O were 
prepared and stored at -20 °C.  
 
Name Sequence (5’→3’) 1 Orientation 
mIL-10 cloning   
m-SP_f CAT GCC ATG GCA CCT GGC TCA GCA CTG CTA TGC (+) 
m-HisKDEL_r 
GCT CTA GAC GGT TTA GAG CTC ATC TTT CTC AGA 
GTG ATG GTG ATG GTG ATG GCT TTT CAT TTT GAT 
CAT CAT GTA TGC 
(-) 
m-TcR_r1 
GAT GGT GGC AGA CAG GAC CCC TTG CTG GTA GGA 
CAC CGA GGT AAA GCC ACA GTC TGC TCT ACC GCT 
TTT CAT TTT GAT CAT CAT GTA TGC 
(-) 
m-TcR_r2 
AAC ACA AGG GCG CTG ACC AGC ACA GCA TAC AGG 
GTG GCC TTC CCT AGC AGG ATC TCA TAG AGG ATG 
GTG GCA GAC AGG ACC CC  
(-) 
m-TcRHis_r3 
GCT CTA GAC GGT TTA GTG ATG GTG ATG GTG ATG 
GAA ATC CTT TCT CTT GAC CAT TGC CAT CAA CAC 
AAG GGC GCT GAC CAG C 
(-) 
m-cytb5_f TTG TCA TGA GCA GGG GCC AGT ACA GCC G (+) 
m-Hiscytb5_r1 
ATG GCT GGG ATC ACC CAG TTG GTC CAC CAA CTG 
GAA TTA GAC TCG ACG TGA TGG TGA TGG TGA TGG 
CTT TTC ATT TTG ATC ATC ATG TAT GC 
(-) 
 
m-cytb5_r2 
 
GCT CTA GAC GGT TTA ATC TTC TGC CAT GTA GAG 
GCG ATA CAT CAG AGC TAC CAC CAG GGC TGA GAT 
GGC TGG GAT CAC CCA GTT GG 
(-) 
Ch_m_f GGA ATT CCA TAT GAG CAG GGG CCA GTA CAG C (+) 
Ch_m_His_r GCT CTA GAT TTA GTG ATG GTG ATG GTG ATG GCT TTT CAT TTT GAT CAT CAT GTA TG (-) 
vIL-10 cloning   
v-SP_f CAT GCC ATG GAG CGA AGG TTA GTG GTC ACT CTG CAG TGC (+) 
v-HisKDEL_r 
GCT CTA GAC GGT TTA GAG CTC ATC TTT CTC AGA 
GTG ATG GTG ATG GTG ATG CCT GGC TTT AAT TGT 
CAT GTA TGC 
(-) 
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v-TcR_r1 
ATG GTG GCA GAC AGG ACC CCT TGC TGG TAG GACA 
CCG AGG TAA AGC CAC AGT CTG CTC TAC CCC TGG 
CTT TAA TTG TCA TGT ATG CTT CTA TGT AGT T 
(-) 
 
v-TcR_r2 
 
ACA CAA GGG CGC TGA CCA GCA CAG CAT ACA GGG 
TGG CCT TCC CTA GCA GGA TCT CAT AGA GGA TGG 
TGG CAG ACA GGA CCC C 
(-) 
v-TcRHis_r3 
GCT CTA GAC GGT TTA GTG ATG GTG ATG GTG ATG 
GAA ATC CTT TCT CTT GAC CAT TGC CAT CAA CAC 
AAG GGC GCT GAC CAG C 
(-) 
v-cytb5_f1 
TAC TTC TAT TGC AGC AAT TTA AAT CAT TTC TTT 
TAA AGC AAA AGC AAT TTT CAC CAT GCA ATG TGA 
CAA TTT TCC CCA AAT G 
(+) 
v-cytb5_f2 
GGA ATT CCT CAA CAC AAC ATA TAC AAA ACA AAC 
GAA TCT CAA GCA ATC AAG CAT TCT ACT TCT ATT 
GCA GCA ATT TAA ATC ATT TC 
(+) 
v-Hiscytb5_r1 
TGG CTG GGA TCA CCC AGT TGG TCC ACC AAC TGG 
AAT TAG ACT CGA CGT GAT GGT GAT GGT GAT GCC 
TGG CTT TAA TTG TCA TGT ATG CTT C 
(-) 
v-cytb5_r2 
GCT CTA GAC GGT TTA ATC TTC TGC CAT GTA GAG 
GCG ATA CAT CAG AGC TAC CAC CAG GGC TGA GAT 
GGC TGG GAT CAC CCA GTT GG 
(-) 
Ch_v_f GGA ATC CAT ATG CAA TGT GAC AAT TTT CCC CAA ATG (+) 
Ch_v_His_r GCT CTA GAT TTA GTG ATG GTG ATG GTG ATG CCT GGC TTT AAT TGT CAT GTA TGC (-) 
Analysis of 
transplastomics   
P5'RB70 GGA TTT GGT ATA GTT GGC C (+) 
P3'RB70 CTT GTT TAC CTA TTA GTT TTC AGT (-) 
paadA136 TCG ATG ACG CCA ACT ACC (+) 
Biological activity   
SOCS3_f CCT TTG TAG ACT TCA CGG CT (+) 
SOCS3_r TTT GGA GCT GAA GGT CTT GAG (-) 
GAPDH_f TGG CCT CCA AGG AGT AAG AA (+) 
GAPDH_r GGT CTG GGA TGG AAA TTG TG (-) 
Sequencing    
m-int_f GCC AGG TGA AGA CTT TC (+) 
m-int_r GCC TTG CTC TTA TTT TCA C (-) 
v-int_f CCT AAG AGA TGC CTT CAG (+) 
v-int_r CCT GCA GCT TGT TAA AGG (-) 
pSS5' ATC CTT CGC AAG ACC CTT CCT CT (+) 
pSS3' AGA GAG AGA TAG ATT TGT AGA GA (-) 
Universe GTT GTA AAA CGA CGG CCA GT (+) or (-) 
Reverse ACA CAG GAA ACA GCT ATG AC (+) or (-) 
1Underlined sequences represent clamps that do not hybridize to the starting DNA template 
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II.1.3 Antibodies 
Antibody Epitope Characteristics Reference 
Primary antibodies    
Rat-anti-mIL-10 Mouse IL-10 Monoclonal BD Pharmingen (Erembodegem, B) 
Rat-anti mIL-10 Mouse IL-10 Monoclonal, biotinylated BD Pharmingen 
Rabbit-anti-mIL-10 Mouse IL-10 Polyclonal ACRIS (Herford, D) 
Rat-anti-h and vIL-10 Human and viral IL-10 Monoclonal BD Pharmingen 
Rat-anti-h and vIL-10 Human and viral IL-10 Monoclonal, biotinylated BD Pharmingen 
Goat-anti-vIL-10 Viral IL-10 Polyclonal R&D Systems (Wiesbaden, D) 
Rabbit-anti-penta His C-terminal His-tag Polyclonal Cell Signaling (Denver, MA, USA) 
Mouse-anti-KDEL C-terminal KDEL tag Monoclonal Assay Design (Ann Harbor, MI, USA) 
Mouse-anti-STAT3  STAT3 Monoclonal Cell Signaling 
Rabbit-anti-phospho-
STAT-3  
STAT3 phosphorylated 
on Tyr705 Polyclonal Cell Signaling 
Rabbit-anti-SOCS3 SOCS3, NH2 terminus  Polyclonal IBL (Tokio, J) 
Mouse-anti-GAPDH GAPDH Monoclonal IBL 
    
Secondary antibodies    
Rabbit-anti-rat 
(RARAP) Rat IgG (H+L) 
Polyclonal, conjugated to 
alkaline phosphatase 
SIGMA  
(Deisenhofen, D) 
Rabbit-anti-rat 
(RARHRP) Rat IgG (H+L) 
Polyclonal, conjugated to 
horse radish peroxidase SIGMA 
Goat-anti-rabbit 
(GARAP) Rabbit IgG (H+L) 
Polyclonal, conjugated to 
alkaline phosphatase 
Jackson 
ImmunoResearch 
(Suffolk, UK) 
Goat-anti mouse 
(GAMAP) Mouse IgG (H+L) 
Polyclonal, conjugated to 
alkaline phosphatase 
Jackson 
ImmunoResearch 
Rabbit-anti-goat 
(RAG10) Goat IgG (H + L) 
Polyclonal, conjugated to 
10 nm gold particles 
BBInternational 
(Cardiff, UK) 
Goat-anti-rabbit 
(GAR10) Rabbit IgG (H + L) 
Polyclonal, conjugated to 
10 nm gold particles BBInternational 
Goat-anti-rabbit 
(GAR680) Rabbit IgG (H+L) 
Polyclonal, conjugated to 
Alexa Fluor680 Invitrogen 
Goat-anti-mouse 
(GAM800) Mouse IgG (H+L) 
Polyclonal, conjugated to 
IRDye800 
Rockland 
(Gilbertsville, PA, 
USA) 
 
II.1.4 Chemicals and consumables 
The chemicals and consumables used throughout the work were purchased from the 
following companies: Acris, Ambion (Austin, TX, USA), Amicon (Witten, D), Assay 
Design, BB International, BD Pharmingen, Biochrom Seromed (Berlin, D), Bio-Rad 
(Munich, D), Bio-Whittaker, (Verviers, B), Cell Signaling, Duchefa (Haarlem, NL), 
Eppendorf (Hamburg, D), Fluka (Neu-Ulm, D), Fuji Film (Dusseldorf, D), GE Healthcare 
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(Uppsala, S), Gibco BRL (Eggenstein, D), Greiner Bio-One (Frickenhausen, D), IBL, 
Invitrogen (Karlsruhe, D), InvivoGen (San Diego, CA, USA), Jackson ImmunoResearch, 
Kodak (Stuttgart, D), Macherey-Nagel (Düren, D), Merck (Darmstadt, D), Millipore 
(Eschborn, D), R&D Systems, Roche (Mannheim, D), Rockland (Gilbertsville, PA, USA), 
Roth (Karlsruhe, D), Schleicher&Schuell (Dassel, D), Schott Glaswerke (Mainz, D), Serva 
(Heidelberg, D), Sigma, Whatman (Bender & Hobein, Bruchsal, D). 
 
II.1.5 Stock solutions, buffers and additives 
Standard media, buffers and stock solutions were prepared according to standard procedures 
(Ausubel et al., 1998; Sambrook and Russel, 2001) using deionized water. Solutions were 
sterilized by autoclaving (20min/121°C/2bar). Heat-sensitive components, such as 
antibiotics, were prepared as stock solutions, filter-sterilized (0.2 µm) and added to the 
medium/buffer after cooling to 50°C. 
 
II.1.5.1 Antibiotics 
 
Antibiotics Final 
concentration Stock solution 
Escherichia coli medium   
Ampicillin (Amp) 100 mg l-1 100 mg ml-1 H2O 
Kanamycin (Kan) 25 mg l-1 100 mg ml-1 H2O 
   
Agrobacterium tumefaciens medium   
Rifampicin (Rif) 100 mg l-1 100 mg ml-1 DMSO 
Kanamycin (Kan) 25 mg l-1 100 mg ml-1 H2O 
Carbenicillin (Carb) 100 mg l-1 100 mg ml-1 EtOH 50% (v/v) 
   
Plant medium   
Kanamycin (Kan) 50 mg l-1 100 mg ml-1 H2O 
Claforan 250 mg l-1 200 mg ml-1 H2O 
Hygromycin 60 mg l-1 100 mg ml-1 H2O 
Streptomycin (Strep) 500 mg l-1 500 mg ml-1 H2O 
Spectinomycin (Spec) 500 mg l-1 500 mg ml-1 H2O 
Tetracyclin (anhydrotetracyclin hydrochloride) 4.64 mg l-1 2.32 mg ml-1 H2O 
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II.1.6 Enzymes and reaction kits 
Restriction enzymes either from New England Biolabs, GibcoBRL or Roche were used for 
DNA digestion. HighFidelity Taq Polymerase (Invitrogen) was used for PCR amplification 
of the constructs, while TaqDNA polymerase produced in-house (home-made Taq) was 
used for check-PCR reactions. The following kits were used: 
 
Kit Supplier 
QIAquick Gel Extraction Kit Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick PCR-Purification Kit Qiagen 
RNeasy RNA mini Qiagen 
Megaprime DNA labelling kit GE Healthcare 
 
II.1.7 Matrices and membranes 
• HybondTM-C nitrocellulose membrane (0.45 µm, GE Healthcare) and Whatman N°1 
paper from Whatman (Maidstone) were used for immunoblot analyses using alkaline 
phosphatase substrate for detection (II.2.4.9). 
• Immobilion-P PVDF membrane (0.45 µm) from Millipore was used for western blot 
preparation using chemiluminescence detection (II.2.4.10). 
• HybondTM-XL nylon membrane (0.45 µm, GE Healthcare) for RFLP (II.2.1.11) and 
northern blot analyses (II.2.1.14). 
• Ni-NTA agarose resin (Qiagen) was used for the purification of recombinant IL-10 
fused to the His6-tag from plant protein extracts (II.2.4.13). 
 
II.1.8 Equipment and applications 
• Centrifuges: Eppendorf 5415 D and 5415 R, AvantiTM J-26 XPI (Beckman Coulter, 
Krefeld, D), Multifuge 3 S-R (Heraeus, Hanau, D),. Rotors: JA-10 and JA 25.50 
(Beckman), 75006445 and 3057 (Hereaeus).  
• DNA gel electrophoresis: wide mini and mini cells for DNA agarose electrophoresis 
and power supplies (Bio-Rad, Muenchen, D). 
• Drilling device: Stirrer RZR1 C63-1000 (Heidolph, Schwabach, D) 
• Electron microscope: EM-400 transmission electron microscope (Philips, Hamburg, 
D). 
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• Electroporation apparatus: Gene pulserTM, Pulse controller unit, Estender unit (Bio-
Rad) and 0.2 cm cuvettes (Bio-Rad). 
• Fluorescence microscope: Olympus BX40 (Muenchen, D). 
• Freeze-dryer: Alpha 1-4 LSC (Christ, Osterode, D). 
• Gel filtration apparatus: ÄKTAprime plus purification system with a Superdex 200 
pre-packed glass column (GE Healthcare). 
• Incubator: InnovaTM 4340 incubator shaker (New Brunswick scientific, Nuertingen, D). 
• Infrared fluorescence detector: ODYSSEY Infrared Imaging system (LI-COR, Bad 
Homburg, D). 
• Luminescent image analyzer: LAS 3000 (Fuji Film, Duesseldorf, D). 
• Mass spectrometer: quadrupole time-of-flight Ultima Global mass spectrometer 
(Waters Micromass, Vienna, AT). 
• Microtiterplate reader: synergy HT (Bio-TEK, Bad Friedrichshall, D). 
• Mixer mill: Mixer Mill MM200 (Retsch, Haan, D). 
• Particle bombardment system: Biolistic PDS-1000/He system (BioRad). 
• PCR Termocyclers: Primus and Primus 96 plus (MWG-Biotech), PE Biosystems 
GeneAmp PCR Systems 9600 (Weiterstadt, D). 
• Photometer: Eppendorf Biophotometer (Eppendorf). 
• Phosphor autoradiography imager: Typhoon Trio+ variable mode imager (GE 
Healthcare). 
• Probe sonicator: UW2070 (Bandelin electronic, Berlin, D), Microtip Titan MS72. 
• Protein gel electrophoresis equipment: Mini PROTEAN IITM (Bio-Rad). 
• Protein gel transfer equipment: Min Trans-blot transfer cell (Bio-Rad). 
• Ultramicrotome: Ultracut E (Leica, Wetzlar, D). 
• UV-crosslinker: BLX-254 (Vilber Lourmat, Eberhardzell, D) 
• UV-Transilluminators: wavelength 302 nm and UVT-20M (Herolab, Wiesloch, D) 
UV-chamber (Bio-Rad). 
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II.2 Methods 
II.2.1 Nucleic acid technologies 
II.2.1.1 PCR amplification 
Polymerase Chain Reaction (PCR) was performed either to amplify the genes of interest 
from template DNA, directly fusing the sequences necessary to create and clone the 
different targeting constructs into the plant transformation vectors (II.1.2.1), or to identify 
positive clones after bacterial transformation (II.2.2.7). DNA amplification was carried out 
in a final volume of 50 µl, containing 1x PCR buffer, 1.5 mM MgCl2, 0.25 mM of each 
dNTP, 10 pmol of each primer, 2.5 units of Taq DNA polymerase and 10-100 ng template 
DNA. The PCR reaction was performed in a GeneAmp PCR Systems 9600 (PE Biosystems) 
as follows: one denaturation step at 94°C for 3 min; 30 cycles of denaturation at 94°C for 30 
sec, annealing at Tm-5°C for 30 sec, extension at 72°C 1 min, followed by a final extension 
step at 72°C for 7 min. 
 
10x PCR buffer (for home-made Taq) 100 mM Tris-HCl, pH 9.0 
  500 mM KCl  
  1 % (v/v) Triton X-100 
II.2.1.2 Nucleic acids quantification 
The DNA (or RNA) concentration was determined by optical density measurement 
(1 OD260nm unit = 50 µg ml-1 of double stranded DNA or 40 µg ml-1 of RNA) as described 
(Jefferson et al., 1987). The DNA (or RNA) purity was controlled by the OD260nm/OD280nm 
ratio. 
II.2.1.3 DNA sequencing  
DNA sequences were determined by the DNA Analysis core facility at the Fraunhofer IME 
using an Applied Biosystems (Weiterstadt, Germany) Abi Prism 3730 sequencer and the 
BigDye-terminator v3.1 chemistry. Premixed reagents were from Applied Biosystems. 
Sequence analyses were carried out with the Wisconsin Package v10.2 (Genetics Computer 
Group, Madison, WI, USA).  
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II.2.1.4 Agarose gel electrophoresis of DNA 
Analytical as well as preparative gel electrophoresis of DNA was performed as described 
(Sambrook et al., 1996) in 0.8-1.2 % (w/v) agarose gels prepared with TBE buffer and 
containing 0.1 µg/ml ethidium bromide. Known amounts of DNA molecular markers, such 
as 1 Kb ladder (Fermentas) or Lambda/PstI marker (Fermentas), were used for evaluation of 
DNA concentration and size. The DNA samples were loaded after the addition of DNA 
loading buffer, and the electrophoretic run was carried out in TBE buffer at 5-10 V/cm. 
Visualization of the DNA bands and documentation of the gels were performed using a UV 
transilluminator at 302 nm and a black and white E.A.S.Y 429K camera (Herolab). In 
preparative electrophoresis, for purification of a particular DNA fragment from a mixture 
after restriction enzyme digestion, the DNA fragment of interest was excised from the gel 
on an UV transilluminator with a clean scalpel. The DNA extraction was performed with the 
QIAquick gel extraction kit (Qiagen) according to the manufacturer’s instructions. The 
concentration of the recovered DNA was measured spectrophotometrically (II.2.1.2), and 
the quality of the extraction was assessed by agarose gel electrophoresis. 
 
 
10x TBE electrophoresis buffer 900 mM Tris-base 
  900 mM Boric acid 
  25 mM EDTA, pH 8.3 
 
6x DNA loading buffer 0.025 % (w/v) Bromphenol blue 
0.025 % (w/v) Xylencyanol 
50 % (v/v) Glycerol 
in 2x TBE buffer 
 
II.2.1.5 Restriction digestion of DNA 
Restriction enzyme digestions were carried out in the buffer supplied with the enzyme, in 
accordance with the manufacturer’s recommendations for temperature and duration of the 
digestion. For 1 µg DNA 1-2 units of the appropriate enzyme were used and the mixture 
was incubated 1-3 h at the enzyme’s optimal temperature. For double digestions, 
combination of the two enzymes at the most suitable buffer was performed. If combination 
of the two enzymes was not possible, sequential digestions were performed, and DNA was 
purified via the QIAquick PCR purification kit (Qiagen) in between to exchange reaction 
buffer and remove the first enzyme. Reactions were stopped by heat inactivation, when 
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applicable, or the DNA was directly purified either by gel extraction (II.2.1.4) or PCR 
purification kit (Qiagen). 
II.2.1.6 Dephosphorylation of DNA 
Dephosphorylation of restricted vector DNA was done with Calf Intestine Phosphatase 
(NEB) according to the manufacturer’s protocol. 
II.2.1.7 Ligation of DNA 
DNA ligation was carried out in a total volume of 20 µl. Concentration of the DNA 
fragments was determined (II.2.1.2), the vector DNA dephosphorylated (II.2.1.6) and the 
reaction was set up mixing around 100 ng of vector in a 1:3 molar ratio with the insert, with 
either 80 U T4 DNA-Ligase or 1 µl Quick T4 DNA-Ligase (NEB) and the appropriate 
ligase buffer. Sticky-end ligations were carried out at 22°C for 30-180 min, and blunt-end 
ligations overnight (o/n) at 16°C. Ligation product was used directly to transform E. coli by 
heat-shock (II.2.2.3). 
II.2.1.8 Isolation of plasmid DNA from E. coli with a commercial kit 
Plasmid DNA was purified using QIAprep Spin Miniprep Kit or the Plasmid Midi Kit 
(Qiagen) according to the manufacturer’s instructions. Quality and yield of plasmid DNA 
were examined by spectrophotometric analysis (II.2.1.2) and agarose gel electrophoresis 
(II.2.1.13). Isolated DNA was stored at -20°C. 
II.2.1.9 Isolation of plasmid DNA from E. coli with the boiling-prep method 
For simultaneous screening of numerous clones, the boiling-prep method (Holmes and 
Quigley, 1981) was used to isolate DNA from recombinant E. coli. One ml of a 5 ml o/n 
culture (II.2.2.1) was harvested by centrifugation at 16000 g, for 5 min, at room temperature 
(Rt) and the pellet resuspended in 150 µl of STETL buffer by vigorous vortexing. The 
suspension was incubated 5 min at Rt, boiled for 30-45 s and then centrifuged 10 min at 
16000 g at Rt. The white pellet was removed with a toothpick and the DNA was precipitated 
with 150 µl of ice-cold isopropanol centrifuging 20 min at 16000 g at 4°C. The pellet was 
washed once with 70 % (v/v) ice-cold ethanol, dried and resuspended in bi-distilled water 
(ddH2O) containing 0.1 mg/ml RNase-A. 
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STETL buffer  8 % (w/v) Sucrose  
  5 % (v/v) Triton X-100 
  50 mM EDTA, pH 8.0 
  50 mM Tris-HCl, pH 8.0 
  autoclave and store at 4°C 
+ 0.5 mg/ml lysozyme prior to use 
 
II.2.1.10 Isolation of DNA from plant material 
High quality total DNA for restriction fragment length polymorphism (RFLP) analysis 
(II.2.1.11) was purified from plant tissue (leaf or callus) as follows. Around 100 mg of 
material were collected in a 2 ml tube and snap frozen in liquid nitrogen. The frozen tissue 
was pulverized with metal beads using a Retsch mill (1 min shaking, 20 ν), resuspended in 
200 µl CTAB-buffer and incubated 30 min at 60°C, vortexing twice. DNA was extracted 
with 80 µl of chloroform/isoamyl alcohol (24:1) and centrifuged 10 min at 13400 g and 4°C. 
The aqueous upper phase was transferred in a new tube and RNA digestion was carried out 
by adding DNase-free RNase at a final concentration of 20 µg/ml and incubating 15 min at 
37°C. Another extraction step was then performed, adding 60 µl of chlorophorm/isoamyl 
alcohol (24:1) to the mixture and centrifuging 10 min at 13400 g and 4°C. Around 150 µl of 
upper phase were transferred to a new tube, and DNA was precipitated adding 0.8-0.9 
volumes of isopropanol, placed 15 min on ice and then centrifuged 30 min at 13400 g and 
4°C. The supernatant was carefully removed, and after washing the pellet with 70 % (v/v) 
ethanol, DNA was resuspended in ddH2O and stored at 4°C until use. 
 
CTAB-buffer  2 % (w/v) CTAB 
  1.4 M NaCl 
  20 mM EDTA, pH 8.0 
  100 mM Tris-HCl, pH 8.0 
  100 mM β-Mercaptoethanol 
II.2.1.11 RFLP analysis  
Total DNA was extracted from leaf samples of transplastomic tobacco lines (II.2.3.2) using 
the CTAB method (II.2.1.10), and 5 µg were digested o/n with the restriction enzyme BglII 
(II.2.1.5). Digested DNAs were separated by electrophoresis on a 0.8 % (w/v) agarose gel 
(II.2.1.4), transferred onto a Hybond-XL nylon membrane by upward capillary blotting in 
20x SSC buffer using standard protocols (Sambrook et al., 1996), and DNA was UV 
cross-linked onto the air-dried membrane (1x 0.120 J/cm2). The blot was pre-hybridized for 
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2 h in Church buffer, and then incubated with 25 ng of PsaB probe produced from a 540 bp 
PsaB photosystem I core protein nucleotide sequence using a [32P]CTP Megaprime labeling 
kit (GE Healthcare) following the manufacturer’s instructions, o/n at 65°C, rotating. Excess 
probe was removed with two 20 min washes in 2x SSC, 0.1 % (w/v) SDS and then 0.5x 
SSC, 0.1 % (w/v) SDS. The washed membrane was placed in a cassette with a phosphor 
screen and after 2-4 h incubation at Rt, the hybridization signals were detected using a 
Typhoon Trio+ phosphoimager (GE Healthcare).  
 
20x SSC buffer  3 M NaCl 
  0.3 M Sodium citrate 
  pH 7.0 
 
Church buffer  1 % (v/v) BSA 
  1 mM EDTA 
  7 % (w/v) SDS 
  0.5 M NaHPO4  
pH 7.2 
 
II.2.1.12 Isolation of total RNA from plant material 
To isolate total RNA from plant tissue, around 100 mg of material were collected in a 2 ml 
tube and snap frozen in liquid nitrogen. The frozen tissue was pulverized with metal beads 
using a Retsch mill (1 min shaking, 20 ν) and extracted with PeqGOLD TriFast reagent 
(Peqlab) following the manufacturer’s instructions. RNA was finally resuspended in 20 µl 
ddH2O, its concentration was determined spectrophotometrically (II.2.1.2) and the integrity 
checked by agarose gel electrophoresis (II.2.1.4). RNA was stored at -80°C until use. 
II.2.1.13 Agarose formaldehyde gel electrophoresis of RNA 
RNA was separated by gel electrophoresis under denaturing conditions in the presence of 
formaldehyde. Briefly, a 1 % (w/v) agarose gel containing 1 % (v/v) formaldehyde was 
prepared with MOPS buffer, and the RNA sample was denatured 10 min at 75°C in 1x RNA 
loading buffer before loading onto the gel. The electrophoresis run was performed in MOPS 
buffer, first at 30 V for 30 min, and then at 5 V/cm.  
 
10x MOPS buffer  0.2 M MOPS 
  0.05 M Sodium Acetate 
  0.01 M EDTA 
  pH 5.5-7.0 
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RNA loading buffer  50 % (v/v) Formamide, deionized 
  6.5 % (v/v) Formaldehyde 
  20 % Glycerol 
  1.25 mM EDTA, pH 8.0 
  0.005 % (v/v) Ethidiumbromide 
  0.1% (w/v) Xylene cyanol 
  0.1 % (w/v) Bromphenol blue 
  in 1x MOPS 
aliquot and store at -80°C 
 
II.2.1.14 Northern blot analysis 
Ten µg of total RNA isolated from transplastomic tobacco leaves were separated by agarose 
formaldehyde gel electrophoresis (II.2.1.13) and transferred onto a Hybond-XL nylon 
membrane by upward capillary blotting in 20x SSC buffer using standard protocols 
(Sambrook et al., 1996). RNA was UV cross-linked onto the air-dried membrane (1x 0.120 
J/cm2). The blot was pre-hybridized for 2 h in Church buffer, and then incubated with 25 ng 
of either murine or viral IL-10 probes produced from a 540 bp mIL-10 or a 468 bp vIL-10 
cDNA sequence (II.1.2.2; Ch_m_f and Ch_m_His_r, Ch_v_f and Ch_v_His_r), 
respectively, using a [32P]CTP Megaprime labeling kit (GE Healthcare) following the 
manufacturer’s instructions, o/n at 65°C, rotating. Excess probe was removed with two 20 
min washes in 2x SSC, 0.1 % (w/v) SDS and then 0.5x SSC, 0.1 % (w/v) SDS. The washed 
membrane was placed in a cassette with a phosphor screen and after 2-12 h incubation at Rt, 
the hybridization signals were detected using a Typhoon Trio+ phosphoimager (GE 
Healthcare).  
II.2.1.15 Isolation of RNA from mammalian cell cultures 
J774 cells were scraped from the wells, washed once with PBS and resuspended in RLT 
buffer (Qiagen). After vigorous vortexing, samples were completely homogenized using a 
1 ml disposable syringe with 20-gauge needle 5-8 times, and total RNA was extracted using 
the RNeasy kit (Qiagen), following the manufacturer’s instructions. RNA was immediately 
checked for integrity by gel electrophoresis (II.2.1.13) and quantified (II.2.1.2), then stored 
at -80°C until use. 
II.2.1.16 Real Time RT-PCR 
Reverse transcription of RNA isolated from J774 macrophage cells (II.2.1.15) was carried 
out using SuperScript II (Invitrogen) following the manufacturer’s instructions. Real time 
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RT-PCR was performed in triplicate from 10 ng cDNA for each sample, using the SYBR 
Green real-time master mix “SYBR Premix Ex Taq™” (Takara Bio Inc, Shiga, J), in the 
presence of 200 nM specific primer pairs purchased from Invitrogen (SOCS3_f and 
SOCS_r; GAPDH_f and GAPDH_r, II.1.2.2). The reaction conditions performed by the 
DNA Engine Opticon 2 System (MJ Research, Waltham, MA, USA), were as follows: 95°C 
for 10 s, followed by 40 cycles of 95°C for 10 s and 60°C for 40 s. Data were calculated 
with LinReg PCR 7.0 and Q-Gene software (http://www.gene-
quantification.de/download.html) and then expressed as mean normalized expression 
(MNE) units after GAPDH normalization. 
 
II.2.2 Manipulation of recombinant bacteria 
II.2.2.1 Growth of E. coli and glycerol stock preparation 
Single E. coli colonies were examined for plasmid integration by PCR (II.2.1.1). Selected 
clones were grown at 37°C either in LB medium on a shaker incubator at 180 rpm, or on 
LB-agar plates (1.5 % (w/v)), containing the appropriate antibiotics (II.1.5.1). For long-term 
storage, 600 µl of an o/n liquid culture was mixed with an equal volume of 40% (v/v) 
glycerol and stored at -80°C. 
 
LB medium  1% (w/v) NaCl 
  1 % (w/v) Trypton 
  0.5 % (w/v) Yeast extract 
  pH 7.4 
     
   
II.2.2.2 Preparation of competent E. coli cells for heat-shock transformation 
E. coli strain DH5α (II.1.1.2) competent cells were prepared for RbCl-mediated heat shock 
transformation. A single bacterial colony was inoculated in 5 ml of LB medium and cultured 
at 37°C, 180 rpm o/n. 100 ml of LB medium were inoculated 1:100 with the o/n culture, the 
cells were cultured at 37°C for 3-4 hours until the OD600nm reached 0.4-0.5 and then 
transferred to an ice-cold tube. After 10 min on ice, the cells were recovered by 
centrifugation (2000 g/4°C/10 min). The pellet was gently dissolved in 30 ml ice-cold TfB-I 
solution and kept on ice for 10 min. The cells were recovered by centrifugation and 
resuspended in 4 ml ice-cold TfB-II buffer. 200 µl aliquots of the suspension were 
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dispensed into pre-chilled 1.5 ml tubes, frozen immediately in liquid nitrogen and stored at 
-80°C. 
TfB-I  100 mM RbCl 
  75 mM MnCl2 
  10 mM CaCl2 
  0.5 mM LiCl 
  35 mM K acetate 
  15 % (v/v) Glycerol 
  pH 5.8 
 
 
TfB-II  10 mM RbCl 
  75 mM CaCl2 
  15 % (v/v) Glycerol 
  10 mM MOPS 
  pH 6.8 
 
II.2.2.3 Transformation of E. coli by heat-shock 
As soon as the competent cells were thawed on ice, around 20-100 ng plasmid DNA 
(II.2.1.8) or ligation products (II.2.1.7), diluted in sterile dH2O if necessary, were mixed 
gently with the competent cells and stored on ice for 30 min. The cells were then incubated 
for 90 seconds at 42°C and immediately placed on ice for 2 min. 800 µl of SOC medium 
were added to the tube and the transformed cells were incubated at 37°C for 45 min. 200 µl 
of cells were plated onto LB-agar plates supplemented with the appropriate antibiotics and 
incubated o/n at 37°C. Single colonies were inoculated in 5 ml of LB selective medium and 
cultivated o/n at 37°C, shaking at 180 rpm. An aliquot of the culture was then used for 
plasmid extraction by the boiling-prep method (II.2.1.9), and the correctness of the insert 
size was assessed digesting the plasmid DNA with appropriate restriction enzymes (II.2.1.5) 
and evaluating the digestion profile after electrophoretic separation of the fragments on 1.2 
% (w/v) agarose gel (II.2.1.4). Plasmid DNA from the positive clones was then extracted 
with commercial kits (II.2.1.8) and sent for sequencing (II.2.1.3). 
 
SOC medium  1 % (w/v) Bacto tryptone 
  0,5 % (w/v) Yeast extract 
  10 mM NaCl 
  2.5 mM KCl 
autoclave, then add   
sterile MgCl2 to 10 mM 
  
sterile MgSO4 to 10 mM 
  sterile Glucose to 20 mM 
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II.2.2.4 Growth of A. tumefaciens and preparation of glycerol stocks 
Single A. tumefaciens colonies were examined for plasmid integration by PCR (II.2.2.7). 
The selected positive clones were grown at 28°C either in YEB medium on a shaker 
incubator at 180 rpm, or on YEB-agar plates (1.5 % (w/v)) containing the appropriate 
antibiotics (II.1.5.1). For long-term storage, 800 µl of a saturated culture was mixed with 
400 µl of glycerol and stored at -80°C. 
II.2.2.5 Preparation of competent A. tumefaciens cells for electroporation 
A single colony of A. tumefaciens grown on a YEB-agar plate containing Rif and Kan 
(YEB-Rif-Kan) was inoculated in 5 ml of YEB-Rif-Kan medium in a 100 ml Erlenmeyer 
flask and incubated at 28°C for two days shaking (180 rpm). One ml of the culture was then 
transferred into 100 ml of YEB-Rif-Kan medium, and cultivated at 28°C for 15-20 h 
shaking (180 rpm) until the OD600nm reached 1-1.5. The cells were chilled on ice for 15 min 
and centrifuged for 5 min at 4000 g, 4°C. The cell pellet was washed tree times with 10 ml 
of ddH2O and finally resuspended in 500 µl of sterile 10 % (v/v) glycerol. The suspension 
was dispensed as 45 µl aliquots into pre-chilled 1.5 ml tubes, immediately frozen in liquid 
nitrogen and stored at -80C. 
II.2.2.6 Transformation of A. tumefaciens by electroporation 
0.2-1.0 µg of plasmid DNA (II.2.1.8) in sterile ddH2O was added to a thawed aliquot of A. 
tumefaciens electrocompetent cells (II.2.2.5), placed on ice for 3 min and then the cell/DNA 
mixture was transferred into a pre-chilled electroporation cuvette (0.2 cm). After application 
of the pulse (25 µF, 2.5 kV, 200 Ω), the cells were diluted in 1 ml of YEB medium and 
incubated for 1 h at 28°C, shaking (180 rpm). One to 10 µl of the culture were plated on 
YEB-Rif-Kan-Carb agar plates and incubated at 28°C for 2-3 days. Single colonies were 
examined for plasmid integration by colony PCR (II.2.1.1). 
II.2.2.7 Identification of recombinant agrobacteria 
For rapid identification and verification of the foreign gene in recombinant agrobacteria, 
isolated single colonies were picked from selective plates using sterile tips and directly 
inoculated in a 0.2 ml PCR tube containing the PCR mix, while the plates were incubated at 
28°C o/n to let the colonies regrow. PCR reaction was carried out as described (II.2.1.1) 
Materials and Methods_______________________________________________________ 
 38 
using a home-made Taq DNA polymerase, and the PCR products were resolved on a 1.2 % 
(w/v) agarose gel by electrophoresis (II.2.1.4).  
II.2.3 Transformation of plants and plant suspension cultures 
II.2.3.1 Growth and maintenance of N. tabacum L. cv. Petit Havana 
Sterile tobacco plants were grown in either plastic Magenta boxes or glass Weck containers 
on MS medium (containing the appropriate antibiotics for selection, if transgenic) in a 
controlled growth chamber with 20-25°C, 16 h photoperiod (7000 lux). 
Non-sterile tobacco plants were grown in a greenhouse in ED73 standard soil (Patzer) with 
0-30 % (v/v) sand under supplementary illumination of 10000 lux (plus the sun light), 
70-90 % humidity and 16 h photoperiod at 24°C (or higher, depending on the outside 
temperature). To prevent cross-pollination, flowers were covered with plastic bags with 
micro pores. Mature, dried seeds were stored in paper bags at Rt. 
 
MS medium  0.44 % (w/v) MS salts with vitamins 
  1 % (w/v) Glucose 
  0.7 % (w/v) Agar, pH 5.8 
II.2.3.2 Transformation of N. tabacum chloroplasts by particle bombardment 
N. tabacum cv. Petit Havana wild type (wt) plants grown in sterile culture (II.2.3.1) were 
used for chloroplast transformation by particle bombardment. The youngest leaves from 
~ 6-8 cm high plants were taken and laid adaxial face upwards, on petri dishes containing 
RMOP medium. For each shot, 1.5 mg of gold particles (0.6 µm) were coated with 20 µg of 
plasmid DNA, prepared at a concentration of 2.5 µg/µl with commercial kits (II.2.1.8). Leaf 
bombardment was performed with a PDS-1000/He System (BioRad) at 1360 psi helium 
pressure, using 1100 psi rupture disks and a hepta adaptor, with a distance from the target of 
9 cm. After shooting, the leaves were cut into 5x5 mm squares and placed adaxial face 
downwards onto RMOP medium containing spectinomycin (500 mg l-1) at 20-25°C, 16 h 
photoperiod (7000 lux), until green calli appeared (4-8 weeks). The calli were then 
transferred onto fresh RMOP-Spec plates until small shoots appeared (4-8 weeks). When 
leaves appeared, they were cut into small pieces (~ 2 x 2 mm) and transferred onto new 
RMOP-Spec plates for the first regeneration round. A double-selection test, placing small 
leaf pieces on RMOP plates containing spectinomycin and streptomycin (both at 500 mg 
ml-1) was also performed to exclude spontaneous resistant mutants. After regeneration of 
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shoots, leaf samples were collected and tested for homoplasmy by RFLP analysis 
(II.2.1.11). The plantlets were subjected to additional regeneration rounds, if necessary, until 
homoplasmic, and they were then transferred in Magenta boxes containing RM-Spec for 
rooting. True homoplasmic transplastomic plants were put in soil and transferred to the 
greenhouse, where they were kept under transparent plastic lids for 1-2 weeks to gradually 
decrease the humidity, and then grown normally. Transplastomic plants were self pollinated 
or, if male-sterile, hand-fertilized with wt pollen, and the seeds were germinated on 
RM-Spec and RM-Spec-Strep medium to confirm homoplasmy of the parental 
transplastomic plant (Figure 5B).  
 
RM macro  0.44 % (w/v) CaCl2 x 2H2O 
  0.17 % (w/v) KH2PO4 
  1.9 % (w/v) KNO3 
  0.37 % (w/v) MgSO4 x 7 H2O 
  1.65 % (w/v) NH4NO3 
 
RM micro  0.169 % (w/v) MnSO4 
  0.086 % (w/v) ZnSO4 x 7 H2O 
  0.062 % (w/v) H3BO3 
  0.0083 % (w/v) KI 
  0.0025 % (w/v) Na2MoO4 x 2 H2O 
  0.00025 % (w/v) CuSO4 x 5 H2O 
  0.00025 % (w/v) CoCl2 x 6 H2O 
 
RMOP medium, pH 5.8 (1 L) 100 ml RM macro  
  10 ml RM micro 
  5 ml FeNaEDTA 1 % (w/v) 
  30 g Sucrose 
  100 mg Myo-inositol 
  1 ml Thiamine HCl 0.001 % (w/v) 
  0.1 ml NAA 0.01 % (w/v) 
  1 ml BAP 0.1 % (w/v) 
  5.4 g Agar 
 
RM medium, pH 5.75 (1 L) 100 ml RM macro 
  10 ml RM micro 
  5 ml FeNaEDTA 1 % (w/v) 
  30 g Sucrose 
  5.6 g Agar   
II.2.3.3 Vacuum agroinfiltration of N. tabacum leaves   
The preparation and vacuum infiltration of tobacco leaves with recombinant A. tumefaciens 
(II.2.2.7) was carried out essentially as described by Kapila et al. (1997). A pre-culture of 
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recombinant agrobacteria (5 µl) from glycerol stock (II.2.2.4), carrying the desired plant 
expression vector of the pTRAkt series (II.1.2.1) was grown in 5 ml YEB-Rif-Carb-Kan 
selection medium (II.2.2.4) for two days at 28°C, shaking (180 rpm). On the third day, this 
saturated culture was used to inoculate 20-100 ml of YEB-Carb-Kan medium 1:100, and the 
suspension was allowed to grow o/n at 28°C, shaking (180 rpm). On the fourth day, the 
culture was induced adding acetosyringone to 20 µM , glucose to 10 mM and MES (pH 5.6) 
to 10 mM, and grown as usual. On the fifth day, the OD600nm of the culture was determined 
(approx. 5.0), the bacterial culture was adjusted to OD600nm ~1.0 with 2x infiltration medium 
and water, and induced for an additional 2 h with 200 µM acetosyringone. N. tabacum cv. 
Petit Havana SR1 wt leaves, freshly harvested, were vacuum-infiltrated at 70 mbar for 20 
min in the bacterial suspension, then placed with the adaxial side upwards in plastic trays 
with moistened Whatman paper. The trays were sealed with Saran wrap and incubated at 
20-25°C with a 16 h photoperiod (7000 lux), for 3 days. 
 
2x Infiltration medium 10 % (w/v) Sucrose 
  20 mM Glucose 
  0.86 % (w/v) MS salts 
  pH 5.6, prepare fresh 
 
II.2.3.4 Syringe agroinfiltration of N. tabacum plants 
Five ml of YEB-Rif-Carb-Kan were inoculated with 5 µl of recombinant agrobacteria from 
a glycerol stock (II.2.2.4) carrying a plant expression vector of the pTRAkt series (II.1.2.1) 
and grown o/n at 28°C, 180 rpm. On the second day, the culture was induced adding 
acetosyringone to 20 µM, glucose to 10 mM, MES pH 5.6 to 10 mM, and grown as usual. 
The following day, the OD600nm of the culture was determined (approx. 3.0), the bacterial 
culture was adjusted to OD600nm ~1.0 with 2x infiltration medium and water, and induced for 
an additional 2 h with 200 µM acetosyringone. The agro-suspension was infiltrated with the 
aid of a 1 ml syringe, without needle, into the leaves of intact N. tabacum cv. Petit Havana 
SR1 wt plants. The infiltrated plants were grown at 20-25°C, 16 h photoperiod (7000 lux), 
for 3-5 days.  
II.2.3.5 Stable nuclear transformation of N. tabacum plants 
Stable nuclear transformation of N. tabacum cv. Petit Havana SR1 was performed according 
to the leaf disc method, using recombinant A. tumefaciens (II.2.2.7), and transgenic T0 
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plants were regenerated from transformed calli (Fraley et al., 1983; Horsch et al., 1985). 
Briefly, wt plants were grown in sterile conditions on MS medium in Weck glasses 
(II.2.3.1) and the youngest leaves (length up to 6 cm) were used for transformation. The 
agrobacteria suspension was prepared inoculating 100 ml of YEB-Rif-Carb-Kan medium 
with 100 µl of glycerol stock of the selected clone and growing the culture o/n at 28°C, 
shaking at 180 rpm. On the next day the cells were pelletted by centrifugation at 5000 g for 
10 min, resuspended in 250 ml of induction medium and cultivated o/n at 28°C, shaking at 
180 rpm. Agrobacteria cells were centrifuged 15 min at 5000 g, resuspended in 50 ml of 
MMA buffer, and kept at Rt for 2 h. The OD600nm was adjusted to 1.0. The leaves were cut 
into small pieces, transferred into Weck glasses containing 50-100 ml of recombinant 
agrobacteria suspension and incubated for 30 min at Rt. The leaf pieces were then 
transferred onto sterile pre-wetted Whatman filters in petri dishes, closed with saran wrap 
and incubated at 25°C in the dark for two days. Afterwards, they were transferred onto 
MS-II plates and incubated first at 25°C in the dark for 3 days, and then with a 16 h 
photoperiod until shoots appeared, transferring them onto fresh plates every 2 weeks. When 
shoots appeared, they were transferred onto MS-III plates, incubated at 20-25°C with a 16 h 
photoperiod (7000 lux), until roots developed and finally transferred into soil and grown in 
the greenhouse (II.2.3.1).  
 
Induction medium  YEB medium 
  10 mM MES 
  pH 5.6 
 
MMA buffer   0.43 % (w/v) 
  10 mM MES  
  2 % (w/v) Sucrose  
  200 µM Acetosyringone (added just before use) 
pH 5.6 
 
MS-II medium  MS medium with 
  1 mg l-1 BAP 
  100  mg l-1 Kanamycin 
  200-500 mg l-1 Claforan 
 
MS-III medium  MS medium with  
100 mg l-1 Kanamycin 
 200-500 mg l-1 Claforan 
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II.2.3.6 Growth and maintenance of Nicotiana tabacum cv. BY-2 cells 
N. tabacum cv. BY-2 suspension cells and calli were cultivated in BY-2 medium at 26°C in 
the dark, shaking at 160 rpm for the suspension cultures. Suspension cells were sub-cultured 
weekly using a 2 % (v/v) inoculum, while pinpoint-sized clumps of callus cells were 
transferred to fresh plates monthly. 
 
BY-2 medium (1L)  4.43 g MSMO 
  30 g Sucrose 
  100 µl 2,4-D (2 mg/ml) 
  150 µl Thiamine-HCl (4 mg/ml) 
  0.2 g KH2PO4 
  (2 g (w/v) Agar) 
 
II.2.3.7 Stable transformation of N. tabacum cv. BY-2 cells 
N. tabacum cv. BY-2 cells were transformed by co-cultivation with recombinant 
A. tumefaciens as follows. 100 ml of BY-2 medium were inoculated with 2 % (v/v) BY-2  
wt cells 3 days ahead of the transformation date, and 10 ml of YEB-Rif-Kan-Carb medium 
were inoculated 1:100 with a glycerol stock of recombinant agrobacteria (II.2.2.4) and 
grown at 28°C, shaking (180 rpm) for 2 days. On the day of transformation, three ml of 
BY-2 culture, induced with 200 µM acetosyringone, were co-inoculated with 150 µl of 
agrobacteria (OD600nm ~1) in a small petri dish (5 cm). After incubation for 3 days in the 
dark at 24°C, the cells were transferred to centrifuge tubes and sedimented (3min/100g/Rt). 
The cells were gently resuspended in 2 ml of BY-2 medium containing 200µg/ml claforan, 
and around 500-700 µl of the resuspended cells were transferred onto a BY-2 medium plate 
containing 100 µg/ml Kan and 200 µg/ml claforan; other 500 µl of BY-2 medium were 
added to facilitate an even distribution of the cells on the plate. After the liquid medium had 
mostly evaporated, the plates were sealed with parafilm and incubated at 24°C in the dark 
for 3-4 weeks, until transgenic calli appeared.  
 
II.2.3.8 Identification of transformants by visualization of DsRed fluorescence 
The fluorescence of the reporter protein DsRed was visualized by incubating the transiently 
infiltrated tobacco leaves (II.2.3.4) or the stably transformed BY-2 cells (II.2.3.7) with an 
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LCD lamp with glass fibre optic (Leica KL1500), an additional filter for green excitation 
(BP545/30) and a coloured foil (# 182, light red). 
 
II.2.4 Protein analysis 
II.2.4.1 Isolation of total soluble proteins from tobacco leaves 
For screening purposes, around 100 mg leaf tissue were collected into a 1.5 ml tube and 
extracted in 3 volumes of pre-cooled protein extraction buffer with a drilling device. 
Aqueous supernatant was collected after centrifugation at 16000 g for 30 min at 4 °C, and 
the samples either used immediately or stored at -20°C. 
 
Plant protein extraction buffer PBS, pH 7.4 
  0.05 % (v/v) Tween 20 
  5 mM EDTA 
  2 % (w/v) PVPP 
 
 
For large scale extraction for IL-10 purification, leaf material, deprived of the midrib, was 
ground to a fine powder using a mortar and pestel in liquid nitrogen. The recovered material 
was weighed and homogenized with 3 volumes of IL-10 extraction buffer and further 
processed according to the IL-10 purification protocol (II.2.4.13). 
 
IL-10 extraction buffer  PBS pH 6.0 
5 mM Ascorbic Acid  
5 mM β-Mercaptoethanol) 
 
 
II.2.4.2 Isolation of total soluble proteins from BY-2 cells 
For screening purposes, around 200 mg of either callus or cell pellet from a liquid culture 
(10 min at 16000 g, 4°C) were weighed in a 2 ml plastic tube, and sonicated on ice for 
1 min, 9 x 10 % cycle,  35 % power with 2 volumes of BY-2 extraction buffer. Clear 
supernatant was separated from cell debris by centrifugation at 16000 g for 30 min at 4°C. 
 
BY-2 extraction buffer PBS pH 7.4 
  0.05 % (v/v) Tween-20 
5 mM EDTA pH 8.0 
  1 % (v/v) DMSO – freshly added 
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For large scale extraction for IL-10 purification, the BY-2 cell pellet (15 min at 5000 g, 
4°C) from 250 ml of a 5 days old liquid culture was washed once with PBS (pH 7.4) and 
then homogenized with 2 volumes of IL-10 extraction buffer (II.2.4.1) with a dip-in blender 
in a metal beaker placed on ice. The extract was further processed according to the IL-10 
purification protocol (II.2.4.13). 
II.2.4.3 Isolation of total soluble proteins from animal cell cultures 
After stimulation (II.2.6.2, II.2.6.4), J774 cells (~1 x 105/well) were diluted in ice-cold PBS 
and centrifuged twice for 5 min at 500 g, 4°C. Cells were then resuspended in lysis buffer 
containing inhibitors of proteases (5 µg/ml leupeptin, 5 µg/ml pepstatin A, 1 mM PMSF, 
1 mg/ml α1-antitrypsin) and phosphatases (1 mM Na3VO4, 10 mM NaF, 10 µM phenylarsin 
oxide), and following a 15 min incubation on ice, cell debris were spun down (12000 g, 
20 min, 4°C) and the supernatants were frozen and stored at -80°C until use. Small aliquots 
of the various extracts were used for protein content determination (II.2.4.4). 
 
Lysis buffer  20 mM HEPES, pH 7.9 
  420 mM NaCl  
  1 mM EDTA  
  1 mM EGTA 
  1 % (v/v) Nonidet P-40 
  20 % (v/v) Glycerol 
  1 mM DTT 
 
II.2.4.4 Total soluble protein quantification 
Bradford reagent Roti-Quant (Roth) was used to determine the concentration of total 
soluble proteins (Bradford, 1976). Standard protein solutions were prepared ranging from 
250 to 31 µg/ml using bovine serum albumin (BSA) to determine the calibration curve. 
Then, 10 µl of a 1/20 and 1/40 dilution of protein extract in PBS (pH 7.4) were mixed with 
200 µl of 1/5 diluted Bradford reagent in a 96-well (flat bottom, low binding) 
microtiterplate (Greiner Bio-one). All samples were assayed in duplicate, the 
spectrophotometer was blanked with 1/5 diluted Bradford reagent alone and absorbance was 
read at 595 nm on a microtiterplate reader (Bio-TEK). Protein concentration was then 
calculated by comparing the OD595nm of each sample with the OD595nm of the standard 
protein (BSA) curve. 
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II.2.4.5 SDS-PAGE with Tris-Glycine gels 
Proteins were electrophoretically separated by discontinuous SDS-PAGE as described 
(Laemmli, 1970). 
 
Running gel (2 gels) 7.5 % 12 % 17 % 
ddH2O 4.8 ml 3.3 ml 1.63 ml 
1.5 M Tris-HCl, pH 8.8 2.5 ml 2.5 ml 2.5 ml 
SDS 10 % (w/v) 100 µl 100 µl 100 µl 
Acrylamyde 30 % (w/v) 2.5 ml 4 ml 5.66 ml 
TEMED 8 µl 4 µl 4 µl 
APS 20 % (w/v) 50 µl 50 µl 50 µl 
 
Stacking gel (2 gels)  
ddH2O 3.645 ml 
1 M Tris-HCl, pH 6.8 625 µl 
SDS 10 % (w/v) 50 µl 
Acrylamyde 30 % (w/v) 830 µl 
TEMED 5 µl 
APS 20 % (w/v) 15 µl 
 
Before loading, proteins were denatured and solubilised in either reducing or non-reducing 
1x SDS sample buffer at 100°C for 10 min. Electrophoresis was carried out in SDS running 
buffer, with a constant voltage of 20 V/cm.  
Proteins were visualised by staining with Coomassie brilliant blue (II.2.4.7), Silver (II.2.4.8)  
or transferred by tank-blotting (90 min at 180 V) onto either nitrocellulose or PVDF 
membranes for immunoblot analysis. 
 
5x Reducing SDS sample buffer 62.5 mM Tris-HCl pH 6.8 
  30 % (v/v) Glycerol 
  4 % (v/v) SDS 
  0.05 % (w/v) Bromphenol blue 
  10 % (v/v) β-Mercaptoethanol 
 
5x Non-reducing SDS sample buffer 62.5 mM Tris-HCl pH 6.8 
  30 % (v/v) Glycerol 
  4 % (v/v) SDS 
  0.05 % (w/v) Bromphenol blue 
 
5x SDS running buffer 125 mM Tris-base 
  960 mM Glycine 
  0.5 % (w/v) SDS 
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II.2.4.6 SDS-PAGE with Tris-Tricine gels 
For total soluble protein separation in the range from 1 to 100 kDa, Tricine-SDS-PAGE was 
performed (Schagger and von Jagow, 1987). 
 
 10 % Separating gel (2 gels) Stacking gel (2 gels) 
Rotiphorese Gel A 3.25 ml 650 µl 
Rotiphorese Gel B 1.5 ml 300 µl 
3M Tris HCl, pH 8.45 3.334 ml 1.25 ml 
10 % (w/v) SDS 100 µl 37.3 µl 
80 % (v/v) Glycerol 1.326 ml - 
ddH2O 450 µl 2.72 ml 
TEMED 3.6 µl 4 µl 
10 % (w/v) APS 36 µl 40 µl 
 
Before loading, proteins were denatured and solubilised in Tricine-sample buffer at 100°C 
for 10 min. Electrophoresis was carried out with the appropriate anode and cathode buffers, 
at 30 V for 1 h and then at 70 V constant for 13 h, with a buffer cooling system. Proteins 
were visualised by staining with Coomassie brilliant blue (II.2.4.7). 
 
2x Tricine-sample buffer 0.1 M Tris-HCl, pH 6.8 
24 % (v/v) Glycerol 
8 % SDS (w/v) 
0.2 M DTT  
0.02 % (w/v) Coomassie Blue G250 
 
10x Anode buffer  2 M Tris-HCl, pH 8.9 
 
10x Cathode buffer  1 M Tris-base 
  1 M Tricine 
  1 % (w/v) SDS 
  pH ~ 8.25 (do not adjust) 
 
II.2.4.7 Coomassie brilliant blue staining 
Proteins separated by SDS-PAGE (II.2.4.5, II.2.4.6) were visualized by Coomassie brilliant 
blue staining as described (Fairbanks et al., 1971). The gel was stained with 100 ml of 
Fairbanks A solution, heated in a microwave (1000 W) until boiling point (ca. 2 min), and 
then let cool down at Rt for ca. 5 min, gently shaking. The solution was discarded, the gel 
briefly rinsed with dH2O, 100 ml of Fairbanks D solution were added and then heated in a 
microwave until boiling point (ca. 1min 20 sec). A piece of kimwipe was added to absorb 
the stain, and the solution was allowed to cool down at Rt for ca. 5 min, gently shaking. The 
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solution was then replaced with fresh Fairbanks D solution, and kept gently shaking until 
the gel background became transparent. The gel was eventually dried between cellophane 
sheets for documentation purposes. 
 
 
Fairbanks A (staining solution) 0.05 % (w/v) Coomassie R-250 
  25 % (v/v) Isopropanol 
  10 % (v/v) Acetic acid 
 
 
Fairbanks D (destaining solution) 10 % (v/v) Acetic acid 
 
 
II.2.4.8 Silver staining 
For higher sensitivity and to detect small amounts of proteins, SDS-polyacrylamide 
(SDS-PAA) gels were silver stained according to the protocol from Shevchenko 
(Shevchenko et al., 1996), summarized as follows: 
Step Solution Time 250 ml (2 minigels) 
Fixation 50 % (v/v) Methanol 5% (v/v) Acetic acid 20 min 
125 ml 
12.5 ml 
Wash 50 % (v/v) Methanol dH2O 
10 min 
10 min 
125 ml 
250 ml 
Sensitizing 0.02 % (w/v) Na2S2O3 1 min 0.05 g 
Silver Reaction 0.1 % (w/v) AgNO3 20 min, 4°C 0.25 g 
Wash dH2O 2 x 1 min  
Developing 0.04 % (v/v) Formaldehyde (37 %) 2 % (w/v) Na2CO3  
750 µl 
5 g 
 
→ keep shaking gently while developing 
→ when the solution is yellow discard it and replace it with a fresh portion 
→ the solution has to be transparent 
 
Stopping 5 % (v/v) Acetic acid 10 min 12.5 ml 
Storing 1 % (v/v) Acetic acid, 4°C  2.5 ml 
 
II.2.4.9 Immunoblot with AP detection system 
Electrophoretically separated proteins were transferred from a SDS-PAA gel onto a 
HybondTM-C nitrocellulose membrane (45 µm) in the presence of transfer buffer for 90 min 
at 180 V. The membrane was blocked with 5 % (w/v) skim milk in PBST for 1 h at Rt, and 
then blotted proteins were probed with the primary antibody o/n at 4°C. The bound antibody 
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was detected by the addition of the appropriate secondary polyclonal antibody coupled to 
alkaline phosphatase (AP) (II.1.3). Both primary and secondary antibodies were diluted in 
PBST. To remove unspecifically bound antibodies, the membranes were extensively washed 
with PBST in between each step. The target proteins were finally revealed by addition of the 
substrate NBT/BCIP dissolved in AP buffer. 
 
Blotting buffer  25 mM Tris-HCl, pH 8.3 
  192 mM Glycine 
  20 % (v/v) Methanol 
 
 
10x PBS  1.37 mM NaCl 
  27 mM KCl 
  81 mM Na2HPO4x 12H2O 
  15 mM KH2PO4 
 
  
PBST  1x PBS, pH 7.4 
  0.05 % (v/v) Tween 20 
   
 
AP Buffer  100 mM Tris-HCl, pH 9.6 
  100 mM NaCl 
  5 mM MgCl2 
II.2.4.10 Immunoblot with HRP detection system 
Electrophoretically separated proteins were transferred from a SDS-PAA gel onto a PVDF  
membrane (45 µm), pre-activated in methanol, in the presence of transfer buffer for 90 min 
at 180 V. The membrane was blocked with 5 % (w/v) skim milk in PBST for 1 h at Rt, and 
then blotted proteins were probed with the primary antibody o/n at 4°C. The bound antibody 
was detected by the addition of the appropriate secondary polyclonal antibody coupled to 
horse radish peroxidase (HRP). Both primary and secondary antibodies were diluted in 
PBST. To remove unspecifically bound antibodies, the membranes were extensively washed 
with PBST in between each step. The target protein were finally revealed with the ECL Plus 
Western Blotting Detection kit (GE Healthcare) and the signal was either captured with a 
LAS 3000 imaging system (Fujifilm) or using a BioMax autoradiography film (Kodak). 
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II.2.4.11 Dot blot analysis 
Dot blot analysis was used to screen either the transgenic plants or the transgenic calli for 
IL-10 production. Two to 20 µl of row extract and 20 or 100 ng of commercial murine (BD 
Pharmingen) or viral IL.10 (R&D Systems), respectively, as positive control were dotted 
directly onto a nitrocellulose membrane. The membrane was blocked with 5 % (w/v) skim 
milk in PBST for 1 h and the primary antibody (1:2000 for the anti murine and 1:1000 for 
the anti viral IL-10, in PBST) was applied o/n, at 4°C. The membrane was then incubated 
with the secondary RARAP antibody (1:5000 in PBST) for 1 h at Rt, and the signal detected 
with the NBT/BCIP substrate. 
II.2.4.12 IL-10 quantification by ELISA 
Determination of the concentration of IL-10, in either row extracts or elution fractions after 
Ni-NTA purification, was performed by sandwich enzyme-linked immunosorbent assay 
(ELISA) according to the following protocol (in between each steps, the plates were washed 
3 times with PBST): 
• Capture antibody: 96-well, flat bottom, high binding microtiterplates (Greiner 
Bio-One) were coated o/n at 4°C with 100 µl of the respective antibodies diluted in the 
appropriate coating buffer:  
mIL-10: monoclonal anti-mIL-10 Ab (BD Pharmingen) diluted to 2 µg/ml in 
mIL-10 Coating buffer Na2HPO4 11.8 g 
NaH2PO4 16.1 g 
dH2O to 1000 ml 
  Adjust the pH 6.5, store at 4°C 
 
vIL-10: monoclonal anti- v-IL-10 (BD Biosciences) diluted to 0.5 µg/ml in 
vIL-10 Coating buffer Na2CO3 1.59 g 
NaH2CO3 2.93 g 
NaN3 0.2 g 
dH2O to 1000 ml 
Adjust the pH 9.6 with acetic acid, store at 4°C 
 
• Blocking: the wells were incubated with 200 µl blocking buffer (1 % (w/v) BSA in 
PBST buffer) for 1 h at Rt.   
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• Sample application: samples were brought to the appropriate dilution with PBS and 
applied to the 96 well plate using a multichannel pipettor and incubated o/n at 4°C. 
Standards for the calibration curve were 12 2-fold serial dilutions of, respectively: 
mIL-10 (BD Pharmingen) diluted to 50 ng/ml starting concentration in PBS, and vIL-10 
(R&D Systems) diluted to 1 ng/ml starting concentration in PBS. 
• Detection biotinylated antibody: 100 µl of either biotinylated monoclonal rat 
anti-mIL-10 (BD Pharmingen) or biotinylated monoclonal rat anti-vIL-10 (BD 
Pharmingen), diluted to 1 µg/ml in blocking buffer, were applied to each well and 
incubated for 1h at Rt. 
• Streptavidin-AP conjugated: 100 µl of Streptavidin-AP (Jackson ImmunoResearch) 
diluted 1:5000 in blocking buffer were applied to each well and incubated for 30 min at 
Rt. 
• Detection: 100 µl of the substrate para-nitrophenylphosphate (SIGMA, #104-105) 
diluted to 1 mg/ml in substrate buffer were added to each well, the colour reaction 
developed at Rt until yellow, and the OD of the plate read at 405 nm using the 
microtiterplate reader. 
Substrate buffer   0.1M Diethanolamine 
  150 mM NaCl  
  1 mM MgCl2 
pH 9.6    
   
II.2.4.13 Ni-NTA purification 
His6-tagged IL-10 was affinity purified from either plant leaves or BY-2 cell pellet by 
immobilized metal ion affinity chromatography (IMAC). 1 ml of Ni-NTA-agarose matrix 
(QIAGEN) was poured in a disposable Econo-Pac column (BioRad) and used for 
purification. After cell disruption (II.2.4.1, II.2.4.2), row extract was centrifuged at 15000 g 
for 15 min, and the supernatant filtered through a paper filter (Macherey-Nagel, #615). 
Afterwards, the filtrate was adjusted to 500 mM NaCl, 5 mM Imidazole, pH 8.0, and 
incubated on ice for 1 h, gently shaking. The extract was then centrifuged at 30000 g for 30 
min, 4°C, the supernatant filtered through miracloth material and then loaded onto the 
column, previously equilibrated with wash buffer. The flow rate for the loading was 
adjusted to 2 ml/min. The column was extensively washed with at least 20 column volumes 
of wash buffer, and elution was performed with 2-3 volumes of elution buffer. All steps 
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were performed at 4°C. The collected elution fractions were dialyzed o/n at 4°C against 
water, and then lyophilized using an Alpha 1-4 LSC freeze-dryer (Christ). Lyophilized 
material was then dissolved in PBS (pH 7.4), the preparation was centrifuged to remove 
residual insoluble material, and IL-10 concentration in the supernatant was determined by 
ELISA (II.2.4.12). 
 
Wash buffer  1x PBS 
500 mM NaCl 
  5 mM Imidazole 
  pH 8.0 
 
Elution buffer  1x PBS 
  500 mM NaCl 
  500 mM Imidazole 
  pH 8.0 
 
II.2.4.14 Gel filtration 
To assess whether plant produced mIL-10 was completely in the dimeric state, the IMAC 
purified protein (II.2.4.13) was analyzed by gel filtration using an ÄKTAprime plus 
purification apparatus (GE Healthcare) and a Superdex 200 column (10/30, GE Healthcare), 
with PBS (pH 7.4) as eluent and a flow rate of 0.35 ml/min. 450 ng of purified recombinant 
mIL-10 were loaded on the column, and 1 ml (elution volumes 7-12 and 17-28 ml) and 0.2 
ml fractions (elution volumes 12-17 ml) were collected. The elution fractions were analyzed 
for IL-10 concentration by ELISA (II.2.4.12). 
II.2.4.15 Mass spectrometry 
Murine and viral IL-10, purified from either leaf material or BY-2 cell pellet by IMAC 
(II.2.4.13), were separated on a 17 % gel by SDS-PAGE (II.2.1.4), and the proteins were 
visualized by Coomassie brilliant blue staining (II.2.4.7). The bands were then excised, 
destained, carbamidomethylated, digested with trypsin and extracted from gel pieces as 
previously described (Kolarich and Altmann, 2000; Kolarich et al., 2006). Subsequent 
fractionation of the peptides by capillary reversed-phase chromatography, with detection by 
a quadrupole time-of-flight (Q-TOF) Ultima Global mass spectrometer (Waters Micromass, 
Manchester, UK), was performed as described previously (Van Droogenbroeck et al., 
2007). The MS data from the tryptic peptides were compared with data sets generated by in 
silico tryptic digestion of the recombinant protein sequences using the PeptideMass program 
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(http://www.expasy.org/tools/peptide-mass.html). Sequences of the N-terminal peptides 
were confirmed by tandem MS experiments. Data were analyzed with MassLynx 4.0 SP4 
Software (Waters Micromass, Mildford, MA, USA). The MS-analyses were performed by 
Johannes Stadlmann from the BOKU, Wien, Austria. 
 
II.2.5 Electron microscopy  
II.2.5.1 Specimen processing for ultrastructure analysis 
Tobacco leaves were cut into small squares of around 1 mm2 with a razor blade and fixed 
o/n at 4°C in fixative solution (2 % (w/v) paraformaldehyde, 2.5 % (v/v) glutaraldehyde in 
0.1 M phosphate buffer (pH 7.4). Specimens were then washed five times for 15 min with 
0.1 M phosphate buffer (pH 7.4) at 4°C. Samples were post-fixed in  a 1 % (w/v) osmium 
tetroxide and 0.8 % (w/v) potassium ferricyanide solution in 0.1 M phosphate buffer (pH 
7.4) for 3 h at 4°C, and the samples were then washed five times for 15 min with 0.1 M 
phosphate buffer (pH 7.4). Dehydration was carried out passing the specimens through an 
acetone series (50 % (v/v), 1 x 10 min; 70 % (v/v), 2 x 10 min; 90 % (v/v), 3 x 10 min; 96 % 
(v/v), 3 x 10 min, and 100 % (v/v), 3 x 15 min) at 4°C. Specimens were then infiltrated in 
Spurr epoxy resin, in a series 1:3, 2:2, 3:1 resin:acetone (v/v), for 3 h each, and 100 % (v/v) 
resin o/n at 4°C. The specimens were then transferred into Beem capsules (SPI Supplies) 
filled with freshly prepared Spurr resin, and allowed to polymerize at 60°C for 48 h. Thin 
sections showing silver interferences were obtained using a Ultracut E ultramicrotome 
(Leica) and were mounted on Formvar-coated 200 mesh gold grids (Sigma). The sections 
were stained for 10 min at Rt with an aqueous 2 % (w/v) uranyl acetate solution, washed 
with ddH2O and air-dried. They were analyzed with a EM 400 transmission electron 
microscope (Philips) running at 80 kV by Elsa Arcalis from the RWTH, Aachen, Germany. 
 
0.1 M Phosphate buffer, pH 7.4 19 % (v/v) 200 mM NaH2PO4 
  
81 % (v/v) 9.9 mM Na2HPO4 
 
Spurr resin  12 % (w/v) DER. 736 Resin 
  0.8 % (w/v) DMAE 
  49 % (w/v) NSA 
  20 % (w/v) VCD 
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II.2.5.2 Specimen processing for immunolocalization 
Tobacco leaves were cut into small squares of around 1 mm2 with a razor blade and fixed 
o/n at 4°C in fixative solution (4 % (w/v) paraformaldehyde, 0.2 % (v/v) glutaraldehyde in 
0.1 M phosphate buffer, pH 7.4). Specimens were then washed five times for 15 min with 
0.1 M phosphate buffer (pH 7.4) at 4°C. Dehydration was carried out first by immersing the 
specimens in a 50 % (v/v) ethanol solution at 4°C for 30 min, then passing the specimens 
through an ethanol series (70 % (v/v), 96 % (v/v) and 100 % (v/v), for 30 min each) at 
-20°C. Specimens were then infiltrated in LR White Resin (London Resin Company), 
containing 0.5 % (w/v) benzoin methyl ether, in a series 1:3, 2:2, 3:1 resin:ethanol (v/v), for 
1 h each, and 100 % (v/v) resin o/n at -20°C. The specimens were then transferred into 
Beem capsules (SPI Supplies) filled with freshly prepared LR White resin, and allowed to 
polymerize under UV light at -20°C for 24 h in an automatic freeze substitution unit (Leica). 
Then, thin sections showing silver interferences were obtained using a Ultracut E 
ultramicrotome (Leica) and were mounted on Formvar-coated 200 mesh gold grids (Sigma). 
II.2.5.3 Immunogold labeling 
For immunogold labeling, grids carrying ultra thin sections of LRW-embedded specimens 
(II.2.5.2) were floated on drops of 6 % (w/v) BSA in phosphate buffer (0.1 M, pH 7.4) for 
20 min at Rt. The sections were incubated o/n at 4°C with either a goat anti-vIL-10 (1:100 
in 0.1 M phosphate buffer; R&D Systems) or a rabbit anti-mIL-10 (1:300 in 0.05 % (v/v) 
Tween 20, 0.1 M phosphate buffer; Acris) antibody, both pre-adsorbed 1:10 in wt extract. 
After washing wit 0.1 M phosphate buffer supplemented with 0.5 % Tween 20 (v/v), the 
sections were incubated with the secondary antibody conjugated to 10-nm gold particles 
(Molecular Probes) diluted 1:30 in phosphate buffer and incubated at Rt for 1 h. The grids 
were then washed with phosphate buffer and water, air-dried and stained with an aqueous 
2 % (w/v) uranyl acetate solution at Rt for 10 min. Electron microscopy was carried out on a 
EM 400 transmission electron microscope (Philips) running at 80 kV, and was performed by 
Elsa Arcalis from the RWTH, Aachen, Germany. 
 
Materials and Methods_______________________________________________________ 
 54 
II.2.6 Biological activity assays 
II.2.6.1 Maintenance of the mouse macrophage cell line 
The mouse macrophage cell line J774 was maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) (Bio-Whittaker) supplemented with 5 % (w/v) low endotoxin fetal bovine 
serum (FBS) (Biochrom Seromed), at 37°C in atmosphere containing 5% (v/v) CO2, and 
passaged twice weekly.  
II.2.6.2 STAT3 phosphorylation assay 
J774 cells were seeded at a density of ~ 8 x 105 cells/well in a 24-well tissue culture plate 
and then stimulated with either commercial murine IL-10 (BD Pharmingen) or viral IL-10 
(R&D Systems), increasing doses of plant purified murine or viral IL-10, or purified extract 
from wt leaves as negative control. After 20 min incubation, the cells were immediately 
blocked with ice-cold PBS, then proteins extracted (II.2.4.3) and quantified (II.2.4.4). For 
tyrosine-phosphorylated and total STAT3 detection, 40 µg of protein extracts were 
separated on a 7.5 % (w/v) gel by SDS-PAGE (II.2.4.5), and two color immunoblots were 
performed with rabbit anti-phospho-STAT3 (Tyr705) and mouse anti-STAT3 124H6 
antibodies (Cell Signaling), respectively, both diluted 1:1000. Detection was simultaneously 
carried out with Alexa Fluor680 goat anti-rabbit (1:5000, Invitrogen) and IRDye800-
conjugated goat anti-mouse (1:2500, Rockland) secondary antibodies. Blotted proteins were 
detected and quantified using the Odyssey infrared imaging system (LI-COR Biosciences) 
and software provided by the manufacturer. 
II.2.6.3 LPS-induced TNFα inhibition assay 
J774 cells were seeded at a density of ~ 4 x 105 cells/well in a 48-well tissue culture plate 
and stimulated with 100 ng/ml ultrapure E. coli LPS (0111:B4 strain, InvivoGen) for 18 h in 
presence or absence of either commercial or plant produced murine or viral IL-10. Cells 
were then spun down by centrifugation, and determination of TNFα levels in cell-free 
supernatants was performed using a commercial ELISA kit (DY410; R&D Systems), 
according to the manufacturer’s instructions. 
II.2.6.4 Analysis of SOCS3 expression 
J774 cells were seeded at a density of ~ 4 x 105 cells/well in a 48-well tissue culture plate 
and stimulated with 100 ng/ml LPS for 18 h in presence or absence of either commercial or 
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plant produced murine or viral IL-10. For SOCS3 gene expression analysis, total RNA was 
extracted (II.2.1.15), reverse transcription was carried out and real time RT-PCR was 
performed in triplicate from 10 ng cDNA for each sample (II.2.1.16). For determination of 
SOCS3 protein amounts, proteins were extracted from the cells (II.2.4.3) and quantified 
(II.2.4.4), and 50 µg of total protein extracts were separated on a 7.5 % (w/v) gel by 
SDS-PAGE (II.2.4.5). Two color immunoblots were performed with rabbit anti-NH2 
terminus SOCS3 (1:150, IBL) and mouse anti-GAPDH antibodies (1:4000, Ambion). 
Detection was simultaneously carried out with Alexa Fluor680 goat anti-rabbit (1:5000, 
Invitrogen) and IRDye800-conjugated goat anti-mouse (1:2500, Rockland) secondary 
antibodies. Blotted proteins were detected and quantified using the Odyssey infrared 
imaging system (LI-COR Biosciences) and software provided by the manufacturer. 
 
II.2.7 Simulated gastrointestinal digestion 
The stability of plant-produced murine and viral IL-10, either embedded in the lyophilized 
tobacco tissue or purified from tobacco leaves (II.2.4.13), was compared, along with the 
commercial counterparts, in in vitro gastrointestinal simulation conditions. The experiments 
were conducted over a range of time points (0 s, 15 s, 30 s, 1 min, 5 min, 15 min, 30 min, 
1 h) at 37°C. Purified IL-10 was digested in either simulated gastric fluid (SGF) or 
simulated intestinal fluid (SIF) at a concentration of 1 ng/ml. At each time point, 10-ng 
aliquots were taken and the digestion reaction was stopped by either adding Na2CO3 to a 
final concentration of 45 mM, for the SGF, or EDTA to a final concentration of 10 mM, for 
the SIF. Samples were then analyzed by ELISA (II.2.4.12) for IL-10 quantification. 
For the analysis of the protective effect of leaf tissue on murine and viral IL-10, stable 
transgenic leaves expressing the recombinant protein (II.2.3.1) were snap-frozen in liquid 
nitrogen, ground with mortar and pestle and freeze-dried as 0.1 g aliquots in 1.5 ml tubes. 
For each time point, a single aliquot of leaf tissue was incubated with 700 µl of either SGF 
or SIF, and the reaction quenched at the appropriate time, as described. After digestion, the 
leaf powder was extracted with 2 volumes of buffer (II.2.4.1) and the IL-10 content in the 
extract was determined by ELISA (II.2.4.12). 
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Simulated gastric fluid (SGF) 3.2 g/l Pepsin 
  2 g/l NaCl 
  pH 1.2 
 
Simulated intestinal fluid (SIF) 10 g/l Pancreatin 
  7.8 g/l NaH2PO4 x H2O 
  pH 6.8 
 
II.2.8 Statistical analysis 
Statistical changes in TNFα production and SOCS3 mRNA expression levels were 
determined using the one-way ANOVA with α set to 0.05, according to the Newman-Keuls 
test. 
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III RESULTS 
 
 
III.1 Expression of IL-10 in tobacco chloroplasts 
III.1.1 Generation of transplastomic plants 
The constructs for chloroplast transformation were generated amplifying the m/vIL-10 
mature sequences by PCR (II.2.1.1) using primers designed to introduce a His6-tag at the 
C-terminus, and to create NdeI and XbaI recognition sites at the 5’ and 3’ ends, respectively 
(II.1.2.2, Ch_m_f and Ch_m_His_r for the murine, and Ch_v_f and Ch_v_His_r for the 
viral IL-10). The resulting amplification products were digested with the appropriate 
restriction enzymes and inserted into the chloroplast expression cassette of the pHK20 
plasmid (II.1.2.1), replacing the nptII coding region. The correctness of the inserted 
fragments was confirmed by sequencing, and the expression cassettes containing the m/vIL-
10 cDNA were excised digesting the pHK20/IL-10 vectors with SacI and HindIII.  
 
Figure 4: Map of the chloroplast transformation vector and its integration site in the tobacco plastome. 
(A) Physical map of the chloroplast genome region into which the pRB95 vector (II.1.2.1) integrates by 
homologous recombination. The transgenes are targeted to the intergenic region between the trnfM and trnG 
genes (Ruf et al., 2001). Selected relevant restriction sites are marked. The BglII restriction sites and the 
hybridization position of the probe used for RFLP analyses (II.2.1.11) are indicated. (B) Structure of the 
plastid transformation vector pRB95_IL-10. The transgene expression cassette consists of the ribosomal RNA 
operon promoter fused to the 5’ untranslated region (5’UTR) from gene 10 of phage 7 (Prrn-T7g10) and the 
3’UTR of the plastid rbcL gene (TrbcL). The selectable marker gene aadA is driven by a chimeric ribosomal 
RNA operon promoter (Prrn) and fused to the 3’UTR from the plastid psbA gene (TpsbA). 
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Finally, the inserts were cloned into the similarly digested chloroplast transformation vector 
pRB95 (II.1.2.1), which allows single copy insertion of the transgene in a defined DNA 
sequence of the tobacco plastome by homologous recombination (Figure 4), and contains 
the aadA gene as selectable marker, conferring resistance to the aminoglycoside-type 
antibiotics spectinomycin and streptomycin. 
Chloroplast transformation of N. tabacum cv. Petit Havana was achieved by biolistic 
bombardment of young sterile tobacco leaves with plasmid DNA-coated gold particles 
(II.2.3.2).   
III.1.2 Selection of homoplasmic lines 
Primary Spec-resistant lines were identified as green calli or regenerating shoots on medium 
containing the antibiotic. During selection of the plant tissue on spectinomycin-containing 
medium, however, spontaneous resistance to the antibiotic can arise by specific point 
mutations in the chloroplast 16S rRNA gene (Svab and Maliga, 1991). To eliminate the 
spontaneous mutants, the leaf pieces were exposed to double selection on medium 
containing both spectinomycin and streptomycin (II.2.3.2). The aadA gene, if inserted, 
confers resistance to both aminoglycoside-type antibiotics, while the spontaneous point 
mutations confer only resistance to spectinomycin (Figure 5A).  
For the murine construct, 5 spectinomycin-resistant lines were obtained, only one of which 
(line #4) survived the double selection test. Line #4 was confirmed to be a true transformant 
containing the aadA and the mIL-10 genes by PCR analysis (II.2.1.1, PaadA136 and m-int_r 
primers, not shown). Homoplasmy of this line was assessed by restriction fragment length 
polymorphism (RFLP) analysis (II.2.1.11) on a few plants derived from the first 
regeneration round, which gave the expected hybridization pattern and demonstrated that 
the line was already in homoplasmic state (not shown). Seeds from two of these plants (C 
and D) were tested by germination on spectinomycin-containing medium (Figure 5B) and 
the T1 plantlets were also analyzed by RFLP analysis (Figure 6A), both assays confirming 
again the homoplasmic state of this transplastomic line. 
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Figure 5: Selection of true transplastomic lines on antibiotic-containing medium. 
(A): During the regeneration of chloroplast transformants on spectinomycin-containing medium, spontaneous 
resistance to the antibiotic can occur through acquisition of specific point mutations in the chloroplast 16S 
rRNA gene. Spontaneous spectinomycin-resistant mutant lines were effectively eliminated by selection on 
synthetic medium containing both spectinomycin (Spec) and streptomycin (Strep), because the point mutation 
does not confer resistance to both antibiotics. When exposed to the double-selective medium, leaf pieces from 
spontaneous Spec-resistant lines bleached out (lower half of the plates), whereas leaf pieces from true 
chloroplast transformants remained green (upper half of the plates). (B): Seeds from transplastomic (Tp) plants 
were tested for germination on spectinomycin-containing medium to confirm the homoplasmic state. 
Homoplasmic lines give rise to 100% spectinomycin-resistant progeny (left), while seedlings free of the 
chloroplast transgene would bleach out like the wt (middle). To ultimately exclude spectinomycin-resistant 
mutants, some seeds from the same transplastomic batch were also tested by germination on double-selective 
medium containing spectinomycin and streptomycin (right). The germinated seedlings, although resistant, do 
not grow nicely due to the high total antibiotic concentration, and are usually discarded afterwards. 
 
For the viral construct, only three spectinomycin-resistant lines could be regenerated after 
bombardment, and of these, only one (line #2) passed the double selection test and turned 
out positive for transgene insertion in PCR analysis (II.1.2.2, paadA136 and v-int_r, not 
shown). Obtainment of vIL-10 homoplasmic transplastomic plants from this line was finally 
confirmed by RFLP analysis on leaf tissue from plants of both the first and second 
regeneration rounds (Figure 6B). As often happens when plants are kept long in tissue 
culture, the transplastomic plants transformed with the vIL-10 construct were male sterile, 
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and they had to be cross fertilized with wt pollen. However, this is not a problem in the case 
of transplastomic plants, due to uniparentally maternal plastid inheritance, which should 
ensure transmission of the transgene to the whole progeny. In fact, as expected, all the seeds 
germinated on spectinomycin-containing medium were resistant to the antibiotics (Figure 
5), confirming both homoplasmy of the parental line and lack of pollen transmission of 
chloroplast transgenes. Molecular analysis of the T1 generation plantlets ultimately 
confirmed that they were homoplasmic, as no hybridization signal with the wt plastome was 
detected for all the transplastomic plants analyzed (Figure 6B). 
 
Figure 6: RFLP analysis assessing homoplasmy of transplastomic plants.  
DNAs were digested with BglII and probed with a radiolabeled psaB fragment (II.2.1.11). Digestion with BglII 
produces fragments of approximately 3.5 kb in the wild type and approximately 6 kb in both murine and viral 
IL-10 transplastomic lines (see Figure 4). In all samples, the probe detects also a faint band at approximately 
2 kb which comes from promiscuous DNA in the nucleus (Ruf et al., 2000; Wurbs et al., 2007). In all 
transplastomic lines, but not in the wild type, the probe detects a more or less intense band at approximately 
3 kb, which most likely reflects recombination events involving the terminator region of the transgene 
(III.1.4.3). (A): Plants transformed with the murine IL-10 construct. The T1 generation of two plants (C and 
D), which are derived form the same primary transformant (line #4), was analyzed individually and pooled.  
(B): plants transformed with the viral IL-10 construct. All plants derive from the same and only primary 
transformant obtained after particle bombardment (line #2). Representative plants from the T1 (lanes 2 and 3) 
and T0 generation (the rest), from the first (lanes 4, 5, 7) and the second regeneration round (lanes 6, 8, 9), 
from the soil (lanes 3-8) and the in vitro culture (lane 9) were analyzed. ‘y’ indicates a yellow plant, ‘y/v’ 
indicates a yellow sector from a variegated plant and ‘g/v’ a green sector from a variegated plant. 
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III.1.3 Phenotype of transplastomic lines 
Regeneration of transplastomic plants after chloroplast transformation with the vector 
encoding the viral IL-10 was extremely difficult and time consuming, as the calli kept 
growing on the selective plates without generating shoots for months. Eventually, one 
slowly-growing pale-green transplastomic plant was obtained (Figure 7A) and was then 
subjected to an additional round of selection and regeneration giving rise to several clones. 
These plantlets also showed variable phenotypes and a slow growth rate, both in tissue 
culture and in soil. Most of the plantlets regenerated were yellow in the beginning, and 
developed later on green sectors that conferred a variegated phenotype to the leaves (Figure 
7B). Some completely green plants were also obtained from the second regeneration round 
(Figure 7C), and had a normal development.  
 
 
 
Figure 7: Phenotype of transplastomic plants.  
Panels A, B and C show plants transformed with the construct for viral IL-10, while panels D, E and F 
represent transplastomic plants for the murine IL-10. 
 
In transformants obtained with the construct encoding the murine IL-10, no obvious 
phenotype was observed in plants from the first regeneration round, neither in sterile culture 
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nor in soil (Figure 7D and E). However, from the second regeneration round, some plantlets 
showed slightly deformed and curled leaves (Figure 7F, indicated by the arrow).  
For both constructs, all plants grown in the greenhouse flowered and, although most of them 
were male sterile and had to be hand-pollinated with wild-type pollen, produced viable 
seeds. 
 
III.1.4 Characterization of homoplasmic plants 
III.1.4.1 Immunoblot analysis 
As the aim of this study was to obtain high accumulation levels of the recombinant 
cytokines in tobacco leaves, gene expression in the transplastomic plants was directly 
investigated at the protein level. It has already been reported that transplastomic plants 
accumulating extremely high amounts of recombinant proteins can have a mutant 
phenotype, as the result of the exhaustion of the gene expression capacity of the chloroplast 
by overuse of its ribosomes for the production of the recombinant protein (Oey et al., 2008). 
Considering this, the impaired growth and yellow phenotype of the vIL-10 transplastomic 
plants could foreshadow extremely high accumulation of the recombinant protein, at least of 
the viral version of the interleukin. Immunoblot analysis was performed on leaf extracts 
from (i) different transplastomic plants of both the T0 and T1 generations, (ii) tissue culture 
and greenhouse-grown plants and (iii) young and older leaves, to assess dependency of 
protein accumulation on leaf age (Birch-Machin et al., 2004; Zhou et al., 2008) (II.2.4.1, 
II.2.4.10).  
Quite disappointingly, only a very faint band corresponding to the viral IL-10 was 
detectable only in the soluble extracts from plants or parts of leaves with a yellow 
phenotype (Figure 8). Even more surprisingly, no detection of a band corresponding to 
murine IL-10 was possible in any of the plant extracts analyzed (data not shown). IL-10 
accumulation levels in the raw plant extract were then assessed by ELISA, and amounts up 
to 0.02 µg/ g FLW for the murine and 0.44 µg /g FLW for the viral IL-10, respectively, 
were determined. 
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Figure 8: Immunodetection of viral IL-10 in leaf extracts of transplastomic plants.  
40 µg of extracted total soluble proteins (II.2.4.1) or the equivalent amount of insoluble protein fractions were 
separated on a 15% (w/v) gel by SDS-PAGE (II.2.4.5), blotted to a PVDF membrane, and incubated with a 
monoclonal vIL-10-specific antibody (II.1.3). As control, a wild-type sample was included and as standard 
(STD), commercial recombinant vIL-10 was used. A faint signal was detectable in the soluble fraction of only 
a few samples (highlighted by the red box), which correspond to plants or part of leaves with a severe bleached 
phenotype. Note that the slightly higher molecular weight (approximately 18 kDa) of the plant-produced IL-10 
compared to the standard is probably due to the presence of the 6xHis tag, and that a double band has been 
previously observed for both the commercial and the plant-produced IL-10 in immunoblots (III.4.1). 
 
III.1.4.2 Northern blot analysis 
Since for both viral and murine IL-10 transplastomic lines, extremely low to null 
recombinant protein levels could be detected by immunoblot (III.1.4.1), examination of 
transgene expression at the transcript level became necessary to unravel the causes of this 
unexpected result. Total RNA was extracted (II.2.1.12) from a few representative plants for 
each construct, and Northern blot analysis was performed (II.2.1.14) with transgene-specific 
probes in order to determine the presence of the viral and murine IL-10 transcript, 
respectively.  For both transgenes, the presence of the transcript in the transplastomic lines 
was confirmed. Viral IL-10 mRNA accumulation was low in green sectors of somatically 
segregating plants (Figure 9A, sample ‘H green’) and undetectable in the green 
transplastomic plant analyzed (Figure 9A, ‘plant F’), although a very faint band could be 
detected upon overexposure of the blot (not shown). Interestingly, the tissues accumulating 
the highest levels of vIL-10 transcript coincided with those, in which at least a little bit of 
recombinant protein could be detected by immunoblot (Figure 8, sample ‘2H’). 
Nevertheless, the Northern blot analysis revealed the presence of stable mRNA of both 
transgenes and therefore does not explain the overall lack of accumulation of IL-10 protein. 
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Figure 9: Northern blot analysis of transplastomic plants.  
Ten µg of total RNA extracted from leaves (II.2.1.12) were loaded for each sample, and a radiolabeled PCR 
product specific for either the viral or the murine IL-10 transgene was used as probe (II.2.1.14). (A) Detection 
of the viral IL-10 transcript. Capital letters denote different plants. The phenotype of the analyzed material is 
also indicated. Note that the band at approximately 0.6 kb corresponds to the vIL-10 transcript, while the band 
at around 1 kb most likely represents a transcriptional read-through product (Zhou et al., 2007). (B) Detection 
of the murine IL-10 transcript in two T1 generation plants. The band at approximately 0.6 kb corresponds to 
the mIL-10 mRNA. To confirm RNA integrity and equal loading, the ethidium bromide-stained agarose gel is 
also shown below each panel. 
 
III.1.4.3 Investigation of recombination events in the transgene expression cassettes       
The almost complete absence of recombinant protein from the transplastomic plants despite 
insertion of the transgene (III.1.2) and accumulation of the transcript (III.1.4.2), together 
with the fact that the pale phenotype observed for the transplastomic plants transformed 
with the viral IL-10 sequence showed somatic segregation (i.e. sectorial variegation, Figure 
7B), prompted us to investigate in more detail the region of transgene integration in the 
chloroplast genome of these plants. 
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Somatic segregation is one of the hallmarks of cytoplasmic inheritance and usually indicates 
heteroplasmy of the plastid genome. Interestingly, green sectors and yellow sectors showed 
no presence of the wild type genome in RFLP analyses (Figure 6B), indicating that both 
green and yellow tissues were homoplasmic for the transgenes. However, the presence in 
the RFLP pattern of an unexpected band of molecular size smaller than the wt, suggested 
that some rearrangements had taken place within the plastid genome. Intriguingly, the 
intensity of this additional band was found to be much higher in the green sectors compared 
to the yellow ones in the plants transformed with the viral construct (Figure 6B, plant ‘2H’), 
but was uniformly much weaker across the green-looking plants transplastomic for the 
murine IL-10 sequence (Figure 6A). Molecular analysis of the plants transformed with 
either the viral or the murine IL-10 performed by PCR (not shown), indicated that for both 
lines homologous recombination between the Rubisco large subunit gene terminator region 
(TrbcL) used as 3’UTR of the transgene in the expression cassette and the endogenous copy 
of the terminator region present on the plastid genome had taken place. This recombination 
event had already been observed in transplastomic plants transformed with the same vector 
backbone (F. Zhou, Max Planck Institute, Golm, Germany, personal communication) and 
results in the excision of a circular DNA fragment which can be detected by amplification 
with outwardly oriented primers (Figure 10). This plastome rearrangement accounts for the 
unexpected band observed in the RFLP pattern of all transplastomic plants. Nevertheless, 
this recombination event should not affect transcription or translation of the transgene, and 
therefore does not explain the almost complete absence of recombinant IL-10 from the 
transplastomic plants. 
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Figure 10: Detection of homologous recombination events between the TrbcL terminator regions of the 
transgene and the endogenous rbcL gene on the plastome. 
A schematic representation of the transformation vector region that integrates into the tobacco plastome is 
shown, together with the position of insertion into the chloroplast genome (orange arrow). The terminator of 
the Rubisco large subunit gene (TrbcL) that undergoes homologous recombination is indicated by a red box on 
both the vector and the plastome, and the position of the endogenous copy present on the chloroplast genome 
is indicated by a green arrow. The annealing position of the primers oriented in opposite directions and used to 
detect the circular DNA molecule that is excised upon recombination of the TrbcL copies is indicated by red 
arrows. A schematic representation of the resulting PCR product is also given (courtesy of F. Zhou). 
 
Therefore, the promoter and 5’UTR regions of the IL-10 transgenes in the transplastomic 
plants were examined. In the pRB95 chloroplast transformation vector, the aadA and the 
transgene are transcribed from divergent rRNA operon-derived promoters. The promoter 
driving the aadA had suffered a deletion of its 5’ portion already in E. coli, presumably by 
microhomology-mediated illegitimate recombination at a directly repeated pentanucleotide 
sequence (CGAGC), resulting in a weaker 46-nucleotide shorter promoter version (Zhou et 
al., 2008). After introduction into the plastid genome, homologous recombination between 
the full-length Prrn promoter upstream of IL-10 (Prrn-long in Figure 11) and the shortened 
version (Prrn-short in Figure 11) can result in reciprocal exchange of the two promoter 
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versions by ‘flip-flop recombination’ (Rogalski et al., 2006) producing two isoforms of the 
plastid genome: one with the shorter Prrn version placed in front of aadA and the full-length 
version in front of the transgene, and the other with the shorter Prrn version in front of the 
transgene and the full-length version in front of aadA (Figure 11). This recombination event 
has already been described for expression of the recombinant protein Nef, whose 
accumulation to high levels in tobacco chloroplast caused a mutant phenotype almost 
identical to the variegated one observed for the viral IL-10 (Zhou et al., 2008). Surprisingly, 
sequencing of the promoter regions of aadA and the IL-10 transgene (amplified by PCR 
from total DNA isolated from one representative transplastomic plant each), revealed that 
rearrangements other than those already described for the nef transgene had occurred. In the 
case of the plant expressing the murine IL-10, the original sequence of the vector used for 
transformation could not be detected, and two different rearrangements had occurred 
(Figure 11). In one of these rearrangements, the flip-flop recombination had involved the 
two Prrn versions and the region in between, which was inverted compared to the original 
vector. In the other one, inversion of the intergenic sequence had also occurred along with 
exchange of the promoters, but additionally a portion of the 5’ sequence of the aadA gene 
had been duplicated and now replaced the T7 phage gene 10 translation control region (G10 
in Figure 11) and part of the IL-10 sequence. The plant transformed with the construct for 
viral IL-10 expression, instead, harbored the initial conformation (Prrn-long driving IL-10, 
Prrn-short driving aadA) and a second conformation, in which the G10 sequence and the 
first 53 nucleotides of the murine IL-10 ORF had been replaced by part of the Prrn-short 
promoter and the aadA coding sequence.  
These results indicate that, for both transgenes, recombination products that condition low 
IL-10 accumulation seem to be favoured over the original configuration, and that 
transcription of the viral IL-10 transgene from the stronger Prrn-long promoter probably 
accounts for detectability of viral IL-10 protein that, even though accumulating at extremely 
low levels, causes a severe pigment-deficient phenotype.  
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Figure 11: Recombination events in the promoter regions of the two transgene cassettes.  
For both transgenes, the promoter region was amplified by PCR (II.2.1.1) from DNA extracted from one 
representative plant each (II.2.1.10), and the resulting fragment was sequenced. In both cases, a partial double 
sequence was obtained, and the two overlapping nucleotide sequences were determined by manually dissecting 
the chromatograms. The figure shows a schematic overview of the rearrangements identified. Note that, where 
a duplication of part of the aadA gene has occurred in front of the transgenes, the first 53 and 40 nucleotides 
are missing from the murine and viral IL-10 reading frames, respectively. aadA: aminoglycoside 
adenylyltransferase gene; Prrn short: short version of the rRNA promoter; Prrn long: long version of the rRNA 
promoter; G10: T7 phage gene 10 translation control region. Not drawn to scale. 
 
III.1.4.4 Analysis of the total soluble protein pattern  
Analysis of the total soluble proteins extracted from two representative transplastomic 
plants per construct, assayed by SDS-PAGE (II.2.4.6) and Coomassie Brilliant Blue staining 
(II.2.4.7), revealed reduced levels of the RuBisCo large subunit in those plants that were 
transformed with the construct for the viral IL-10 and displayed the yellow phenotype 
(Figure 12). In contrast, there was no appreciable difference between the TSP patterns of 
wild type plants and plants transformed with the construct for murine IL-10 (data not 
shown). 
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Figure 12: Analysis of the total soluble protein patterns of vIL-10 transplastomic plants.  
Total soluble proteins (TSP) were extracted from either transplastomic or wild type leaf material (II.2.4.1). 
Samples of 30 µg TSP were separated on a 10% (w/v) Tris-Tricine gel by SDS-PAGE (II.2.4.6), and the gel 
was stained with the Coomassie Brilliant Blue dye (II.2.4.7). Lane 1: molecular weight marker; lane 2: wild 
type; lanes 3-5: different areas of the same leaf, the phenotype is indicated. Large (LS) and small (SS) subunits 
of RuBisCo are marked at the right. A clear reduction in LS and consequently SS amounts is observed in the 
transgenic plants in a manner that correlates with the bleached phenotype. ‘y/v’ indicates a yellow sector from 
a variegated plant, ‘g/v’ a green sector from a variegated plant and ‘g’ a green plant. 
  
 
III.2 Nuclear expression of IL-10 in tobacco 
III.2.1 Generation of the plant expression constructs for subcellular targeting 
Three constructs each were designed for the mIL-10 and vIL-10 cDNAs, targeting the 
recombinant proteins to three different sub-cellular localizations: (i) the endoplasmic 
reticulum (ER), achieved by retaining the native N-terminal signal peptide and adding a 
C-terminal SEKDEL motif for ER retention (Figure 13, ER-m/vIL-10) (Mitoma and Ito, 
1992); (ii) the plasma membrane (IL-10 facing the apoplast), achieved using the native 
signal peptide and adding the C-terminal hinge and transmembrane domain from the human 
T-cell receptor (Figure 13, Apo-m/vIL-10) (Schillberg et al., 2000); and (iii) the ER 
membrane (IL-10 facing the cytosol), achieved by deleting the native signal sequence and 
adding the C-terminal cytochrome b5 (cytb5) membrane anchor domain (Figure 13, 
Cyt-m/vIL-10) (Mitoma and Ito, 1992; Schouten et al., 1996; Zhao et al., 2003).  
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Figure 13: T-DNA region of the pTRAkt plant expression vector and gene cassettes targeting murine 
and viral IL-10 to different subcellular locations.  
LB and RB, left and right border of the T-DNA; Pnos and pAnos, promoter and terminator of the nopaline 
synthase gene; nptII, coding sequence of the neomycin phosphotransferase gene; SAR, scaffold attachment 
region; P and pA, 35S promoter with duplicated enhancer and terminator of the cauliflower mosaic virus 
(CaMV) 35S gene; TL, 5’ UTR of the tobacco etch virus (TEV); sp, native N-terminal signal peptide; IL-10, 
mature IL-10 sequence; His6, histidine tag; SEKDEL, ER retention signal; TcR, C-terminal hinge and 
transmembrane domain of the human T-cell receptor; cytb5, transmembrane domain of the rat cytochrome-b5. 
On the right of each construct, the predicted molecular weight for the corresponding mature polypeptide is 
given. Not drawn to scale. 
 
These constructs, all bearing a His6-tag at the C-terminus to facilitate protein purification, 
were generated by subsequent PCR reactions (II.2.1.1) using up to three overlapping primer 
pairs (Table 2), designed to fuse the different localization sequences at the 5’ of the 
transgene and to introduce the sequences for the appropriate restriction enzymes at the 3’ 
and 5’ ends (in case of the Cyt-vIL-10 construct it was necessary to fuse the TEV 5’ UTR 
region (II.1.2.1) up to the XmnI site directly to the IL-10 mature sequence, to avoid insertion 
of an additional amino acid at the 5’ end). Each of the final fragments generated by PCR 
was gel purified (II.2.1.4), cloned into a pTOPO vector (II.1.2.1), transferred into E. coli 
DH5α competent cells (II.2.2.2) by heat shock (II.2.2.3), and its correctness was confirmed 
by sequencing. The inserts were then cut out of the pTOPO vector by restriction digest with 
the appropriate enzymes (II.2.1.5), ligated (II.2.1.7) into the digested and dephosphorylated 
(II.2.1.6) pTRAkt-gfp plant expression vector (II.1.2.1) and transformed into E. coli 
(II.2.2.3). For each transformation, a positive clone was selected upon plasmid restriction 
digestion (II.2.1.5), and the correct insertion into the vector was confirmed by sequencing 
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with primers designed on the vector backbone (pSS5’, pSS3’, II.1.2.2). All plasmids were 
transferred into A. tumefaciens strain GV3101 by electroporation (II.2.2.6), and glycerol 
stocks of a recombinant clone (II.2.2.7) were prepared (II.2.2.4). 
 
Table 2: Primer pairs used to generate the different targeting constructs.  
The m/v-IL-10 sequences were amplified from the respective plasmid containing the full-length cDNA 
(II.1.2.1) by PCR, performing up to three subsequent reactions to generate the final targeting constructs. The 
overlapping primer pairs used (II.1.2.2), designed to directly fuse the localization and His-6 sequences to the 
5’ end of the IL-10, are listed in the table and referred to each PCR step; the restriction sites introduced for 
cloning the fragments into the pTRAkt vector (II.1.2.1), are indicated in the right column.  
Construct (m/v) PCR reaction Primer pair  Cloning enzymes (5’-3’) 
ER-IL-10 1/1 m/v-SP_f ; m/v-HisKDEL_r NcoI-XbaI 
Apo-IL-10 1/3 m/v-SP_f ; m/v-TcR_r1  
 2/3 m/v-SP_f ; m/v-TcR_r2  
 3/3 m/v-SP_f ; m/v-TcRHis_r3 NcoI-XbaI 
Cyt-IL-10 1/2 
m-cytb5_f ; m-Hiscytb5_r1 
v-cytb5_f1 ; v-Hiscytb5_r1 
 
 2/2 
m-cytb5_f ; m-cytb5_r2 
v-cytb5_f2 ; v-cytb5_r2 
BspHI -XbaI (mIL-10) 
XmnI-XbaI (vIL-10) 
 
III.2.2 Agrobacterium-mediated transient expression 
III.2.2.1 Vacuum-infiltration of whole detached leaves 
Transient expression in Nicotiana tabacum cv. Petit Havana SR1 leaves was carried out at 
least three and up to 5 times for each construct (III.2.1) by vacuum agroinfiltration of whole 
detached leaves (II.2.3.3). After 2-3 days of incubation, the infiltrated leaves sometimes 
appeared wilted, dried out and/or necrotic (not shown). This phenomenon was observed in 
most of the infiltrations performed, but not always, and the severity of the phenotype also 
varied between the experiments and, to some extent, between the constructs. However, due 
to the high variability of the leaf phenotype observed after vacuum agroinfiltration, it was 
difficult to attribute a specific phenotype to a specific construct. 
Analysis of IL-10 accumulation levels in vacuum infiltrated leaves was performed using a 
sandwich ELISA (II.2.4.12) on the crude leaf extracts (II.2.4.1). Despite the high variation 
in the overall accumulation levels observed between experiments, the ratio between the 
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amount of IL-10 detected for each construct was always constant and reproducible within 
each experiment, and showed that both mIL-10 and vIL-10 accumulated to the highest 
levels in the ER (up to 10-16 µg/g fresh leaf weight (FLW), Figure 14).  
 
Figure 14: Comparison of IL-10 levels in leaves agroinfiltrated with the different targeting constructs. 
N. tabacum cv. Petit Havana SR1 leaves were vacuum-infiltrated (II.2.3.3) with A. tumefaciens carrying the 
different plant expression constructs (III.2.1). For each construct, three to four leaves from different wild type 
plants were infiltrated; they were incubated on wet filter paper for 3 d, with a 16-h photoperiod at ~20°C. 
Quantification of IL-10 accumulation levels in the leaf extracts was performed by sandwich ELISA (II.2.4.12). 
The left and right bars represent the data for the viral and murine IL-10, respectively; the localizations reported 
on the x-axis refer to the constructs described in Figure 13. The data shown represent the mean ± SD of three 
independent experiments performed. 
 
Immunoblot analysis of leaf extracts with IL-10-specific monoclonal antibodies (II.1.3) was 
also performed, to have a preliminary indication of correct processing of the recombinant 
proteins. The molecular weights of the detected proteins were consistent with those of the 
mature native polypeptides, taking into account the C-terminal His6 and C-terminal 
localization tags (Figure 15), suggesting that they are properly synthesized and processed. 
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Figure 15: Immunoblot analysis of IL-10 transiently expressed in tobacco leaves by agroinfiltration. 
Total soluble proteins were extracted grinding tobacco leaf tissue in two volumes extraction buffer (II.2.4.1), 
and separated by 17 % (w/v) SDS-PAGE. (A): murine IL-10 analysis. 65 µg TSP were blotted onto a 
nitrocellulose membrane and immuno detection was carried out with a monoclonal anti murine IL-10 (1:2000) 
followed by 1 h incubation with RARAP (1:5000) and NBT/BCIP detection at Rt (II.2.4.9). Commercial 
recombinant murine (20 ng, BD Pharmingen) was used as positive control. (B): viral IL-10 analysis. 50 µg 
TSP were blotted onto a PVDF membrane, immuno detection was carried out with a monoclonal anti viral IL-
10 (1:1000) followed by 1 h incubation with RARHRP (1:5000), and the signal revealed with the ECL Plus 
Western Blotting Detection kit (GE Healthcare) (II.2.4.10II.2.4.9). Fifty ng of commercial recombinant viral 
IL-10 (R&D Systems) were used as positive control. C: recombinant IL-10 used as positive control; M: 
prestained protein marker; 1: extract from leaves infiltrated with the construct for ER-retained IL-10; 2: extract 
from leaves infiltrated with the construct for apoplastic IL-10; 3: extract from leaves infiltrated with the 
construct for cytosolic IL-10. Arrows indicate the IL-10 monomer. 
 
III.2.2.2 Agroinjection in intact plants 
To exclude that the variability in phenotype of the vacuum agroinfiltrated leaves was 
somehow influenced by the growth conditions and status of the wt plant/leaf used for 
infiltration, in planta agroinjection was performed with all the constructs on the same leaf in 
parallel. Additionally, the use of intact plants rather than detached leaves for 
agroinfiltration, allows to keep the leaf material under observation for longer times and to 
follow more carefully the evolvement of the eventual necrotic lesions. The experiment was 
repeated 4 times on two plants each, trying to minimize the position effect as much as 
possible within every experiment, injecting all constructs in three different leaves of the 
same plant, and in different sectors of the leaf. The phenotype observed after agroinjection 
of intact plants was more reproducible than the vacuum infiltration: injection with the 
constructs encoding the apoplastic versions of both murine and viral IL-10 (Apo-m/v-IL-10) 
Results____________________________________________________________________ 
 74 
always caused necrosis and, in all cases, resulted in the fastest and most severe symptoms, 
when compared to the other constructs of the same IL-10 version (Figure 16A-B).  
 
 
Figure 16: Symptoms caused by in planta agroinjection of the different IL-10 targeting constructs. 
(A-B) Agrobacteria harbouring the pTRAkt vectors encoding the generated versions of murine and viral IL-10 
(III.2.1) or the control vector TRAkc-rTPrfp (II.1.2.1) were injected into different sectors of the same leaf of 
intact N. tabacum cv. Petit Havana SR1 plants, and the infiltrated plants were grown at 20-25°C, 16 h 
photoperiod (7000 lux), for 3-5 days (II.2.3.4). The experiment was repeated 4 times, trying to randomize as 
much as possible the injection site for every construct. Partial (A) or complete (B) necrosis of the infiltrated 
areas developed 2-5 days after injection, in a construct-specific manner, and with the apoplastic version of 
both murine and viral IL-10 always causing the earliest and most severe symptoms. (C-D) Injection of 
agrobacteria carrying the pTRAkc-rTP-DsRed vector (II.1.2.1) was performed in parallel as negative control 
(C), and accumulation of DsRed (D) was visualized with an LCD lamp with glass fiber optic (Leica KL1500), 
an additional filter for green excitation (BP545/30) and a color foil (No. 182, light red). 
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Agroinjection of the construct for ER localization of the viral, but not the murine, IL-10 also 
constantly resulted in partial to complete necrosis of the infiltrated area, while the cytosolic 
version of murine IL-10 gave rise to necrotic lesions in two of the four experiments 
performed, and only in correspondence of those leaves that showed the most severe 
symptoms overall (Figure 16B). A culture of agrobacteria carrying a pTRAkc-rTPrfp 
plasmid encoding the fluorescent protein DsRed (II.1.2.1) was used both as visual positive 
control for the agroinfiltration procedure, and as negative control for the onset of the 
necrotic phenotype, as this construct has been extensively used in the laboratory and was 
never deleterious to the plants. As expected, the leaf sectors infiltrated with agrobacteria 
carrying the pTRAkc-rTPrfp plasmid showed DsRed fluorescence and no necrotic lesions 
(Figure 16C-D). 
III.2.3 Stable expression in transgenic tobacco plants 
Stable nuclear transformation of N. tabacum cv. Petit Havana SR1 was carried out 
according to the leaf disc method (II.2.3.2) using the most promising ER-m/vIL-10 
encoding vectors (pTRAkt_ER-mIL-10 and pTRAkt_ER-vIL-10) that yielded the highest 
accumulation levels in the transient expression experiments (III.2.2).  
III.2.3.1 Phenotype of stable transgenic plants 
In vitro regeneration of plantlets from tobacco transformation with the construct encoding 
the murine IL-10 was straightforward, and also once transferred into soil, plants expressing 
mIL-10 did not display any mutant phenotype and grew as the wt (not shown). 
Differently, transformation of N. tabacum Petit Havana SR1 with the construct encoding the 
ER-retarded version of the viral IL-10 gave rise to many normal looking plantlets, but also 
to a number of plantlets that appeared very pale in color and had a retarded growth (Figure 
17A). Also after transfer into soil, these plants grew slowly, appeared lighter green, showed 
leaf thickening and more pronounced veining (Figure 17B); in some cases the flowers were 
impaired, and the plants had to be hand-pollinated because the stamens were shorter than the 
pistil (Figure 17C); some other plants never produced seeds because the flowers dried out 
and fell off the plant before opening (Figure 17D), and some very dwarf ones died without 
even developing flower buds (not shown).  
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Figure 17: Phenotype of transgenic plants expressing vIL-10. 
Transformation of N. tabacum cv. Petit Havana SR1 was performed by the leaf disc method (II.2.3.2) using 
agrobacteria carrying the plasmid encoding the ER-retarded version of viral IL-10 (III.2.1). Regeneration of 
transgenic plants on selective medium after transformation gave rise to many pale green – almost white –  
shoots, which had thicker leaves and grew more slowly compared to the green ones (A).  Once moved from 
the sterile culture into soil, these shoots developed into slow growing, stunted plants that had more elongated 
leaves, thicker than wt plants, with unusually pronounced veining and sometimes a dark-light spotted 
appearance (B). Some of these plants developed abnormal flowers (C) which having the stamens shorter than 
the pistil had to be pollinated by hand, but eventually produced viable seeds. Instead, those plants showing the 
overall strongest phenotype, did not produce seeds because the floral buds dried out and fell off the plant 
before developing into mature flowers (D). 
Despite the variety and multiplicity of phenotypic traits observed within the vIL-10 
transgenic population (Figure 17), the degree of dwarfism was identified as a good indicator 
to summarize the overall severity of the symptoms. Interestingly, the pale green, stunted 
plantlets regenerated in vitro - which were initially regarded as unhealthy and discarded 
from the selection of 40 plants to constitute the starting T0 population - turned out to be the 
plants accumulating the highest amounts of vIL-10, when later analyzed for recombinant 
protein levels by ELISA (II.2.4.12). As a matter of fact, a striking positive correlation was 
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always found between the vIL10 accumulation levels measured in the leaves and the 
size/phenotype of the transgenic plants (Figure 18).  
 
Figure 18: Phenotype of transgenic plants correlates with vIL-10 accumulation levels. 
Analysis of vIL-10 accumulation levels in transgenic tobacco plants (II.2.4.12) revealed a strikingly 
correlation between the stunted phenotype and the amounts of recombinant protein detected in the leaf tissue. 
In this figure, three T1 sister plants of the same age and grown under the same conditions, representative of the 
range of phenotypic alterations observed, are shown, and the corresponding accumulation levels of vIL-10 
measured by ELISA in the leaf extract are reported below each plant (A). No differences could be detected 
regarding the appearance or the growth rate of the transgenic plant accumulating vIL-10 to the lowest level 
and the wt (not shown). (B) Enlargement of the dwarf plant in (A), which accumulates vIL-10 at the highest 
levels and displays the strongest phenotype observed. Note that, besides the stunted appearance, with shorter 
internodes and smaller leaves, this plant is still in a vegetative state, while the normal-looking sister is already 
flowering. (C) Side view of the same transgenic plants shown in (A), underlining the enormous difference in 
growth and development between the three expressors. 
This same range of phenotypic characteristics, and their same correlation to the vIL-10 
accumulation levels displayed by the tissue-culture derived plants, were also observed for 
the T1 generation. Therefore, taking into consideration the high number of regenerated 
shoots displaying the phenotype (at least 20), the facts that also T1 plants were affected, and 
the clear correlation between the severity of the symptoms and the vIL-10 accumulation 
levels, the abnormalities observed for the transgenics could not be adequately explained by 
position or tissue-culture effects. Rather, these observations strongly suggested that they 
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were most likely caused by the expression of the transgene/recombinant protein itself, rather 
than being the result of somaclonal variation induced by the in vitro tissue culture 
conditions. 
III.2.3.2 Analysis of IL-10 accumulation levels in subsequent generations 
For each construct, 40 transgenic plants were regenerated and the amount of IL-10 in the 
leaves of the hemizygous T0 plants was estimated by ELISA (II.2.4.12). For mIL-10, the 
best yield was 21.3 µg/g FLW, whereas the best yield of vIL-10 was 8.9 µg/g FLW, 
mirroring the results of the transient expression assays (III.2.2). 
Seeds from self-pollination of the six highest expressing plants for each construct were 
tested for germination on kanamycin-containing agar plates, and 20 resistant plants per line 
were transferred into soil and grown in the greenhouse (II.2.3.1). They were screened for 
IL-10 accumulation by immunodotblot (Figure 19, II.2.4.9), and the most promising ones 
were also analyzed by ELISA. In the T1 generation, accumulation levels up to 37.0 µg/g 
FLW for mIL-10 and 10.8 µg/g FLW for vIL-10 were observed.  
 
Figure 19: Dotblot screening of T1 plants for IL-10 accumulation.  
Total soluble proteins were extracted from leaf samples (II.2.4.1) and directly applied onto a nitrocellulose 
membrane (II.2.4.11). Protein extract from a wild type plant was used as negative control (wt), and either 20 or 
100 ng of commercial murine or viral IL-10 were used as positive controls (STD), respectively. (A) Screening 
of T1 plants for murine IL-10 accumulation. (B) Screening of T1 plants for vIL-10 accumulation. 
The same screening and analysis procedure was applied to the T2 generation plants 
expressing mIL-10, and the highest accumulation level observed was 43.7 µg/g FLW, which 
is a further increase compared to the T1 generation.  
For the plants transformed with the construct for the expression of vIL-10, it was not 
possible to obtain seeds from the T1 generation plants, as they developed a severe 
phenotype (III.2.3.1) and never produced mature flowers (Figure 17F). 
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III.2.4 Immunolocalization of IL-10 in transgenic tobacco leaves  
In order to confirm that, in the stable nuclear transformants, the IL-10 bearing the KDEL 
signal at the C-terminal was truly localized and accumulated in the ER, immunogold 
labelling and electron microscopy studies were performed. For both the murine and the viral 
IL-10 expressing plants of the T1 generation, the localization studies confirmed that the 
recombinant proteins were retained and accumulated in the ER, as expected (Figure 20). No 
significant labeling was found in other cell compartments (data not shown). 
 
 
 
Figure 20: Immunolocalization of recombinant IL-10 in tobacco leaves.  
Small squares of N. tabacum T1 transgenic tobacco leaves expressing viral (A) or murine  IL-10 (B) were fixed 
in 4% (w/v) formaldehyde, 0.2% (w/v) glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 (II.2.5.2). Specimen 
were infiltrated and polymerized in LR White Resin. Ultra thin sections were obtained and incubated with 
either a goat anti-vIL-10 or a rabbit anti-mIL-10 as primary antibody, and with a secondary antibody 
conjugated to 10-nm gold particles (II.2.5.3). Gold labeling can be seen in the ER as indicated by arrowheads. 
Note that no labeling can be found in the cell wall and in the apoplast. 
 
III.2.4.1 Ultrastructural analysis of transgenic leaves  
Given the severe impact on plant development and the pale phenotype caused by expression 
of vIL-10, electron microscopy studies were performed on stable transgenic leaf material 
(T1 generation), to investigate whether major alterations were also evident at the 
ultrastructural level. The differences noticed were related to the number of plastoglobules 
within the chloroplasts. Plastoglobules are low density lipoprotein particles attached to the 
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thylakoid membranes, and constitute an interior compartment of the chloroplast that 
functions for both lipid biosynthesis and storage. Figure 21 clearly shows that, while 
transgenic leaves expressing murine IL-10 had two to four small plastoglobules per 
chloroplast, like in wt leaves (not shown), the number of plastoglobules was considerably 
increased in chloroplasts from leaves expressing the viral variant of the cytokine, with up to 
10-20 plastoglobules per chloroplast.  
 
 
Figure 21: Ultrastructural details from chloroplasts of transgenic tobacco leaves expressing IL-10. 
Small squares of N. tabacum T1 transgenic tobacco leaves expressing murine (A-B) or viral  IL-10 (C-D) were 
fixed in 2% (w/v) formaldehyde, 2.5% (w/v) glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 (II.2.5.1). 
Specimen were first osmificated, then infiltrated and polymerized in Spurr resin. Ultra thin sections were 
obtained and analyzed with a transmission electron microscope. Some plastoglobules are indicated by arrows. 
apo, apoplast, cw, cell wall; v, vacuole. 
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III.3 Expression of IL-10 in BY-2 suspension cultures 
III.3.1 Constitutive expression of murine and viral IL-10 
Given the relatively low accumulation levels obtained for vIL-10, connected to the severe 
phenotype, in the stable nuclear transformants, tobacco BY-2 suspension cells were also 
transformed with the construct for ER-retention of vIL-10, in the attempt to reach higher 
vIL-10 accumulation levels without deleterious effects in this expression system. 
Transformation of BY-2 cells with the murine construct was also performed to have a mean 
of comparison with transgenic plants on the expression levels.  From BY-2 transformation 
(II.2.3.7) with the pTRAkt_ER-vIL-10 and pTRAkt_ER-mIL-10 vectors (III.2.1), 25 calli 
per construct were analyzed. They were screened for recombinant protein production by 
immunodotblot analysis (II.2.4.9) of the protein extracts (II.2.4.2) and, for each construct, 
the seven most promising lines were tested in ELISA for IL-10 quantification (II.2.4.12). 
For the murine construct, the highest expression level observed was 18.1 µg/g FW, while 
for the viral one expression levels were up to 0.6 µg/g FW. For each construct, liquid 
suspension cultures of BY-2 cells from the highest expressing callus were established 
(II.2.3.6). IL-10 accumulation levels in the cell pellet were determined by ELISA at 3, 5 and 
7 days after inoculation of the culture in fresh medium (dpi). These time-course 
measurements were repeated in three independent experiments, and the highest 
accumulation levels, observed for both lines at 5 dpi, were 9.3 ± 1.4 µg/g FW for the murine 
and 1.4 ± 0.4 µg/g FW for the viral IL-10 (Figure 22). Secretion of IL-10 in the culture 
medium was found to be less than 0.2% for both proteins (not shown). No obvious 
difference in the growth of the suspension cultures was observed, and the average weight of 
the cell pellet at 7 dpi was not substantially different for the two lines (Figure 22, upper 
right panel). 
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Figure 22: Accumulation of murine and viral IL-10 in BY2 suspension cultures. 
Time course analysis of IL-10 accumulation levels in the cell pellet of BY-2 suspension cultures at 3, 5 and 7 
days post inoculation (dpi) in fresh medium (II.2.3.6), assayed by ELISA, and expressed as µg/g fresh cell 
weight (FW); in the upper right panel, the average fresh pellet weight of the suspension cultures at 7 dpi is 
shown. Values are means ± SD of data from three independent time-course experiments with the highest 
producing line. 
 
III.3.2 Inducible expression of vIL-10 
A possible explanation for such low accumulation levels of the viral IL-10 compared to the 
murine IL-10 also in BY-2 cells, despite no obvious differences in the culture growth, was 
that if the viral IL-10 was indeed harmful to the plant cell in a concentration-dependant 
manner, we were actually selecting against high-expressing lines. It was therefore decided 
to use an inducible promoter, to assess whether induction of IL-10 expression at a defined 
time point of the cell culture growth could lead to higher accumulation levels of the 
recombinant protein. The tetracycline(Tet)-specific de-repressible expression system (Gatz 
and Quail, 1988) was chosen, which has already been successfully used in BY-2 cells 
(David and Perrot-Rechenmann, 2001). Initially, the construct for ER localization of vIL-10 
was cloned as a KpnI-XbaI fragment into the pBinHygTx vector (II.1.2.1), in which the 
transgene is under the transcriptional control of a modified 35S promoter (‘Triple Op’), that 
contains three Tet-Repressor binding sites surrounding the TATA box (Figure 23). The 
plasmid was transferred into A. tumefaciens strain GV2260 by electroporation (II.2.2.6) and 
this was used to over-transform a BY-2 line stably transformed with the pBinTetR vector 
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(Gatz et al., 1992), which constitutively synthesizes the bacterial repressor protein TetR 
(kindly provided by Dr A. Schiermeyer, Fraunhofer IME, Aachen, Germany).  
 
 
Figure 23: Tetracycline inducible ‘Triple Op’ promoter. 
Sequence of the tetracycline inducible promoter region including one Tet-Operator (the 19 bp palindromic 
binding site for the Tet-Repressor) 1bp upstream of the TATA-box, a second operator 1bp downstream of the 
TATA-box and a third operator 23 bp downstream of the TATA-box of the normally constitutive CaMV 35S 
promoter. The CAAT-box and TATA-box are underlined. 
 
However, the use of the pBinHygTX vector for tetracycline-specific de-repressible 
expression of vIL-10 in BY2 cells turned out to be more complicated than expected. In 
particular, setting up the induction conditions for transgene expression in the transformed 
calli to identify the transgenic clones was not straightforward.  
Therefore, a vector containing an expression cassette with the Tet-inducible vIL-10 gene in 
tandem with the DsRed screenable marker gene under the control of a constitutive promoter 
was preferred. It was also decided to switch onto the pTRA vector backbone, which allows 
easier manipulation compared to the low-copy pBin-derived plasmids. 
 
 
 
 
Figure 24: Schematic overview of the T-DNA region of the pTRA plant expression vector used for the 
tetracycline de-repressible expression of viral IL-10 in BY2 cells.  
LB and RB, left and right border of the T-DNA; Pnos and pAnos, promoter and terminator of the nopaline 
synthase gene; hyg, coding sequence of the hygromycin phosphotransferase gene; SAR, scaffold attachment 
region; P35SSTX, 35S promoter of the cauliflower mosaic virus (CaMV) 35S gene with three Tet-Repressor 
binding sites surrounding the TATA box and duplicated enhancer; pA, terminator of CaMV 35S gene; TL, 5’ 
UTR of the tobacco etch virus (TEV); SP, native vIL-10 signal peptide; viral IL-10, mature vIL-10 sequence; 
His6, histidine tag; SEKDEL, ER retention signal; P35SS, promoter of the 35S gene of CaMV with duplicated 
enhancer; TP, transit peptide of the barley granule bound starch synthase gene; DsRed, red fluorescent protein 
from Discosoma sp.. Not drawn to scale. 
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The TetR synthesizing BY2 transgenic line was over-transformed with this new 
pTRAhDsRed-eTXvIL-10 vector (Figure 24) (from Dr. T. Rademacher, RWTH Aachen 
University, Germany). 
As DsRed accumulation is usually a good indicator of transgene expression levels when 
transformed in tandem with the target gene, only calli displaying the highest 
macroscopically visible DsRed fluorescence were selected, transferred to liquid culture and 
used for further analysis (Figure 25). 
 
 
 
Figure 25: Selection of BY2 transgenic clones based on DsRed fluorescence. 
Monitoring of Discosoma red fluorescent protein (DsRed) in transgenic BY-2 cells calli and suspension 
cultures transformed with the pTRAheTXvIL-10 vector. DsRed fluorescence was visualized with an LCD 
lamp with glass fiber optic (Leica KL1500), and additional filter for green excitation (BP545/30) and a colored 
foil (#182, light red). (A) Four transgenic BY-2 calli representing independent clones that show 
macroscopically different fluorescence intensity. (B) Liquid suspension cultures of BY-2 cells; wt cells on the 
left and transgenic on the right.  
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A preliminary evaluation of four clones showing the highest DsRed fluorescence was 
performed, inducing the BY-2 suspension cultures with tetracycline and monitoring vIL-10 
accumulation in the cell pellets after 24, 48 and 72h. A clear correlation between the amount 
of recombinant protein and the macroscopic DsRed fluorescence intensity was observed. 
The conditions for induction -in terms of tetracycline concentration and time of induction- 
were optimized (10 µM Tet, directly after subculturing), and the highest producing clone 
was evaluated for vIL-10 accumulation by ELISA in three independent time-course 
experiments (Figure 26, striped bars). The results obtained were highly reproducible, and 
accumulation levels of vIL-10 up to 5.3 µg/g FW were reached. These levels are 3.5 times 
higher than those previously obtained in BY-2 suspension cultures which constitutively 
express the same transgene (1.5 µg/g FW) (Figure 26, solid bars). Negligible basal vIL-10 
amounts were measured for the un-induced negative controls (< 0.055 µg/g FW), indicating 
a tight repression of transcription in the Tet-R expressing clone used for over-transformation 
(not shown).  
 
Figure 26: Improvement of viral IL-10 accumulation levels in BY2 suspension cultures upon expression 
of the transgene from a tetracycline inducible promoter.  
Tet-R BY2 suspension cultures, over-transformed with the pTRAhDsRed-eTXvIL-10 vector carrying the 
vIL-10 gene under the control of the tetracycline-inducible promoter, were induced with 10 µM tetracycline 
when a saturated culture was transferred into 50 ml fresh medium at 2%(v/v) density (striped bars). 
Suspension cells were grown at 26°C, 180 rpm shaking, and 2ml aliquots were withdrawn daily from 3 to 7 
days post induction (dpi) for analysis. Viral IL-10 accumulation was determined by ELISA on the cell pellet 
extracts. For comparison, the results obtained previously (III.3.1) with the constitutive expression of vIL-10 in 
BY2 cells at 3, 5 and 7 dpi are also shown (solid bars). The data reported are the means ± SD of the data from 
three independent experiments. 
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III.4 Characterization of plant-derived IL-10 
III.4.1 Investigation of IL-10 dimeric state 
The biological activity of IL-10 depends strictly on its dimeric state (Zdanov et al., 1995). In 
order to determine whether or not mIL-10 and vIL-10 were properly assembled into dimers, 
the His6-tagged proteins were purified from stable T1 transgenic tobacco leaves via 
immobilized-metal affinity chromatography (IMAC) on a nickel-nitrilotriacetic acid 
(Ni-NTA) column (II.2.4.13), concentrated, and fractionated by sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) under either reducing or non-reducing 
conditions (II.2.4.5). Immunoblot analysis (II.2.4.9) confirmed the correct molecular 
weights of both proteins (19 and 21 kDa for the viral and murine IL-10, respectively; Figure 
27A and B, right panels). When separated under non-reducing conditions, the plant-derived 
vIL-10 predominantly formed stable dimers (Figure 27A, left panel), whereas mIL-10 was 
partly dimeric and partly monomeric (Figure 27B, left panel). Since commercial mIL-10 
also gives rise to a monomer band under these conditions, this is most likely an artifact of 
the SDS-PAGE method. This was confirmed by gel filtration analysis (II.2.4.14), which 
showed that the plant-derived mIL-10 eluted as a single peak with a profile corresponding to 
the size of the dimeric form (Figure 27C).  
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Figure 27: Assessment of IL-10 integrity and dimerization. 
Viral (A) and murine (B) IL-10, purified from transgenic tobacco leaf extracts by IMAC, were analyzed by 
immunoblotting after separation by non-reducing (left panels) and reducing (right panels) SDS-PAGE. 
Commercial recombinant viral IL-10 produced in E. coli (rvIL-10) or murine IL-10 produced in insect cells 
(rmIL-10) were used as controls, and different amounts of plant-derived IL-10 were loaded, as indicated on top 
of each lane. (C) Elution profile of plant-derived mIL-10 from a Superdex 200 column showing a single peak 
which, compared to the elution volumes of standard reference molecules on the same columns (not shown), 
matches with the expected size of the dimer. Detection of IL-10 in the elution fractions was carried out by 
ELISA. 
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III.4.2 Analysis of N-glycans and N-terminus peptides 
The mature mIL-10 polypeptide has two potential N-glycosylation acceptor sites, whereas 
vIL-10 has a single site. To determine the glycan composition, both plant-derived 
recombinant proteins were purified from transgenic tobacco leaves by affinity 
chromatography using a Ni-NTA column and separated by SDS-PAGE; the Coomassie 
Brilliant Blue stained bands were excised from the gel, digested with trypsin and analyzed 
by mass spectrometry (MS) (Dr. F. Altmann, J. Stadlmann, BoKu Vienna, Austria).  
Despite the presence of a glycan acceptor site at Asn127, the plant-derived vIL-10 was not 
glycosylated, as expected.  
Murine IL-10 was glycosylated, but at only one of the two potential acceptor sites, as is the 
case for the native protein (Moore et al., 1990; Mosmann et al., 1990). Unexpectedly for a 
protein bearing a SEKDEL tag, oligo-mannose-type (OMT) N-glycans accounted for only 
46% of the total N-glycan population, with Man7 being the most abundant glycoform (not 
shown). Complex type N-glycans accounted for 44% of the total, with GnGnXF and 
GnGnX being the most prominent. GnMX was present at lower levels, while the other 
complex type N-glycans were found in only trace amounts (N-glycan abbreviations 
according to Proglycan).  These results indicated that murine IL-10 was secreted instead of 
being retained in the ER, as most of these complex glycans carried terminal 
N-acetylglucosamine (Gn) residues, which is a typical feature of secreted proteins that pass 
through the trans-Golgi network on their way to the apoplast (Fitchette et al., 1994; Lerouge 
et al., 1998). 
LC-MS analysis of plant-derived mIL-10 was performed on both the upper and lower bands 
in which the cytokine separates after SDS-PAGE (Figure 27B). No substantial differences in 
the MS spectra were found for the two proteins, indicating that the lower band does not 
represent a degradation product (not shown). Moreover, detailed analysis of the 
glycosylated peptide indicated that the protein in the two bands has the same 
N-glycosylation pattern (Figure 28A and B), suggesting that the difference in migration is 
probably the consequence of different conformations assumed by IL-10 during the 
SDS-PAGE. In support of this hypothesis is the fact that also the commercial mIL-10 –and 
even the non-glycosylated commercial vIL-10– show the same migrating behavior upon 
SDS-PAGE separation. 
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In contrast, when murine IL-10 purified from transgenic BY-2 cells was subjected to 
N-glycan analysis, the N-glycans found on the protein were only of the oligo-mannose-type, 
as expected for a protein retained in the ER (Figure 28C).  
 
Figure 28: Liquid chromatography-mass spectrometry (LC-MS) of the glycosylated peptide 
EDNNCTHFPVGQSHMLLELR of murine IL-10. 
Murine IL-10 purified by IMAC (II.2.4.13) and separated by SDS-PAGE (II.2.4.5) was digested with trypsin 
and the peptides subjected to LC-MS analysis (II.2.4.15). The spectrum of the glycosylated peptide is shown. 
(A) sample corresponding to the upper band of plant-derived mIL-10; (B) sample corresponding to the lower 
band of plant-derived mIL-10; (C) mIL-10 purified from transgenic BY-2 suspension cells (III.3.1). See 
http://www.proglycan.com for an explanation of N-glycan abbreviations. 
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However, it has to be pointed out that the recombinant protein had been purified from the 
cell pellet of a BY-2 suspension culture, therefore this result does not rule out the possibility 
that murine IL-10 is indeed secreted by the cells. As a matter of fact, the observation that the 
amount of mIL-10 secreted in the culture supernatant was lower than 0.2% (III.3.1) could be 
the consequence of a rapid degradation of the recombinant protein in the culture medium, 
rather than reflecting a tight ER retrieval of mIL-10. Actually, the results of the N-glycan 
analysis of the plant-purified mIL-10 combined with those obtained for the BY-2 derived 
cytokine, could be explained assuming that murine IL-10 is not efficiently retained in the 
ER and secreted in both expression systems, but is more rapidly degraded in the BY-2 
supernatant than in the leaf apoplast. 
Nevertheless, the high amount of complex type N-glycans found on the plant-purified 
mIL-10 contradicted the electron microscopy results, that had clearly localized the protein in 
the ER (Figure 20). As the only obvious difference between the leaf samples utilized for 
immunolocalization and for protein purification was the age of the plant material, mIL-10 
was purified from young or old leaves of young and old plants and subjected to N-glycan 
analyses, to figure out if there was a correlation between the leaf or plant age and the 
intercellular fate of recombinant IL-10 in tobacco plants (Figure 29). The results of the 
N-glycan analysis confirmed that murine IL-10 in young leaves of young plants (4 weeks) 
bears mostly oligo-mannose type glycans (~93%) typical of a ER-retarded protein. The 
small amount of complex type glycans (<7%) is probably due to a minimal escape from the 
KDEL-mediated ER retrieval mechanism, which has been often observed for other 
recombinant proteins (Floss et al., 2008; Triguero et al., 2005). The N-glycan profile of 
mIL-10 purified from 6 weeks old plants, instead, showed around 50% of complex-type 
glycans on the protein, no matter if purified from young or old leaves (Figure 29). 
Additionally, the type of complex glycans found on these samples carried terminal 
N-acetylglucosamine (Gn) residues suggesting secretion of the recombinant protein from the 
plant cell (Fig. 4). This suggests that mIL-10 escaping the ER is secreted by the plant cell 
and not, for example, redirected to the lysosomal compartment. These results indicate that 
the increase in leakage of mIL-10 from the ER endomembrane system is dependent on the 
plant age rather than the leaf age. 
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Figure 29: N-glycan analysis of plant produced murine IL-10 purified from leaf material of different 
age. 
Murine IL-10 purified from stable transgenic leaf material of different age by IMAC (II.2.4.13) was digested 
with trypsin and the peptides subjected to liquid chromatography-mass spectrometry (LC-MS) analysis 
(II.2.4.15). The ‘4 week / top’ sample corresponds to the material that was analyzed by immunolocalization 
and electron microscopy. The ‘6 weeks / bottom’ sample corresponds to the plant material from which mIL-10 
was purified for N-glycan analysis the first time. For each sample, the glycosylated peptide containing 
asparagine-30 of mIL-10 (EDNNCTHFPVGQSHMLLELR) was analyzed by mass spectrometry. The MS data 
from the tryptic peptides were compared with data sets generated by in silico tryptic digestion of the 
recombinant protein sequences using the PeptideMass program (http://www.expasy.org/tools/peptide-
mass.html). See http://www.proglycan.com for an explanation of N-glycan abbreviations. 
 
 
For both murine and viral IL-10, the identity of the N-terminal peptide was established by 
tandem MS analysis. The sequence of the mature mIL-10 polypeptide started with QYSRE 
while vIL-10 started with TDQCD (Figure 30), confirming co-translational ER translocation 
and correct cleavage of both signal peptides, as predicted by the SignalP 3.0 server 
(http://www.cbs.dtu.dk/services/SignalP/). 
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Figure 30: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) profile of the viral IL-10 
N-terminal tryptic peptide. 
The Coomassie-stained band (II.2.4.7) of viral IL-10 purified from tobacco leaves (II.2.4.13) was digested 
with trypsin, extracted from gel pieces, and analyzed. First, the sample was analyzed in plain MS mode, and 
then the sequence of the N-terminal peptide was confirmed by tandem MS. 
 
 
III.4.3 Detection of the KDEL-tag on mIL-10 
A possible reason for the consistent mIL-10 escape from the ER, could be the loss of the 
KDEL tag upon cleavage by cell proteases, whose activity varies with the plant 
developmental stages (Stevens et al., 2000). Therefore mIL-10 purified form bottom leaves 
of 6-week-old plants was analyzed for presence of the KDEL-tag by immunoblot, and the 
analysis confirmed that the tag was still present on the protein (Figure 31). 
As the recombinant protein still bears the KDEL tag, and the mIL-10 accumulation levels 
are not exceptionally high to suggest saturation of the KDEL retrieval machinery, the most 
likely explanation for the presence of complex type N-glycans on mIL-10 is that the tag is 
partially occluded following assembly of the IL-10 dimer, and is not completely accessible 
to the KDEL receptor. 
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Figure 31: Confirmation of KDEL presence by immunoblot analysis. 
To confirm the KDEL presence on the C-term of mIL-10, the plant purified recombinant protein was analyzed 
by immunoblot with antibodies against the KDEL, the 6xHIS tag, and the mIL-10 itself. (A) Five micrograms 
of mIL-10 purified from bottom leaves of 6 week old plants (lane 1) were separated on a 17% SDS gel, and the 
same amount of M12 antibody bearing a KDEL tag on the heavy chain was loaded as positive control (lane 2). 
Immunodetection was carried out with a mouse α KDEL antibody. (B) The same amount of mIL-10 as shown 
in panel A (lane 1) was analyzed in parallel with a rabbit anti 6xHIS antibody. Although the overall intensity 
of the signal is slightly lower, the results reflect precisely what obtained with the anti KDEL antibody. (C) As 
control, 100 ng of mIL-10 (lane1) were separated by SDS-PAGE and detected by a rat anti mIL-10 antibody. 
 
 
III.5 Assessment of murine and viral IL-10 biological activity 
III.5.1 STAT3 Phosphorylation assay 
All the anti-inflammatory effects of IL-10 require the activation of signal transducer and 
activator of transcription 3 (STAT3), which acts downstream of the IL-10 receptor in both 
mouse and human cellular models (Moore et al., 2001). Therefore, the ability of 
plant-derived mIL-10 and vIL-10 to phosphorylate the Tyr705 residue of STAT3 was tested. 
To exclude possible interference from plant proteins co-purifying with the recombinant 
IL-10 molecules, equal amounts of wild type leaf material were subjected to the same 
purification procedure on a Ni-NTA column, and the eluate was used as a control in all 
biological activity assays. Stimulation of the mouse macrophage cell line J774 with different 
doses of plant-derived mIL-10 and vIL-10 triggered STAT3 tyrosine phosphorylation within 
15 min and in a dose-dependent manner (Figure 32). The concentration of plant-derived 
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IL-10 required to elicit STAT3 tyrosine phosphorylation to a degree comparable to that 
observed in response to commercial mIL-10 (20 ng/ml) and vIL-10 (150 ng/ml) was 50 
ng/ml for the murine protein (Figure 32A) and 500 ng/ml for the viral protein (Figure 32B). 
STAT3 phosphorylation resulted specifically from the presence of recombinant IL-10, since 
control eluate from wild type plant extracts had no detectable effect even at the highest dose 
tested. 
 
 
Figure 32: Activation of STAT3 phosphorylation by murine and viral IL-10 produced in tobacco plants. 
STAT3 phosphorylation (STAT3-YP) was assessed by immunoblot analysis on protein extracts of macrophage 
cells treated with increasing doses of plant-derived IL-10 (II.2.6.2). (A) J774 cells were cultured for 15 min in 
the presence of eluate from wild type tobacco plants (lane 1; protein amount equivalent to the 150 ng/ml 
sample of the mIL-10-producing tobacco line), 20 ng/ml of commercial mIL-10 produced in insect cells (lane 
2) or increasing concentrations of plant-derived mIL-10 (lanes 3-6). (B) J774 cells were cultured for 15 min in 
the presence of the eluate from purification of wild type tobacco plants (lane 1; protein amount equivalent to 
the 500 ng/ml sample of the vIL-10-producing tobacco line), 150 ng/ml of commercial vIL-10 (lane 2) or 
increasing concentration of plant vIL-10 (lanes 3-6). Total cell extracts (50 µg) were separated by SDS-PAGE 
and immunoblots were performed as described in the Materials and Methods section (II.2.6.2). One 
experiment representative of two is shown. The blots were scanned on the Odyssey Infrared Imaging System 
at 700 and 800 nm. The relative STAT3-YP levels, as quantified by the Odyssey software and normalized for 
the total STAT3, are reported below each panel. 
 
III.5.2 Enhancement of LPS-induced SOCS3 modulation 
It has been reported that suppressor of cytokine signaling 3 (SOCS3) is one of the targets of 
murine IL-10 (Cassatella et al., 1999; Ito et al., 1999). Indeed, SOCS3 mRNA and SOCS3 
protein expression in lipopolysaccharide (LPS)-stimulated J774 cells (II.2.6.4) is enhanced 
in the presence of commercial mIL-10 (Berlato et al., 2002). Similarly, purified 
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plant-derived mIL-10 increased the expression of LPS-induced SOCS3 mRNA (Figure 33A) 
and SOCS3 protein (Figure 33B). 
 
 
Figure 33: Effect of plant-derived murine IL-10 on LPS-induced SOCS3 mRNA and SOCS3 protein 
expression.  
(A): J774 cells were stimulated for 2 h with 100 ng/ml of LPS alone or in combination with commercial 
mIL-10 (20 ng/ml), or plant mIL-10 (50 and 100 ng/ml). Non stimulated cells (‘medium’) were included in the 
analysis to determine SOCS3 basal expression levels. Total RNA was extracted (II.2.1.15) and then analyzed 
for SOCS3 mRNA expression by real time RT-PCR (II.2.1.16). The graph shows the SOCS3 mRNA levels 
(mean ± SD) assayed in triplicate and normalized to GAPDH expression. (B): J774 cells were incubated for 18 
h in the presence of LPS alone (lane 2) or in combination with 20 ng/ml commercial IL-10 (lane 3) or 50 
ng/ml (lane 4) or 100 ng/ml (lane 5) plant derived mIL-10. Non stimulated cells (‘medium’) were included in 
the analysis to determine SOCS3 basal expression levels. Whole cell extracts (50 µg) were immunoblotted 
using anti-NH2 terminus SOCS3 antibody (upper panel) and antibodies specific for GAPDH (lower panel), 
followed by incubation with AlexaFluor 680 goat anti-rabbit and IRDye 800 goat anti-mouse antibody. The 
relative levels of SOCS3 protein, as quantified by the Odyssey software and normalized for the total GAPDH 
content, are reported at the bottom of each lane. The data shown in (A) and (B) are representative of two 
independent experiments. ** p<0.001. 
 
III.5.3 Inhibition of LPS-induced TNFα production 
The full functionality of plant-derived mIL-10 and vIL-10 was verified testing their 
inhibitory activity on the LPS-induced production of tumor necrosis factor alpha (TNFα). 
The amount of TNFα released into the culture supernatant of J774 cells stimulated with LPS 
for 18 h was reduced in the presence of plant-derived mIL-10 to the same extent observed 
with the commercial mIL-10 (Figure 34A). Similarly, the ability of plant-derived vIL-10 to 
inhibit LPS-induced TNFα production was equivalent to that of its commercial counterpart 
(Figure 34B). Addition of control eluate from wild type plants had no effect on the J774 
response to LPS, or the suppressive activity of IL-10. These results confirmed that the 
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inhibition of TNFα production was dependent on the recombinant cytokines, and not on any 
co-purified plant proteins. 
 
 
Figure 34: Inhibition of LPS-induced TNFα production by plant-derived murine and viral IL-10. 
J774 cells were stimulated for 18 h with IL-10 alone, LPS alone, or LPS plus IL-10 (II.2.6.3). The eluate of the 
purification of wild type leaves (wt) was also included, alone or in combination with commercial IL-10, to 
exclude the interference of plant proteins with the assay. TNFα secretion in the culture medium (med) was 
quantified by ELISA and is reported as pg/ml supernatant. Values are the means ± SD of four independent 
experiments for the murine IL-10 (A) and three independent experiments for the viral IL-10 (B). ** p<0.001. 
 
III.6 Stability studies 
III.6.1 Investigation of different storage conditions and temperatures 
In order to plan the feeding studies in the animal model, the stability of the recombinant 
proteins in different formulations and at different temperatures over three months was 
investigated. Transgenic leaf material was ground in liquid nitrogen and either stored frozen 
as a powder, lyophilized and stored at room temperature or directly used for protein 
extraction and the extract was then stored in the freezer. The amount of IL-10 in the samples 
was quantified by ELISA at every time point. Both murine and viral IL-10 behaved the 
same in terms of stability in the investigated conditions, and both resulted to be stable in the 
raw extract at -80°C or in the powder either at -20°C or -80°C over a three months period. 
In Figure 35  the results obtained for the murine IL-10 are reported as representative of both.  
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Figure 35: Stability studies of murine IL-10 in different storage conditions. 
IL-10 levels were determined in the leaf extract at each time point by ELISA, and results are reported as  % 
relative to the amount of IL-10 at time-point 0. (A): leaf powder stored at -20°C; (B): leaf powder stored at 
-80°C; (C): leaf extract stored at -80°C; (D): lyophilized leaf powder stored at room temperature.  
 
III.6.2 Resistance of IL-10 to gastrointestinal degradation 
The stability of murine and viral IL-10 produced in transgenic plants, either embedded in 
the lyophilized tobacco tissue or purified from the plant tissue, was compared using 
simulated gastric fluid (SGF, 3.2 g/L pepsin, pH 1.2) and simulated intestinal fluid (SIF, 10 
g/L pancreatin, pH 6.8).  
Both murine and viral plant-produced IL-10 resulted more resistant to gastric degradation 
when retained within the leaf tissue (Figure 36, upper panels), indicating that the plant 
matrix contributes to protect the recombinant proteins against proteolytic enzymes and 
low-pH conditions. This increased stability was especially relevant in the case of the viral 
IL-10, as after 30 s of digestion there was <4% of commercial IL-10, while in the 
lyophilized tissue >90% was still present. 
Also in SIF digestion experiments, IL-10 embedded in the plant material turned out to be 
more resistant to degradation (Figure 36, lower panels). For both murine and viral IL-10, 
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>30% of the cytokine was still present after 30 min incubation, while the commercial 
counterparts were already undetectable.  
In both digestion setups, the stability of plant purified IL-10 was comparable to, if not 
higher than, that of the respective commercial counterparts. 
 
 
 
Figure 36: Stability of plant produced IL-10 in simulated gastrointestinal fluids.  
The stability of plant-produced murine and viral IL-10, either embedded in the lyophilized tobacco tissue or 
purified from tobacco leaves, was compared, along with the commercial counterparts, in in vitro 
gastrointestinal simulation conditions (II.2.7). Purified IL-10 at a concentration of 1 ng/ml or 0.1g aliquots of 
lyophilized leaf tissue were digested in either simulated gastric fluid (SGF, 3.2 g/L pepsin, pH 1.2) or 
simulated intestinal fluid (SIF, 10 g/L pancreatin, pH 6.8) at 37°C. The digestion reactions were stopped with 
45 mM Na2CO3 for SGF, or 10 mM EDTA for SIF, respectively. IL-10 content was determined by ELISA 
directly in the quenched digestion solution for the pure IL-10 samples, or in the plant extract for the 
lyophilized leaf material. The results shown are the mean of three independent experiments. 
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IV  DISCUSSION 
 
 
IV.1 Expression of IL-10 in the chloroplast of tobacco plants 
 
Plastid transformation is a very attractive tool in molecular farming, due to the extremely 
high foreign protein accumulation levels that can be reached, compared to nuclear 
transformation (up to 100 times higher - De Cosa et al., 2001). This is most likely due to 
both higher stability of many foreign proteins inside the chloroplast than in the 
nucleo-cytoplasmic compartment, and to the high expression levels that result from the 
enormous numbers of genome copies and thus transgene copies per cell (Bock, 2001). 
In the attempt to reach high IL-10 accumulation levels in plants, chloroplast transformation 
of N. tabacum cv. Petit Havana was performed using the pRB95 vector bearing the coding 
sequence of either the murine or the viral IL-10. However, quite disappointingly, chloroplast 
transformation turned out not to be a feasible approach for IL-10 production, as only 
unsatisfactory levels of recombinant protein could be obtained in the transplastomic plants 
generated. 
The first hypothesis considered to explain the lack of recombinant protein accumulation, 
was protein degradation. Proteolytic degradation during plant development can be an 
important factor affecting yield and homogeneity of heterologous proteins produced by 
transgenic plants (Stevens et al., 2000) and, in particular, massive protein degradation is 
known to occur during tissue senescence. In the case of IL-10, however, the absence of 
recombinant protein did not seem to depend on leaf age (as observed in several earlier 
studies - Birch-Machin et al., 2004; Zhou et al., 2008), as both older and younger leaves 
were analyzed for IL-10 accumulation, and no obvious differences were observed between 
the samples. 
Incorrect folding of IL-10 within the chloroplast, which would in turn lead to its rapid 
degradation, was also taken into consideration. The chloroplast stroma constitutes a 
reducing rather than oxidizing environment, and within each IL-10 monomer subunit there 
are two disulfide bonds which are susceptible to reduction (Zdanov et al., 1995). Several 
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examples in the literature suggest that disulfide bond formation in the chloroplast stroma 
may not be problematic: human somatotropin has been synthesized at high levels in 
chloroplasts in a biologically active form that depends on the formation of two disulfide 
bonds (Staub et al., 2000). The cholera toxin B pentamer with five disulfide bonds was also 
expressed in chloroplasts as functional oligomers up to 4.1% of TSP (Daniell et al., 2001). 
Nevertheless, this might be protein dependent, and it has to be considered that the redox 
state of the stroma is strongly influenced by the level of photosynthetic activity (Ruelland 
and Miginiac-Maslow, 1999) which, for example, was obviously impaired in the plants 
transformed with the viral IL-10 construct. Failure of IL-10 disulfide bonds formation in the 
chloroplasts of transplastomic plants could have possibly increased its susceptibility to 
proteolysis. Chloroplasts contain a range of proteolytic activities that target mis-folded, 
mis-targeted and damaged proteins for destruction (reviewed in Adam and Clarke, 2002), 
and proteolysis alone might account for the apparent lack of accumulation of IL-10. As a 
matter of fact, Menassa and colleagues have reported that the highly homologous human 
IL-10 protein targeted to the chloroplast of nuclear transgenic tobacco plants accumulated at 
extremely low levels (up to 0.0043 % TSP) and did not assemble into a homodimer, 
supporting the possibility of IL-10 protein instability inside the chloroplast environment 
(Menassa et al., 2004). Chloroplast proteases are indeed of prokaryotic type (e.g. Clp, Deg), 
and therefore have different substrate specificities compared to eukaryotic proteases 
(ubiquitin-proteasome system) which could be a reason for protein instability within the 
chloroplast. 
However, the observations collected and the analyses performed on the transplastomic 
plants altogether, suggested that something more complex than simple protein degradation 
was taking place in IL-10 expressing plants. First of all, regeneration of transplastomic 
plants after biolistic bombardment was extremely difficult, as the callus tissue kept growing 
undifferentiated without producing shoots. Also, only five spectinomycin-resistant lines 
were eventually obtained for the murine construct and three for the viral one. Of these, only 
one line per construct turned out to be a true transplastomic line after the resistance test on 
double selective medium. This is an unusual and extremely low transformation efficiency, 
as upon one bombardment of tobacco leaves with the same vector backbone, usually around 
10 independent transplastomic lines are obtained. Furthermore, plants derived from this only 
transplastomic line developed a yellow or variegated phenotype in the case of viral IL-10, 
and slightly deformed and curled leaves in the case of the murine transgene (Figure 7). 
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Interference of IL-10 with gene expression (e.g., at the level of codon usage) in the 
chloroplast was excluded in light of the fact that obvious toxicity problems, although with a 
different phenotype, arose also when the transgenes were expressed in the nucleus. This 
observation, together with the fact that the sequences of the murine and viral versions of 
IL-10 are highly homologous only at the amino acid level and retain an almost identical 
quaternary structure, strongly suggest that the IL-10 protein itself, and most probably its 
dimeric form, is responsible for the phenotypic alterations observed. The yellow phenotype 
could suggest a deleterious interaction of the recombinant protein with the plant 
photosynthetic apparatus. This has been seen before, for example, in a study where the outer 
surface protein A (OspA) produced in tobacco chloroplasts strongly affected the 
photosystem II in a concentration-dependent manner, rendering the plants unable to grow 
without exogenously supplied sugars (Hennig et al., 2007). However, in the case of IL-10, 
the impaired growth of transplastomic plants already on complex medium in the tissue 
culture led us to exclude that IL-10 interferes directly with photosynthesis, because the 
plantlets grew slowly and developed abnormalities despite the availability of nutrients, in 
particular sugars as carbon source. Interestingly, vIL-10 expression was accompanied by a 
sharp decline in the accumulation of plastid-encoded proteins, most notably Rubisco, by far 
the most abundant protein in plant cells (Figure 12). This observation raised the hypothesis 
that vIL-10 might interfere with the overall translation or protein folding processes, possibly 
by interacting with molecular chaperons or translation factors. However, to date, there is no 
published evidence or indication of such an interaction. 
Sequencing of the promoter region of both transgenes indicated that the lack of IL-10 
accumulation was a direct consequence of recombination events that had occurred within 
the plant, leading to either the deletion of the first 40-50 nucleotides of the IL-10 ORF or to 
the exchange of the transgene promoter (Prrn-long) with the weaker version (Prrn-short) 
(Figure 11). In fact, although the shorter Prrn promoter still contains the -35 consensus 
sequence and the -10 element, it is apparently much less active than the full length promoter 
(Zhou et al., 2008). Northern and western blot analyses indicated that the yellow phenotype 
observed for the viral IL-10 construct correlated with high mRNA and detectable foreign 
protein accumulation levels, indicating that even extremely low amounts of IL-10 are 
apparently detrimental to the plant. A yellow and variegated phenotype similar to the one 
observed for vIL-10, and an analogous correlation of high transgene mRNA accumulation 
levels with yellow and low transcript amounts with green plants or plant sectors, have been 
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recently described by Zhou et al. (2008). In that work, Nef-expressing transplastomic plants 
were generated by transformation of N. tabacum cv. Petit Havana with a plasmid based on 
the same pRB95 vector, and five out of 14 independently generated transplastomic lines 
displayed the altered phenotype. Analysis of the promoter region in those plants revealed an 
inverse relationship between expression and/or accumulation of AadA and Nef, and a 
positive correlation of the yellow phenotype with very high accumulation levels of the 
recombinant protein (~4 % TSP). As upon expression of Nef in the chloroplast as a fusion 
protein with p24, massive accumulation levels were reached without causing growth 
abnormalities (up to roughly 40% of TSP), the authors could exclude that the phenotypic 
alterations observed upon expression of Nef alone were the result of the exhaustion of the 
gene expression capacity of the chloroplast by overuse of its ribosomes for the production of 
the recombinant protein. They rather suggested a toxic effect of Nef, possibly caused by 
interference of the lipidated (Glenz et al., 2006) N-terminus of the recombinant protein with 
thylakoid structure and function which, in turn, would inhibit photosynthesis. Similarly, in 
the case of IL-10, the amount of the recombinant protein in transplastomic plants is so low 
that it is extremely improbable that such accumulation levels are exhausting the overall 
protein production capacity of the chloroplast. Instead, a more general harmful effect of the 
cytokine to the cell metabolism and/or development is more likely, also considering the 
plant’s stunted phenotype and the cell death symptoms observed upon nuclear expression of 
the same proteins (III.2). The alterations of the original genome configuration leading to the 
exchange of the promoters between the transgene and aadA that were found for the only 
transplastomic line obtained, in the case of murine IL-10 (Figure 11), and in all lines 
generated, in the case of Nef (Zhou et al., 2008), indicate that there might be some selective 
pressure favouring the recombination product over the original configuration. This selective 
pressure could be either enhancement of the antibiotic resistance level, as achieved by 
combination of aadA with a stronger promoter which should confer a fitness advantage to 
the high selective pressure of spectinomycin, or a decrease in the expression level of the 
antigens, if high-level transgene expression is selected against. The antibiotic concentration 
that was used for transplastomic tissue selection in both studies is in accordance to the 
standard protocols for chloroplast transformation and it has never been reported as toxic, 
rendering the augmented antibiotic resistance level a weak explanation for the 
recombination events observed. Additionally, for the viral IL-10, the rearrangements 
occurred within the IL-10 expression cassette region and should not result in an increase in 
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AadA synthesis, because the aadA gene retained the short version of the promoter, but 
undoubtedly caused a reduced transgene expression and recombinant protein synthesis 
(Figure 11). Therefore, a high selective pressure against high-level IL-10 accumulation is 
definitely the most likely explanation for the results obtained upon chloroplast expression of 
IL-10. 
If this is the case, it implies that even if the promoter rearrangements could be prevented by 
replacing the short Prrn promoter upstream the aadA gene with the strong version in the 
pRB95 vector, this would probably prevent the regeneration of any transplastomic plants, 
because high levels of toxic IL-10 would be lethal to the plant cells. Therefore, it becomes 
clear that a prerequisite to increase IL-10 accumulation levels in the chloroplast would be to 
understand the molecular basis of IL-10 interference with essential functions in this cell 
compartment, in order to generate truncated versions of IL-10 or design fusion proteins 
aimed at preventing the detrimental effects of IL-10 to the chloroplast. However, this is not 
a trivial task, especially considering that IL-10 has to be dimeric to retain its biological 
activity, and even little changes in the amino acid sequence of the protein might severely 
invalidate its conformation-dependent functionality, and tackling this problem was beyond 
the scope of this PhD work. 
 
 
IV.2 Nuclear expression of IL-10 and subcellular targeting 
 
The intracellular targeting of a recombinant protein often has a significant effect on its yield 
and, in some cases, also on its biological properties. In this work, targeting of both versions 
of IL-10 to three different subcellular compartments – the ER, cytosol and apoplast – was 
investigated in order to assess the impact on protein accumulation, and with the aim of 
exploiting the most promising strategy to generate stable transgenic tobacco plants. 
Preliminary studies of murine IL-10 transient expression driven by a PVX-based system in 
N. benthamiana (data not shown), had indicated that the ER was by far the most suitable 
compartment for mIL-10 accumulation compared to the cytosol and the apoplast, where 
IL-10 seemed to be extremely unstable (ER-retained reached around 10 µg/g FLW; 
cytosolic and apoplastic expression was nearly undetectable as determined by immunoblot 
analyses). A promising strategy to stabilize recombinant proteins which are otherwise 
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rapidly degraded in the cytosol or the apoplast, is to associate them with the plasma 
membrane (Vitale and Pedrazzini, 2005). Therefore, in the attempt to increase the overall 
IL-10 accumulation levels, new targeting constructs were generated to fuse the IL-10 
sequence to membrane anchors that allow the recombinant proteins to be exposed to the 
apoplast or cytosol while retaining them in the membrane. To anchor IL-10 to the cytosolic 
side of the ER membrane, the mammalian ER isoform of cytochrome b5 (cytb5), a protein 
belonging to the type IV transmembrane polypeptides, also called tail-anchor (TA) proteins 
(Borgese et al., 2003), was exploited. Cytb5 does not have an N-terminal signal but holds a 
hydrophobic transmembrane domain (TDM), followed by a few polar luminal residues at 
the C-terminus, that allows spontaneous integration into the cytosolic face of the 
endoplasmic reticulum membrane post-translationally (D'Arrigo et al., 1993). To anchor 
IL-10 to the apoplastic side of the plasma membrane, instead, IL-10 was fused to the 
transmembrane domain of the human T cell receptor β chain, maintaining the native IL-10 
signal peptide sequence to direct the recombinant protein into the secretion pathway. Both 
mammalian transmembrane domains have already been shown to be effective membrane 
anchors in plant cells, and to increase stability of the fused recombinant proteins (Schillberg 
et al., 2000; Barbante et al., 2008). For both murine and viral IL-10 these constructs, and the 
one for ER retention, were cloned into the pTRAkt binary vector for plant expression. 
The three targeting strategies were evaluated by transient expression in tobacco leaves 
following agroinfiltration, since this provides a reliable indication of performance much 
more rapidly than the generation of stably transformed plants. Transient expression of the 
construct, by either vacuum-infiltration of detached leaves or by agroinjection on whole 
plants, showed a detrimental effect of both murine and viral IL-10, that was clear in its 
symptoms (dryness and necrosis of the infiltrated area) and dependent on the recombinant 
protein localization (apoplast and ER for the viral, apoplast and cytosol for the murine 
IL-10, respectively), but varied in intensity and reproducibility in between the experiments 
(Figure 16). Nevertheless, reliable recombinant protein quantification and comparison of all 
the constructs tested in parallel was possible, sampling the infiltrated leaf material before 
the onset of the cell death symptoms. Despite the addition of membrane anchors to stabilize 
the recombinant proteins in the cytosol and the apoplast, both versions of IL-10 
accumulated to the highest levels in the ER, confirming the previous observation for mIL-10 
with the PVX-mediated expression, and in line with what has been observed for hIL-10 
stably expressed in tobacco (Menassa et al., 2004). An immunoblot evaluation of the 
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recombinant viral IL-10 bearing the membrane anchors transiently expressed in 
agroinfiltrated leaves was not possible, as the accumulation levels of the 
membrane-anchored versions of the viral interleukin were too low to be visualized by 
immunodetection on a western blot without prior protein purification or concentration 
(Figure 15). The absence of an immunoblot that, showing the size of the products, would 
ensure the authentic expression of the heterologous proteins, could rise some concerns on 
the real expression of the constructs, considering the extremely low IL-10 amounts 
measured by ELISA. However, it has to be pointed out that the ELISA setups that were used 
for quantification are extremely sensitive (down to ~10 pg/ml for the viral and to ~50 pg/ml 
for the murine IL-10, respectively) and highly specific (no cross-reactivity was observed 
with protein extracts of wt tobacco plants) ensuring a reliable determination of even very 
low amounts of recombinant protein in the crude leaf extracts. Additionally, considering 
that the sandwich ELISA for both murine and viral IL-10 were performed with two different 
monoclonal antibodies for coating and capturing, which recognize different epitopes on the 
molecules, it is very unlikely that the accumulation levels measured for the 
membrane-anchored IL-10 are artefacts. Moreover, as already mentioned, the accumulation 
levels measured, as well as the increased stability of IL-10 in the ER, are in line with the 
results reported by Menassa and colleagues for the highly homologous human IL-10 
(Menassa et al., 2001; Menassa et al., 2004), suggesting that the extremely low amounts of 
IL-10 facing the cytosol and the apoplast are the results of the protein instability and/or 
susceptibility to degradation, rather than the impaired expression of the targeting constructs. 
Many other recombinant proteins have also accumulated to the highest levels in the ER 
when different targeting strategies were compared (Conrad and Fiedler, 1998; Twyman et 
al., 2005; Petruccelli et al., 2006). The data obtained in this work confirm the beneficial 
environment within the ER, favoring correct protein folding and assembly, and high protein 
stability. 
Stable transgenic tobacco plants were therefore generated with the constructs that yielded 
the highest accumulation levels by targeting the recombinant proteins to the endoplasmic 
reticulum. In T1 transgenic plants, the highest level of mIL-10 accumulation was 37.0 µg/g 
FLW (0.6% total soluble protein (TSP)) and the highest level of vIL-10 accumulation was 
10.8 µg/g FLW (0.1% TSP). These yields fall into the 0.1-1.0% TSP range typically 
observed for pharmaceutical proteins produced in nuclear transgenic plants (Twyman et al., 
2003) and are much higher than the 0.0055% TSP previously reported for the ER-targeted  
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hIL-10, which is very similar in structure to the murine and viral orthologs (Menassa et al., 
2001). The accumulation of murine IL-10 increased between the T0 and T1 generations 
(form 21.3 to 37.0 µg/g FLW), indicating that recombinant protein yields are partly 
dependent on the transgene copy number and/or zygosity. Differently, for vIL-10 an 
improvement in protein accumulation levels between the T0 and T1 generations could not be 
observed (8.9 and 10.8 µg/g FLW, respectively), most likely because expression of the viral 
cytokine caused a phenotype, whose severity correlated with the level of protein 
accumulation, and the highest vIL-10 accumulating T0 plants did not produce seeds.  
In addition to the macroscopic phenotypic alterations observed, ultrastructural analysis of 
transgenic leaves expressing high levels of vIL-10 revealed an increased number of 
plastoglobules within the chloroplasts. Plastoglobules are lipid bodies produced by plastids 
which constitute a distinct structural and functional sub-compartment of thylakoids, and 
contain both lipid binding proteins and enzymes involved in lipid biosynthesis and 
metabolism. Plastoglobule numbers increase in plants subjected to environmental conditions 
that increase oxidative stress on the photosynthetic apparatus. These include high 
concentrations of CO2 (Sallas et al., 2003), drought (Munne-Bosch and Alegre, 2001), high 
saline concentration (Sam et al., 2003) and viral infection (Hernandez et al., 2004). In fact, it 
has been shown that plastoglobules contain the enzyme tocopherol cyclase, whose increased 
activity during oxidative stress protects the thylakoid membranes and photosynthetic 
proteins form oxidative damage caused by activated oxygen species (Austin et al., 2006). 
The increased number of plastoglobules within the chloroplasts of transgenic tobacco leaves 
accumulating high levels of viral IL-10, therefore, most likely represents a sign of cellular 
stress associated with the expression of the viral cytokine. 
Excluded that the phenotypic abnormalities observed for the vIL-10 transgenic plants could 
be the result of transgene position effects – as they were observed for many independent 
transgenic lines – or somehow related to the in vitro tissue culture conditions – as they 
persisted also in the T1 generation – they were most likely caused by the expression of the 
recombinant protein itself. Therefore, expression of the recombinant protein in BY2 cells 
was also investigated, hoping that viral IL-10, whatever the cause of its harmfulness might 
be, would not be detrimental to the plant cell in this expression system and could reach 
higher yields. However, in tobacco cell suspension cultures, accumulation levels of murine 
IL-10 were almost one order of magnitude higher than those reached for the viral cytokine, 
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despite no obvious phenotype of the transgenic cells expressing vIL-10 (Figure 22). 
Interestingly, inducible expression of the viral transgene driven by a tetracycline inducible 
promoter, led to an increase in vIL-10 accumulation levels of 3.5 fold compared to those 
reached using a constitutive promoter in the same expression platform (Figure 26). These 
results show that vIL-10 accumulation levels can be improved upon usage of an inducible 
transgene expression system, may possibly be further increased with additional optimization 
of the induction conditions, and indirectly confirm that, at least to some extent, vIL-10 is 
harmful to plant cells above a certain threshold. Likewise, inducible expression of vIL-10 
should also lead to higher accumulation levels in whole plants, and generation of stable 
transgenic tobacco lines exploiting a regulatory system that allows transgene expression at a 
defined time point is a promising strategy that remains to be explored. 
 
IV.3 Characterization of plant-derived IL-10 
 
The expression of a recombinant protein containing a native signal peptide requires the 
signal peptide to be correctly interpreted by the heterologous host cell, otherwise the protein 
could be improperly cleaved or not cleaved at all. This is especially relevant for 
pharmaceutical proteins, where imprecise cleavage could affect the biological activity of the 
protein and might raise safety concerns (Streatfield, 2007). The mIL-10 signal peptide was 
correctly processed in tobacco, as shown by sequencing the N-terminal peptide of the 
mature protein, which had the same QYSRE N-terminus previously reported for native 
mIL-10 (Moore et al., 1993). There are at least two different N-terminal sequence reported 
for vIL-10: QCDNF and TDQCD. The former is claimed in several publications (Zdanov et 
al., 1997; Ding et al., 2000; Yoon et al., 2005) and is most likely based on the prediction 
first reported by Moore and colleagues (Moore et al., 1990). The latter is predicted by the 
latest version of the widely-used SignalP 3.0 Server (Bendtsen et al., 2004; Emanuelsson et 
al., 2007), and is reported in at least one publication (Salek-Ardakani et al., 2002). Tandem 
MS analysis of the N-terminal peptide of the purified vIL-10 produced in tobacco showed 
the N-terminal sequence to be TDQCD, in line with the prediction of the SignalP 3.0 Server 
(Figure 30). To our knowledge, this is the first time that the N-terminal amino acidic 
sequence of mature vIL-10 determined by bioinformatic tools, has been experimentally 
confirmed following expression in a eukaryotic cell. 
Discussion_________________________________________________________________ 
 
 108 
Although vIL-10 is not glycosylated (Hsu et al., 1990), both the native and recombinant 
mIL-10 are heterogeneously N-glycosylated at an acceptor site near the N-terminus (Moore 
et al., 1990). This glycosylation has no known influence on mIL-10 activity (Moore et al., 
2001), but the presence of plant complex type N-glycans on therapeutic glycoproteins 
renders them potentially immunogenic and thus raises safety concerns, particularly in the 
case of parenteral administration. Even so the potential immunogenicity of plant glycans 
may also be important for orally administered proteins, especially in patients with severe 
food allergies. The glycan modifications that occur in the ER produce high-mannose-type 
N-glycans that are conserved between mammals and plants, so the use of a KDEL signal for 
ER retention not only increases protein yields, but also prevents the addition of plant 
complex type glycans. N-glycan analysis (Figure 29) indicated that mIL-10 bears only 
ER-specific glycans in young plants, while in mature plants, although carrying a SEKDEL 
tag, is not efficiently retrieved to the ER, and is modified by enzymes located in the 
trans-Golgi network (Fitchette et al., 1994; Pagny et al., 2000). In addition, the presence of 
terminal GlcNAc residues on the complex glycan structures would suggest that mIL-10 
escaping the ER is secreted by the plant cell and not, for example, directed to the vacuole 
(Lerouge et al., 1998). The high efficiency of ER retrieval has been documented for a 
number of recombinant proteins produced in plants (Gomord et al., 1997; Frigerio et al., 
2001; Sriraman et al., 2004), but there are also several examples of KDEL-tagged 
recombinant proteins containing complex type glycans, indicating that the retrieval system 
can be leaky and must be evaluated on a case-by-case basis (Triguero et al., 2005; Floss et 
al., 2008). As immunoblot analysis of the purified protein confirmed that the KDEL-tag is 
still present (Figure 31) and IL-10 yields are not high enough to suggest saturation of the 
KDEL retrieval machinery (Crofts et al., 1999), the most likely explanation for the presence 
of complex type N-glycans on mIL-10 is that the tag is partially occluded following 
assembly of the IL-10 dimer, and is not completely accessible to the KDEL receptor. As a 
matter of fact, limited exposure of the KDEL sequence has previously been discussed as a 
potential explanation for differences in retrieval efficiency for different recombinant 
proteins (Sriraman et al., 2004).  
Non-reducing SDS-PAGE followed by immunoblot analysis and (for mIL-10) gel filtration 
analysis confirmed that both vIL-10 and mIL-10 assemble into dimers in tobacco leaves. 
Moreover, it appears that the dimerization of both plant-derived versions of IL-10 is more 
efficient than that of their commercially produced counterparts (Figure 27). Since the higher 
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dimer/monomer ratio is consistent regardless of the total amount of protein loaded onto the 
gel, the possibility that this is an artifact caused by high protein concentration can be ruled 
out. It is also unlikely that the presence of plant glycans is responsible, since vIL-10 is not 
glycosylated. The most probable explanation is that the presence of the C-terminal SEKDEL 
and His6 tags may enhance the stability of the dimers. However, to confirm this assumption, 
it would be necessary to express non-tagged versions of the proteins and compare the 
dimer/monomer ratios. Increased stability of plant-derived IL-10 dimers was also observed 
for hIL-10 by Menassa and colleagues (Menassa et al., 2001). Interestingly, hIL-10 is not 
glycosylated and the C-terminal tags had been cleaved from the plant-derived hIL-10 by 
thrombin digestion, which should remove all additional amino acids except a lysine and a 
valine. This would suggest that as little as two additional amino acids are sufficient to 
increase the stability of the IL-10 dimer; however, the authors did not comment on this. 
The ability of both vIL-10 and mIL-10 to form dimers indicated that the recombinant 
proteins were likely to retain their biological activity, a hypothesis that was tested by 
exposing LPS-stimulated J774 mouse macrophage cells to different amounts of recombinant 
IL-10 and assaying the effect on downstream components of the signaling pathway. A clear 
dose-dependent effect on STAT3 phosphorylation after treatment with both variants of 
IL-10 was observed, indicating that the plant-derived proteins properly interacted with the 
IL-10 receptor and initiated the signal transduction cascade. Moreover, mIL-10 was able to 
upregulate the expression of the intracellular negative regulator of cytokine responses, 
SOCS3. Most importantly, given that IL-10 is best known for its ability to inhibit 
pro-inflammatory cytokine and chemokine expression in LPS-stimulated macrophages, it 
was demonstrated that both mIL-10 and vIL-10 are able to inhibit the LPS-induced 
production of TNFα. Higher doses of the plant-derived proteins as compared to the 
corresponding commercial IL-10 products were required. As put forward also in the 
discussion of the increased stability of the plant-produced IL-10 dimers compared to the 
commercial counterparts, it seems very unlikely that plant glycans are responsible for the 
higher doses of plant-derived IL-10 required to elicit the same biological response in in vitro 
assays, because the viral variant of this cytokine is not glycosylated. Therefore, the most 
plausible difference that could account for this discrepancy is the presence of the KDEL and 
His6 tag sequences at the C-terminus of the plant-produced proteins. As a matter of fact, 
preliminary results from the laboratory showed that murine IL-10 bearing the KDEL tag 
(without the His6 tag), expressed in Arabidopsis thaliana seeds, is able to induce STAT3 
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phosphorylation and to inhibit LPS-induced TNFα secretion to the same extent of the 
commercial mIL-10 in in vitro assays using the same J774 macrophage cell line (Francesca 
Morandini 2009, PhD thesis). This observation strongly suggests that the presence of the 
His6 tag at the C-terminus of the protein is responsible for the slightly lower biological 
activity of the murine IL-10 purified from tobacco leaves. This could be due to little 
modifications of the IL-10 dimer structure, possibly caused by repulsion between the two 
charged histidine tails brought in proximity upon formation of the dimer. To confirm this 
assumption, however, the viral version of the cytokine bearing only the KDEL tag should 
also be generated and tested in vitro for its biological activity. Additionally, structural 
analyses of the IL-10 dimers with or without His-tag could also be performed to verify 
eventual conformational modifications between the different variants. Nevertheless, it is 
important to point out that this slightly lower biological activity of plant-derived IL-10 
compared to the commercial counterparts will have no impact on the planning of feeding 
studies since the dose of IL-10 necessary to enhance oral tolerance needs to be determined 
empirically by administering different amounts of transgenic plant material to the mice. 
As the future goal is to deliver IL-10 expressed within the plant tissue as a dietary 
supplement to NOD mice, it was critical to determine whether plant-produced IL-10 was 
resistant to gastrointestinal degradation, and whether the plant cellular matrix contributed to 
any protection against enzymes and low-pH conditions. In vitro studies with simulated 
digestive solutions are widely used as models of animal digestion to investigate the 
controlled release of experimental pharmaceuticals (Doherty et al., 1991), as well as the 
digestibility of plant and animal proteins and food additives (Zikakis et al., 1977; Tilch and 
Elias, 1984). The stability of murine and viral IL-10 produced in transgenic plants, either 
embedded in the lyophilized tobacco tissue or purified form the plant tissue, was compared 
using simulated gastric fluid (SGF) to model stomach conditions, and simulated intestinal 
fluid (SIF) for proximal small bowel conditions. Both variants of the cytokine resulted more 
resistant to gastric degradation when retained within the leaf tissue in both simulated fluids, 
indicating that the plant matrix indeed contributes to protect the recombinant proteins 
against proteolytic enzymes (Figure 36). Moreover, a slightly increased resistance to 
simulated gastrointestinal degradation was observed also for plant produced IL-10s 
compared to the commercial counterparts, which, once again, may be a result of the 
increased stability of the dimer produced in plants. In SGF experiments, the increased 
stability of IL-10 embedded in leaf tissue was especially relevant in the case of the viral 
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IL-10. Perhaps this is due to the fact that transgenic plants expressing this cytokine, but not 
the murine one, have thicker and harder leaves, among the other phenotypic abnormalities, 
which render them more resistant to degradation. Taken together, these results indicate that 
murine and viral IL-10 are protected in plant tissue. This enhanced resistance to degradation 
within the gut represents and advantage for transgenic plant delivery of IL-10 and supports 
the concept of edible vaccines, as biologically relevant amounts of recombinant protein 
could be directly delivered to the GALT using the oral administration of minimally 
processed plant material. 
 
IV.4 Deleterious effects of heterologous IL-10 expression 
 
Leaving untouched the promising results achieved in this thesis, it seems important to make 
a conclusive remark and overview of the problems associated with the expression of these 
recombinant proteins in plants. In fact, in order to succeed in establishing plants as a 
competitive platform for production of high amounts of IL-10, it is a fundamental 
prerequisite to overcome or avoid the detrimental effects caused by high accumulation 
levels of the recombinant protein. 
In this PhD work, IL-10 - be it murine or viral - has shown to be harmful, at least to some 
extent, in all subcellular compartments investigated, and the amount of recombinant protein 
sufficient to cause cell death seemed to depend on the protein localization (i.e. the different 
accumulation levels, but same phenotype, observed upon transient expression of the 
targeting constructs by agroinfiltration). Expression of IL-10 in the chloroplast was also not 
tolerated by the plant. Unfortunately, as already mentioned, it was not possible to find in the 
available literature or in the existing protein databases any evidence or indication of a 
possible interaction of neither murine nor viral IL-10 with any plant cell components.  
The highly homologous human IL-10 has been expressed in nuclear transformed tobacco 
plants (Menassa et al., 2001; Menassa et al., 2004; Patel et al., 2007). As a matter of fact, in 
their works Menassa and colleagues report extremely low accumulation levels in all the 
subcellular compartments investigated (ER, cytosol, chloroplast, mitochondrion; at the most 
0.0055% TSP in the ER) and unusually low numbers of transgenic plants regenerated and 
analyzed for each construct (from 16 to 22). In the light of the results obtained in this PhD 
work, these observations raise the doubt that high hIL-10 expressing lines could not be 
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regenerated from the in vitro cultures or that high expressing shoots have been discarded as 
unhealthy during the experimental work, transferring only the good looking – but low 
expressing – ones into soil. However, the authors deny any regeneration problems or altered 
phenotype encountered upon human IL-10 expression in tobacco (Rima Menassa, personal 
communication), and are focusing their research on proving mistargeting of the recombinant 
protein into the vacuole and its consequent degradation therein (R. Menassa et al,. PBVA 
conference 2006, poster presentation).  
Conversely, a research group at the Arkansas State University that has also performed 
nuclear stable transformation of tobacco with the sequence encoding human IL-10, 
encountered major difficulties in regenerating transgenic plants, observed a stunted 
phenotype with thick, curled leaves very similar to the one here reported for nuclear 
expression of the viral IL-10, and extremely low accumulation levels that induced them to 
abandon the project without further investigating the causes of such abnormalities (Maureen 
Dolan, personal communication).  
Intriguingly, Lothar Steidler and co-workers at the University of Cork, Ireland, who 
successfully expressed human IL-10 in Lactococcus lactis (Schotte et al., 2000; Steidler et 
al., 2000), refer that in all the other bacterial species they tested hIL-10 expression was 
lethal (Bradbury, 2003). 
The results on murine and viral IL-10 expression, together with these information on the 
human one, prompt to think that IL-10 harmfulness is indeed related to the protein itself, 
and most probably to its quaternary structure, which is highly conserved among the three 
cytokine variants. Moreover, it seems clear that IL-10 must interfere with some molecule or 
structure which is conserved among plant cells, chloroplasts and bacteria.  
To prove whether the protein itself was responsible for the observed detrimental effects, 
either the plant-derived or the commercial IL-10 were injected into tobacco leaves, but no 
alterations or necrosis of the infiltrated area could be detected (not shown). This could be 
due to the inadequate amount of protein used, or simply reflect the fact that IL-10 is only 
deleterious within the plant cell and could not enter the plasma membrane upon injection 
into the apoplast. This experiment, therefore, does not allow clear conclusions. Attempts to 
isolate a putative binding partner of IL-10 within the plant cell, performing in vivo 
cross-linking by formaldehyde infiltration of transgenic leaves and subsequently purifying 
the his-tagged IL-10 by IMAC, were also not successful (not shown). Immunoprecipitation 
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of the recombinant protein from stable transgenic or agroinfiltrated leaf extracts is another 
possibility that could be considered in the future to identify possible interacting molecules.  
Unraveling the molecular mechanisms underlying the serious adverse effects of IL-10 seems 
to be the basic requirement to develop future strategies to achieve satisfactory accumulation 
levels of IL-10 in various expression systems. 
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V CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
Taken together, the results presented in this thesis clearly demonstrate that tobacco plants 
can express the viral and murine IL-10 genes, and correctly process and assemble the 
corresponding proteins into functional, biologically-active dimers.  
Further strategies could be employed to boost accumulation of mIL-10 avoiding its 
detrimental effects, e.g. exploiting sequences for the accumulation and sequestration in oil 
or protein bodies, or through the co-expression of shielding molecules (Patel et al., 2007). In 
the case of vIL-10, as already mentioned, generation of stable transgenic plants with the 
transgene under the control of inducible promoters would allow expression in a target tissue 
only following a specific treatment, such as chemical spraying, restricting recombinant 
protein accumulation to a fine timeframe to limit detrimental effects on plant growth and 
perhaps leading to higher vIL-10 yields (Streatfield, 2007). Nevertheless, it has to be 
pointed out that the yields of both recombinant proteins in tobacco plants generated during 
this work are already high enough to allow delivery to mice of an immunologically relevant 
dose of IL-10 in a reasonable amount of leaf material, without the need of extensive 
purification. In fact, on the basis of comparable feeding experiments (Ma et al., 2004), 2-10 
µg of IL-10 per day should be sufficient to elicit immunomodulatory effects; this would 
require the administration of a few milligrams of lyophilized plant tissue, which could be 
ingested by a mouse without substantially interfering with its dietary needs and should be 
well tolerated by the animals (Menassa et al., 2007). Additionally, in simulated digestion 
experiments, it was demonstrated that IL-10 is protected in the plant tissue, as the plant 
cellular matrix confers resistance to degradation within the gut. This represents a great 
advantage for transgenic plant delivery of IL-10, and underlines the suitability of exploiting 
tobacco as production platform for IL-10 aimed at oral administration.  
The use of tobacco as expression system for heterologous proteins aimed at oral 
administration may raise concerns related to the fact that it is not an edible plant. As a 
matter of fact, the common practice for oral delivery of recombinant antigens produced in 
tobacco is their purification and administration by gastric intubation. Certainly, if the 
proof-of-concept in the NOD mice will be demonstrated and oral delivery of IL-10 will be 
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confirmed as a promising strategy to enhance oral tolerance to co-fed antigens, it will be 
necessary to consider edible plants as expression systems for the production of this cytokine 
in order to further proceed with the studies and, eventually, with the clinical trials. However, 
for our purposes, delivery of unprocessed tobacco leaf material to mice does not represent a 
limitation.  
Therefore, this work paves the way to performing feeding studies in animal models of 
autoimmune diseases to comparatively evaluate the effectiveness of the viral and murine 
IL-10 as immunomodulators. In particular, it will allow to determine whether simultaneous 
feeding of NOD mice with plant material containing GAD65 and IL-10 could reduce the 
amount of auto-antigen necessary to prevent the onset of T1DM. 
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VI SUMMARY 
 
 
Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine, with therapeutic applications 
in several autoimmune and inflammatory diseases. Oral administration of this cytokine, 
alone or in combination with disease-associated autoantigens, could confer protection form 
the onset of a specific autoimmune disease through the induction of oral tolerance.  
Transgenic plants are attractive systems for production of therapeutic proteins because of 
the ability to do large scale-up at low cost, and the low maintenance requirements. They are 
highly amenable to oral administration and could become effective delivery systems without 
extensive protein purification.  
The ability of tobacco plants to produce high levels of biologically-active viral and murine 
IL-10 was investigated. To reach high accumulation levels of the transgenes, plastid 
transformation of the IL-10 genes as well as different targeting strategies of the nuclear 
encoded recombinant proteins were investigated. Chloroplast transformation turned out not 
to be a feasible approach for the recombinant production of IL-10, as unsatisfactory 
accumulation levels were obtained upon expression of both transgenes. 
For tobacco nuclear transformation, three different subcellular targeting strategies, directing 
the recombinant protein into the endoplasmic reticulum (ER), cytosol and apoplast, were 
first assessed in transient expression experiments, and stable transgenic plants were then 
generated with the constructs that yielded the highest accumulation levels by targeting the 
recombinant proteins to the ER. The recombinant proteins were purified from transgenic 
leaf material and characterized in terms of their N-glycan composition, dimerization, 
stability and biological activity in in vitro assays. Both molecules formed stable dimers, 
were able to activate the IL-10 signaling pathway and to induce specific anti-inflammatory 
responses in mouse J774 macrophage cells. 
It was therefore demonstrated that tobacco plants are able to correctly process viral and 
murine IL-10 into biologically active dimers, representing a suitable platform for the 
production for these cytokines. The accumulation levels obtained are high enough to allow 
delivery of an immunologically relevant dose of IL-10 in a reasonable amount of leaf 
material, without extensive purification. This study paves the way to performing feeding 
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studies in mouse models of autoimmune diseases, that will allow evaluation of the 
immunomodulatory properties and effectiveness of the viral and murine IL-10 in inducing 
oral tolerance. 
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RIASSUNTO 
 
 
L’interleuchina-10 (IL-10) e’ una citochina immunosoppressiva con potenziale applicazione 
terapeutica in diverse malattie autoimmuni e infiammatorie. La somministrazione orale di 
questa citochina, da sola o in combinazione con autoantigeni associati alla malattia, 
potrebbe conferire protezione dall’insorgenza di specifiche malattie autoimmuni attraverso 
l’induzione di tolleranza orale. 
Un valido sistema alternativo per la produzione di proteine ricombinanti di interesse 
farmaceutico è rappresentato dalle piante transgeniche, data la possibilità di estendere la 
produzione su larga scala a bassi costi, e i minimi requisiti che richiedono per il loro 
mantenimento. Le piante, inoltre, possono essere assunte direttamente come alimento e 
potrebbero diventare esse stesse veicoli per la somministrazione delle proteine ricombinanti 
eliminando la necessità di purificarle. 
Ci si è proposti di valutare se le piante di tabacco fossero in grado di produrre alti livelli di 
IL-10 virale e murina biologicamente attiva. Per ottenere alti livelli di espressione dei 
transgeni, sono state effettuate sia la trasformazione dei plastidi, sia la trasformazione 
nucleare, valutando diverse strategie di localizzazione delle proteine ricombinanti. La 
trasformazione dei cloroplasti è risultato un approccio non attuabile per la produzione di 
IL-10 virale o murina ricombinante, in quanto i livelli di accumulo sono risultati 
decisamente insoddisfacenti per entrambi i transgeni. 
Invece, per quanto riguarda la trasformazione nucleare, sono state valutate tre diverse 
strategie di localizzazione sub-cellulare, per dirigere la proteina ricombinante nel reticolo 
endoplasmico (RE), nel citosol e nell’apoplasto, dapprima in esperimenti di espressione 
transiente e, successivamente, sono state generate piante transgeniche stabili con il costrutto 
che aveva fornito i più alti livelli di accumulo indirizzando la proteina nel RE. Le proteine 
ricombinanti sono state purificate da materiale fogliare transgenico e sono state 
caratterizzate rispetto alla composizione degli N-glicani, alla dimerizzazione, alla loro 
stabilità e attività biologica in saggi in vitro. Entrambe le molecole prodotte in pianta 
formano dimeri stabili, e sono in grado di attivare la cascata di trasduzione del segnale di 
IL-10 e di indurre risposte anti-infiammatorie specifiche nella linea cellulare di macrofagi 
murini J774. 
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E’ stato dimostrato che le piante di tabacco sono in grado di processare correttamente 
l’IL-10 virale e murina in dimeri biologicamente attivi, e che quindi rappresentano una 
valida piattaforma per la produzione di queste citochine. Inoltre, i livelli di accumulo 
ottenuti sono sufficientemente elevati da permettere di somministrare una dose 
immunologicamente rilevante di IL-10 in una ragionevole quantità di materiale fogliare, 
senza richiedere laboriose purificazioni. 
Questo lavoro apre la strada alla realizzazione di studi di somministrazione orale in modelli 
murini di malattie autoimmuni, che permetteranno di effettuare una valutazione comparativa 
delle proprietà immunomodulatorie nonché dell’efficacia delle IL-10 virale e murina 
nell’indurre tolleranza orale. 
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